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Stroke is an important public health problem worldwide. It is a non-communicable disease of 
increasing importance in the ageing population. There are four major types of stroke: a) 
ischaemic stroke, b) primary intracerebral haemorrhage, c) subarachnoid haemorrhage and d) 
undetermined stroke (no computed tomography [CT], magnetic resonance imaging [MRI], 
autopsy or cerebral angiography). 
The risk factors and fatalities for stroke vary worldwide and stroke accounts for about 
9.7% of all deaths worldwide. Unfortunately, most stroke deaths occur in the less developed 
countries, where stroke research is scanty. Patients who survive stroke will have a wide range 
of functional limitations that affect their daily activities.  
To date, only few reliable data are available for identifying the risk factors and 
understanding the stroke fatalities in the low- and middle-income countries. The effect of 
stroke on daily activities is also understudied. Measuring the effect of stroke on daily activities 
is important to evaluate the recovery process. Understanding the factors affecting daily 




In this thesis, I have worked on the questions that will improve my knowledge and 
understanding of the natural history of stroke in the state of Kelantan, Malaysia. In this study, 
we posed questions to subjects from the population of interest to reflect our results across 
the greater Kelantan population to develop a model of risk factors for stroke, models of case-
fatalities and survival to compare the characteristics and outcomes of two main types of 
stroke, i.e. ischaemic stroke and haemorrhagic stroke, and lastly to assess the longitudinal 
change in functional health status using the Barthel Index post-stroke. 
This thesis includes four draft papers, in which several modelling data collection and 
data analysis strategies were applied to four datasets: one was provided by the hospitals, two 
were extracted by us and the final one was based on personal interviews with stroke survivors. 
The first draft paper is based on an observational study using data from the records 
offices of two major hospitals in Kelantan. In this paper, I analysed and modelled the risk 
factors for stroke using a case–control study design. This dataset contained individual-level 
variables (patient variables from hospitals) and area-level variables supplied by the 
Department of Statistics, Malaysia, and we utilised logistic regression to model the risk factors 
for stroke. In the results, we showed the non-linear relationship between age and odds for 
stroke and the interaction of age with sex in the model.  
In the second draft paper, we explored the important prognostic factors for in-hospital 
stroke fatalities. Using Cox proportional hazard regression, we found that the only two 
independent prognostic factors for stroke fatality in the hospitals were: a) stroke subtype and 
b) age. 
To further investigate the different prognostic effect of stroke subtype on admission 
and on fatality, we recruited consecutive in-hospital stroke patients. In the analysis, we 
performed Cox proportional hazard regression to quantify the odds of stroke fatality for: a) 
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ischaemic stroke and b) haemorrhagic stroke. In this third draft paper, we showed the 
prognostic effect of stroke subtype on stroke fatality.  
In the fourth draft paper, we recruited stroke patients and interviewed them on three 
occasions. In this longitudinal assessment, we assessed the functional health status of stroke 
patients until 3 months after hospital discharge. I conducted all interviews and assessed the 
functional outcome using the well-known Barthel Index. Considering the longitudinal format 
of the data, we used the linear mixed effect model to model the rate of change of the Barthel 
Index at the three measurement occasions. 
We have identified several limitations in this PhD project and have taken several 
measures to minimize the biases caused by those limitations. The limitations include the need 
for us to do handsearching for data abstraction, potential informative censoring due to our 
study design and short follow-up times, limited generalizability of results, small sample sizes, 
missing observations, missing important variables (to be modelled as covariates), absence of 
residential coordinates and using data on arrival to Emergency department (no pre-arrival 
data). If the censoring mechanism provides significant information with time (T), numerical 
estimates from Kaplan-Meier and Cox proportional hazard regression are biased.   
The new knowledge stemming from the stroke modelling and outcome assessment 
developed and analysed in this thesis could help improve our understanding of stroke in 
Kelantan. The thesis will also improve our understanding and knowledge of the natural history 
of the disease, i.e. the progression from risk factors to outcome (fatality or functional 
residuals) after stroke. In conclusion, our data and the four draft papers written based on this 
PhD project have added new stroke data and knowledge on the progression of stroke, which 
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Chapter 1  Introduction 
In this chapter, I begin by introducing stroke as an important public health problem and give 
the definition of stroke. Next, I classify stroke and describe stroke according to the World 
Health Organisation (WHO) International Classification of Diseases 10th Revision (ICD-10). 
Following that, I describe the epidemiology of stroke, globally and regionally, including in 
Malaysia. Next, I discuss the common risk factors and the outcomes after stroke, which all 
motivated this work. In the following four sections, I outline the foundations of the 
epidemiological and statistical methods I have applied in my study. These foundations include 
the modelling of binary outcome, time-to-event outcome and longitudinal data. I also briefly 
discuss important issues in model building in epidemiology such as the presence of 
confounders, interaction and the choice of functional form for numerical covariates. Finally, I 
present a summary of the thesis, including 4 draft papers planned for submission stemming 
from this work. 
1.1 Stroke as a public health problem  
Cardiovascular diseases are important public health problems in the 21st century. This is largely 
due to an epidemiological phenomenon known as epidemiologic transition. In epidemiologic 
transition, the process of disease transition in the population from a population infected with 
largely infectious diseases (communicable) to a population burdened with non-infectious 
(non-communicable) diseases takes place (Omran, 1971, Omran, 1983, Omran, 2005, Gaziano, 
2010). Due to epidemiologic transition, countries in Southeast Asia (SEA), including Malaysia, 
previously known for their communicable diseases, are now facing an epidemic of non-
communicable diseases (Dans et al., 2011).  
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Due to falling fertility rates and prolonged life expectancy, the number of people aged 
65 or older is projected to grow to 1.5 billion in 2050, with most of the increase in developing 
countries. This aging, as well as diet and changes in lifestyle, drive the  rise in chronic non-
communicable diseases in today’s developing countries (World Health Organization, 2011a). 
Non-communicable diseases, also known as chronic diseases, affect the low- and 
middle-income countries disproportionately. Of all non-communicable diseases, 
cardiovascular diseases account for most non-communicable deaths. With more than 150 
known causes, stroke is an example of a heterogeneous cardiovascular disease (Amarenco et 
al., 2009){Amarenco, 2009 #554} which causes major morbidity and mortality in both the 
developed and developing countries (Lindley, 2008, Venketasubramanian and Chen, 2008, 
Venketasubramanian et al., 2015, Liu et al., 2001, Thorvaldsen et al., 1997, Feigin et al., 2003, 
Feigin, 2007, Feigin et al., 2009, Feigin et al., 2014, Krishnamurthi et al., 2014) . 
Based on the WHO data, it was estimated that there were 15.3 million strokes 
worldwide in 2002, causing 10% (5.5 million) of deaths in the same year (Johnston et al., 2009). 
In the developed countries, stroke is the third most common cause of death after heart disease 
and cancer (Lindley, 2008). However, more stroke deaths (85%) occur in the low- and middle-
income countries (Lopez et al., 2006).  
The Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) also 
provides estimates for difference disease burden including stroke. GBD 2010 searched 
databases including Medline, Embase, Scopus, Pubmed and many others to estimate the 
global and regional burden of stroke during 1990 and 2010. GBD 2010 used an analytical 
technique (DisMod-MR) to calculate these estimates: stroke incidence, prevalence, mortality 
and disability-adjusted life-years (DALYs) lost by age group and country income level (high-
income and low-income and middle-income) for 1990, 2005, and 2010 (Krishnamurthi et al., 
2014, Feigin et al., 2014, Krishnamurthi et al., 2013). Unfortunately, there were limited data 
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sources with questionable quality from low-income and middle-income countries (Fuentes 
and Tejedor, 2014, Feigin et al., 2014). Of 14 of 61 articles or 23% (that provided data to GBD 
2010) were rated as high-quality (Fuentes and Tejedor, 2014).  
GBD 2010 shows that the stroke mortality has increased in the low- to middle-income 
countries (Feigin et al., 2014) but has not been shown as such: based on a review of 56 
population-based studies, stroke case–fatality only differed by −0.6% between 1980 and 2008 
in the low- to middle-income countries (Feigin et al., 2009). Among those who have survived 
stroke, disabilities such as limb weakness, spasticity, pain, psychological issues, language 
impairment and functional limitations set in, and are frequently profound (Norrving and 
Kissela, 2013). 
This thesis reports on stroke research in Malaysia, and we impress on the reader how 
more stroke studies must be done in Malaysia. The reasons are: a) the great impact of stroke 
in the low- to middle-income countries such as Malaysia, b) lack of Malaysian stroke data 
(Malaysia is categorised as a country with moderate epidemiological data (Asian Acute Stroke 
Advisory Panel., 2000), and c) the need to improve understanding of stroke risk factors and 
outcome to help in stroke prevention and treatment (Johnston et al., 2009). 
1.2 Definition of stroke 
Stroke is defined as: a clinical syndrome which is characterised by ‘rapidly developing clinical 
symptoms and/or signs of focal, and at times global (applied to patients in deep coma and 
those with subarachnoid haemorrhage), loss of cerebral function, with symptoms lasting more 
than 24 hours or leading to death, with no apparent cause other than that of vascular origin’ 
(Lindley, 2008, Hatano, 1976, O'Donnell et al., 2010a, World Health Organization, 2014). 
Stroke is also known as ‘brain attack’ (Lindley, 2008) or ‘cerebrovascular accidents’ (Adams, 
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2007), which indicate that the major pathological events in stroke occur in the first 24 hours 
(Lindley, 2008). 
The definition excludes transient ischaemic attacks and stroke-mimicking symptoms 
secondary to trauma, shock and hypertensive encephalopathies (World Health Organization, 
2014). Given the non-adherence to the definition, transient episodes of cerebral ischaemia 
(less than 24 hours) and cerebrovascular lesions discovered at autopsy without having shown 
clinical manifestations before death are not registered as stroke (Hatano, 1976, Good, 1990). 
The definition implies that stroke is a clinical diagnosis—without the need for imaging—but 
with the wider availability of brain imaging methods, radiological diagnosis is almost always 
requested by clinicians to help ascertain the final diagnosis of stroke. 
1.3 Classification of stroke  
Early studies required necropsy results to confirm the diagnosis and classification of stroke. 
With the advancement of brain imaging methods such as computed tomography (CT) scan, 
magnetic resonance imaging (MRI), MR angiography (MRA) and CT angiography (CTA), it has 
become possible to classify stroke in living patients and so to an extent identify the type of 
vascular lesion, location in the brain, stroke mechanism and stroke outcome (Caplan, 2011). 
Generally, clinicians and stroke scientists categorise stroke into four major types: a) 
ischaemic stroke, b) primary intracerebral haemorrhage (PICH), c) subarachnoid haemorrhage 
(SAH) and d) undetermined stroke (Feigin et al., 2003). This rather crude classification is still 
being used in daily clinical practice in our setting in Malaysia. 
The primary distinction between stroke types almost always requires clinical 
assessment and neuroimaging (CT or MRI) (O'Donnell et al., 2010a, Caplan, 2011). The 
distinction—stroke subtype classification—is useful in: a) daily clinical practice, and b) 
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epidemiological and genetic studies, and should be able to classify (at least): a) ischaemic 
stroke (IS), b) haemorrhagic stroke (HS) and c) subarachnoid haemorrhage (SAH) (Amarenco 
et al., 2009). The classification for stroke also needs to be reliable (Department of Statistics, 
2015). 
1.3.1 Ischaemic stroke (IS) 
Ischaemic stroke is the most common type of stroke (Shiber et al., 2010, Feigin et al., 2014, 
Feigin et al., 2003, Feigin et al., 2009). In ischaemic stroke, blood supply to the brain diminishes 
mainly due to one of these medical conditions: a) atherosclerosis (80% of ischemic stroke), b) 
stenosis of the small intracranial arteries, c) emboli from the heart or d) haematological 
causes, dysplasia or vasculitis (less common causes) (Good, 1990, Lindley, 2008). 
In atherosclerosis, the atherosclerotic process activates platelet activation, which then 
forms a clot. This clot—a thrombi or emboli—develops in situ but some pieces of the clot may 
break away then migrate to the brain through a process known as embolization (Adams, 
2007). Such a clot can occlude the small blood vessels, causing hypoxia (lack of oxygen). If this 
clot occurs in the brain, the oxygen-deprived brain tissue dies—a process known as cerebral 
infarction—and a patient with this condition will show the signs and symptoms of stroke. 
CT scan images remains the mainstay of imaging in acute stroke and ischaemic stroke; 
CT scans show the hyperdense segment of a vessel, loss of grey–white matter differentiation 




Figure 1-1 Signs of cerebral ischaemic on CT images. Hypo-attenuation of brain tissue is due 
to the increased brain water content inside the brain. Swelling of the gyri is due to the brain 
oedema. Hyperdense middle-cerebral artery (MCA) sign is a result of thrombus or embolus 
in the MCA. Blurred basal ganglia in MCA infarct and in insular ribbon sign refers to 
hypodensity and swelling of the insular cortex (Ahmed Abd Rabou and Frank Gallard, 2012). 
 
1.3.2 Haemorrhagic stroke (HS) 
In haemorrhagic stroke, a blood vessel ruptures and bleeds into the brain, the spinal cord or 
the adjacent structures, causing cell damage in the surrounding area (Torpy et al., 2010, 
Bernardini and DeShaies, 2001). Haemorrhagic stroke more often leads to a worse outcome 
than ischaemic stroke (Trevor and Fedi, 2013, Bernardini and DeShaies, 2001) because the 
bleeding inside the brain (haemorrhage) can progress for several hours with expansion of the 
haematoma (blood clot) (Adams, 2007, Brott et al., 1997, Kazui et al., 1996). This accumulation 
of blood inside a confined area, in this case, the brain, causes neuronal injury via hypo-
perfusion and ischaemia in the adjacent areas in the brain. Eventually, neuronal death occurs 
as a result of apoptotic (normal cell deaths) and necrotic (cell deaths due to injury) events and 
oedema (swelling) due to the accumulation of proteins within the clot, and as well as 
7 
 
disruption of the blood–brain barrier secondary to ischaemia (Adams, 2007, Kazui et al., 1996, 
Qureshi et al., 2001). 
The three common subtypes of haemorrhagic stroke are: a) Primary intra-cerebral 
haemorrhage (PICH), b) Subarachnoid haemorrhage (SAH) and c) other intracranial 
haemorrhage such as extradural or subdural haemorrhage (Krishnamurthi et al., 2014, 
Bernardini and DeShaies, 2001). 
1.3.2.1 Primary intracerebral haemorrhage (PICH)  
In PICH, haemorrhagic stroke is caused by an arterial blood vessel in the brain that leaks or 
bursts (Lindley, 2008, Bernardini and DeShaies, 2001, Trevor and Fedi, 2013). In PICH, the 
bleeding from the artery spreads along the planes of white matter, leaving areas of intact 
neural tissues surrounding the haematoma (Adams, 2007, Qureshi et al., 2001). 
1.3.2.2 Subarachnoid haemorrhage (SAH)  
With SAH, bleeding occurs primarily in the subarachnoid space and the clinical hallmark is a 
history of severe and sudden headaches (van Gijn and Rinkel, 2001). In SAH, CT scanning is the 
first line of investigation, and SAH is characterised by the hyperdense appearance of the 
extravasated blood (van Gijn and Rinkel, 2001). Localised clots also form as a result of the 
trabeculations of tissue between the innermost pia and the arachnoid layers of the 
meninges (Adams, 2007). SAH may be pure subarachnoid bleeding though it may also arise 




Figure 1-2 (a) Non-contrast CT brain and (b) MRI brain of a patient with a basal ganglia 
haemorrhage. This location is typical for a hypertensive intracerebral haemorrhage (ICH). (c) 
Non-contrast CT brain of a different patient demonstrating a large, acute left parietal intra-
parenchymal ICH. The location and appearance of the lesion is suggestive of amyloid 
angiopathy. (d) CT brain of another patient, showing the classic appearance of a 






Figure 1-3 Subarachnoid haemorrhage (SAH) on CT images. CT scan is the first line of 
investigation for haemorrhagic stroke. This image shows positive sign for hyperdense 
appearance of extravasated blood in the basal cistern. False positive SAH could be due to 
generalized brain oedema. In this figure, sedimentation in the left occipital horn is the only 
positive finding (van Gijn and Rinkel, 2001). 
 
 
Figure 1-4 Subarachnoid haemorrhage (SAH) on CT images appears as a high-attenuating, 
amorphous substance that fills the normally dark, CSF-filled subarachnoid spaces around the 
brain, appear white in acute haemorrhage, most evident in the largest subarachnoid spaces, 





1.3.2.3 Other types of haemorrhagic stroke  
Other types of haemorrhagic stroke include: a) extradural haemorrhage and b) subdural 
haemorrhage.  
 
Figure 1-5 Extradural haemorrhage on CT scan images (Hacking and Gaillard, 2012b). 
 





1.4 Coding of stroke  
the International Statistical Classification of Diseases and Related Health Problems, 10th 
revision (ICD-10) is the global health information standard for mortality and morbidity 
statistics of all diseases (World Health Organization, 2012, World Health Organization, 2011b). 
It facilitates the storage, retrieval, analysis and interpretation of health data and their 
comparison among the member states (World Health Organization, 2010). 
The ICD-10 is the most widely used nosology (systematic classification of diseases). In 
a clinical setting, trained medical coders code diagnoses according to the ICD-10 using a 
computerised software programme (called ‘a grouper’) (O'Malley et al., 2005). It has been 
proven useful in the coding of stroke (Kokotailo and Hill, 2005). 
The ICD-10 places stroke in Chapter IX inside Blocks I60–I69 (the cerebrovascular 
diseases blocks). Blocks I60–I69 contain more detailed codes for cerebrovascular diseases 
(stroke): a) Block I60 for SAH, b) Block I61 for intracerebral haemorrhage, c) Block I62 for other 
non-traumatic intracranial haemorrhage, d) Block I63 for cerebral infarction, e) Block I64 for 
stroke (not specified as haemorrhagic or infarction), f) Block I65 for occlusion and stenosis of 
precerebral arteries, not resulting in cerebral infarction, g) Block I66 for occlusion and stenosis 
of cerebral arteries, not resulting in cerebral infarction, h) Block I67 for other cerebrovascular 
diseases, i) Block I68 for cerebrovascular disorders in diseases classified elsewhere, and j) Block 
I69 for sequelae of cerebrovascular disease (World Health Organization, 2015). 
The ICD-10 shows good coverage, with the percentage of correct coding ranging 
between 91% and 100% depending on stroke subtype. The limitations of ICD-10 include 
generalisation of results and misinterpretation of doctors’ clinical diagnosis by the coders 
(Kokotailo and Hill, 2005). A validation study supported the use of routinely collected 
administrative data like ICD-10 for stroke diagnosis in a clinical setting (Aboa-Eboule et al., 
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2013) provided the coding is restricted to acute stroke diagnosis. This is because in acute 
stroke setting, the incidence estimate based on the ICD shows close agreement with the true 
stroke incidence rate using a stroke register (Ellekjaer et al., 1999). 
1.5 Epidemiology of stroke 
In the 21st century, the importance of public health diseases such as cardiovascular disease, 
including stroke, have increased for a number of reasons, including: a) the decline of the 
worldwide scourge of infectious disease, b) better public health programmes that have 
improved health surveillance and c) economic advances that have led to increased life 
expectancy (Adams, 2007). 
Although there has been a 42% decrease in stroke incidence in the high-income 
countries, stroke incidence in the low- to middle-income countries has increased by more than 
100% (Feigin et al., 2009). The trend is generalised because studies suggest that the 
geographical variations in stroke incidence and prevalence are small (Feigin et al., 2003). While 
the geographical variation of stroke incidence is small worldwide, the burden of stroke shows 
larger geographical variation (Feigin et al., 2014, Krishnamurthi et al., 2014). Unfortunately, 
most stroke burden is carried by the low- to middle-income countries (Feigin et al., 2014) and 
the less developed countries (Norrving and Kissela, 2013). In addition, the early stroke case–
fatality rate in the low- to middle-income countries (in 2000–2008) was 25% higher than that 
in the high-income countries (Feigin et al., 2009). 
Despite the alarming threat of stroke as a major public health problem in Asia, stroke 
epidemiology is not well studied in this region. In Asia, only a few countries such as China, 
Taiwan and Japan are actively engaged in stroke studies (Burke and Venketasubramanian, 
2006). There was a call for more studies on stroke prevalence especially: a) with a study design 
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that utilises door-to-door surveying, b) with a focus on people aged over 85 years old, and c) 
on the verification of stroke type and mortality data (Feigin et al., 2003, Feigin et al., 2014). 
Table 1-1 The International Classification of Disease 10th Revision (ICD-10), Chapter IX 
(Diseases of circulatory system), Blocks I60-I69 (Cerebrovascular diseases). 
Block Stroke subtypes  
I60 Subarachnoid haemorrhage 
I61 Intracerebral haemorrhage 
I62 Other non-traumatic intracranial haemorrhage, 
Subdural haemorrhage (acute) (non-traumatic), 
Non-traumatic extradural haemorrhage 
I63 Cerebral infarction 
I64 Stroke, not specified as haemorrhage or infarction 
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral 
infarction 
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral 
infarction 
I67 Other cerebrovascular diseases 
I68 Cerebrovascular disorders in diseases classified elsewhere 
I69 Sequelae of cerebrovascular disease 
Source: (World Health Organization, 2015) 
1.5.1 Incidence, prevalence and burden for stroke 
The current incidence and prevalence of stroke has led people to describe the situation as an 
epidemic (deVeber, 2003). A review of 56 population-based studies from 28 countries showed 
noticeable variation in the crude and age-adjusted stroke incidence (Feigin et al., 2009). 
Among the high-income countries, the total crude incidence rate (per 100,000 person–years) 
ranged from 125 to 460 in 1970–1979, 156 to 466 in 1980–1989, 131 to 451 in 1990–1999 and 
112 to 223 in 2000–2008. Among the low- to middle-income countries, the total crude 
incidence rate for stroke was 15–50 per 100,000 population in 1970–1979; 202–217 per 
100,000 population in 1980–1989; 167–281 per 100,000 population in 1990–1999 and 73–165 
per 100,000 population in 2000–2008 (Feigin et al., 2009). 
Between 1990 and 2010, the overall age-standardised stroke incidence in the low- and 
middle-income countries increased by 12% (from -3% to 22%) but the mortality rates for all 
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stoke types decreased significantly at 20% (from 15% to 30%) (Feigin et al., 2014). In the high-
income countries, the age-adjusted stroke incidence rates decreased by 42% from 1970 to 
2008 (from 163 per 100,000 person–years in 1970–1979 to 94 per 100,000 person–years in 
2000–2008) (Feigin et al., 2009). The estimated age-adjusted incidence rate in 2010 was 138.9 
per 100,000 person–years in the high-income countries and 182.6 per 100,000 person–years 
in the low- and middle-income countries (Feigin et al., 2014). Studies from 61 low-income and 
middle-income countries have shown that between 1990 and 2010, the incidence of 
haemorrhagic stroke and ischaemic stroke saw a significant increase of 22% (from 5% to 30%) 
and a non-significant increase of 6% (from -7% to 18%), respectively (Krishnamurthi et al., 
2013). 
Overall, the prevalence rates of stroke are about 10 per 1000 population, which 
corresponds to about 50 per 1000 population in those over 65 years of age and it is expected 
that a third of these will die from stroke (Lindley, 2008). In the high-income countries, the 
prevalence of stroke (per 100,000 population) was 411.3, 504.0 and 534.8 in 1990, 2005 and 
2010, respectively (Feigin et al., 2014). In the low- and middle-income countries, the 
prevalence of stroke (per 100,000 population) was 278.0, 296.0 and 300.0 in 1990, 2005 and 
2010, respectively (Feigin et al., 2014). 
Globally, the WHO has estimated that in 2001, death from stroke in the low- and 
middle-income countries accounted for 85.5% of stroke deaths worldwide, and the disability-
adjusted life years (DALYs) lost in those countries was almost seven times that of the high-
income countries (Mathers et al., 2006). 
GBD 2010 reported that between 1990 and 2010, the mortality rates for ischaemic 
stroke fell by 14% (from 9% to 19%) and that for haemorrhagic stroke was reduced by 23% 




Stroke is also the primary cause of death in China and other countries in Eastern 
Asia (Adams, 2007, Asplund, 1996, Kubo et al., 2003, Stegmayr et al., 2000). The Asian 
populations have higher stroke mortality than the Western populations (Hata and Kiyohara, 
2013, Ueshima et al., 2008). 
Among the Asian countries, Japan has the lowest stroke mortality, similar to that in 
the Western countries, with age-adjusted rates of stroke mortality of less than 50 per 100,000 
person–years, while in Malaysia, the estimated stroke mortality rate is between 50 and 100 
deaths per 100,000 person–years (Hata and Kiyohara, 2013, Ueshima et al., 2008). 
1.5.2 Proportional frequency of stroke types 
A review of 15 population-based studies (mostly in the developed countries) between 1966 
and 2002 showed that the proportional frequency of stroke types was as follows: 67.3% to 
80.5% of strokes were ischaemic, 6.5% to19.6% were PICH, 0.8% to 7.0% were SAH and 2.0% 
to14.5% were undefined (undetermined) (Feigin et al., 2003). 
A later review based on 56 population-based studies among the high-income 
countries (2000–2008), the proportion of ischaemic stroke ranged from 73% to 90%, while 
that for PICH and SAH ranged from 9% to 13% and from 1% to 6%, respectively (Feigin et al., 
2009). The review also found that between 2000 and 2008, among the low- to middle-income 
countries, the proportion of ischaemic stroke, PICH and SAH ranged from 54% to 85%, from 
14% to 27% and from 5% to 10%, respectively (Feigin et al., 2009). The ratio of cerebral 
infarction to cerebral haemorrhage was approximately 2:1 to 3:1 in East Asian countries 
whereas it is 5:1 to 10:1 in the Western countries (Ueshima et al., 2008). 
Among high-income countries over there decades (1970 to 2008), the pooled 
proportional frequency of stroke subtypes has only slightly changed: ischaemic stroke was 74% 
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(1980 to 1989), 77% (1990 to 1999) and 82% (2000 to 2008) and the frequencies for PICH was 
9%, 13% and 11%, respectively (Feigin et al., 2009). Data for low-income and middle-income 
countries were only available for 2000 to 2008 and it showed that the proportional frequency 
for ischaemic stroke was lower in low-income to middle-income countries than in high income 
countries (67% and 82%, respectively) but the frequencies for PICH and SAH were twice the 
frequencies in high-income countries for the same decade (Feigin et al., 2009).  
In countries where there has been an increase in the proportional frequencies for 
haemorrhagic stroke, this was largely the result of an increase in the prevalence of risk factors 
such as raised blood pressure and smoking (Feigin et al., 2009, Tosteson et al., 1990, Mensah, 
2008). Other contributing factors include an increase in the prevalence of hypertension and 
chronic hepatic disease. It is also the case that clinical measures to diagnose and combat 
stroke, such as the , use of anti-coagulation therapy and the increase use of CT scans which 
enables earlier detection (by better detection of intracranial bleeding), contribute for the 
increase in the proportion of haemorrhagic strokes (O'Donnell et al., 2010a, O'Donnell et al., 
2010b, Shiber et al., 2010). The situations in India, Pakistan, Bangladesh and Indonesia suggest 
that with the increase of uncontrolled hypertension, the percentage of haemorrhagic stroke 
is high (19% to 46%) (Kim, 2014). Unfortunately, many countries especially in the low-income 
and middle-income countries do not have previous data on stroke subtypes to enable 
researchers to look for the change in trend of the proportional frequencies for stroke.  
1.5.2.1 Proportional frequency for ischaemic stroke (IS)  
Generally, the proportion of all strokes that are ischaemic is higher among the high-income 
countries than among the low- to middle-income countries (Feigin et al., 2009). Among 
patients with ischaemic stroke, a large proportion of patients in the Western population has 
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extracranial large artery embolism while small vessel occlusion or intracranial atherosclerosis 
are more common in the Asian populations (Department of Statistics, 2015). 
Ischaemic stroke comprised 51.4% and 62.4% of all stroke cases in Okinawa and China, 
respectively (Burke and Venketasubramanian, 2006), and in India, 83.9% of first-ever stroke 
patients were classified as ischaemic stroke (Sridharan et al., 2009). A recent study showed 
that in the Korean population, the proportion of ischaemic stroke in comparison to 
haemorrhagic stroke increased from 64.7% to 76.1% over the span of a few years (Hong et al., 
2013). In Malaysia, ischaemic stroke comprised 56.3% of all strokes (Jaya et al., 2002). 
1.5.2.2 Proportional frequency for haemorrhagic stroke (HS) 
PICH and SAH account for 10% to 27% of all stroke worldwide, respectively (Feigin et al., 2009). 
These estimates however vary with time and geographical area. For example, an earlier review 
of population studies worldwide showed that the proportional frequency of subarachnoid 
haemorrhagic stroke was between 1% and 7% of all stroke (Feigin et al., 2003). 
The proportion of haemorrhagic stroke in the Asian populations is higher than that in 
others. For example, a study in Korea showed that in 2000, the proportion of patients with 
haemorrhagic stroke was 35.3% (Hong et al., 2013). In Okinawa, Japan, and in China, the 
proportions of patients with SAH were 9.3% and 1.8% (of all stroke), respectively (Burke and 
Venketasubramanian, 2006). In India, 10.6% of patients with stroke had intracerebral 
haemorrhage (ICH) and 5.5% had SAH (Sridharan et al., 2009). 
The scenario in Malaysia shows that from a hospital-based study in Kelantan, 
haemorrhagic stroke comprised 32.9% and subarachnoid haemorrhagic stroke comprised 




1.5.3 Stroke trends 
Between 1990 and 2010, the age-standardised incidence of stroke significantly decreased in 
the high-income countries but increased though non-significantly (by 12%). Between 1990–
2010, mortality rates decreased significantly in both the high-income (37%) and low- and 
middle-income countries (-20%) but the overall global burden of stroke was still great and 
increasing (Feigin et al., 2014). 
Most of the burden of stroke falls on the low- and middle-income countries 
(Krishnamurthi et al., 2013), with the countries in the South-East Asia (SEA) region having the 
highest stroke incidence and mortality rates (Krishnamurthi et al., 2014). 
In countries such as Japan, where stroke incidence is decreasing, the attributing 
factors could be: a) improvement in blood pressure management in hypertensive 
respondents, and b) reduction in the rate of smoking. Unfortunately, the decrease has slowed 
from 1998 to 2000, possibly due to a steep increase in metabolic risk factors and inadequate 
blood pressure reduction (Kubo et al., 2003, Hata and Kiyohara, 2013). 
With regards to stroke mortality, in stroke referral centres recording decreasing stroke 
mortality trends (during hospitalisation), the decrease could be due to: a) advancement of 
healthcare services (Zhang et al., 2007), and b) improvements in acute cardiac and medical 
treatment (Cheng et al., 2005). 
1.6 Demography of Malaysia and Kelantan and stroke as a public 
health problem  
Malaysia is located between 2° and 7° north of the Equator. Peninsular Malaysia is separated 
from the states of Sabah and Sarawak by the South China Sea. To the north of Peninsular 
19 
 
Malaysia is Thailand while its southern neighbour is Singapore. Sabah and Sarawak are ringed 
by Indonesia; Sarawak also shares a border with Brunei. 
1.6.1 Demography of Malaysia  
The demographic information of Malaysia is shown in Table 1-2. The urban population for 
Malaysia has grown from 26.6% (1960) to 49.8% (1990) and 74.7% (2015), leaving the rural 
population at near 25% in 2015. The percentage (of total) for population ages 65 and above 
has increased from 3.6% (1990), 4.0% (2000), 5.0% (2010) and 5.9% (2015) (The World Bank, 
2016). The geographical map and the population density of Malaysia are shown in Figure 1-7. 
1.6.2 Demography of Kelantan, Malaysia  
Malaysia consists of 14 states. The state of Kelantan has a large area of 15,105 km2 and in 
2012, the population was 1.65 million; 50.4% was male and 49.6% was female. The average 
annual population growth rate for the three years spanning 2010 and 2012 were 1.3%, 1.8% 
and 2.0%, respectively. The demography of Kelantan is summarised in Table 1-3. 
Table 1-2 Demography of Malaysia for year 2010, 2011, 2012 and 2013. 
    2010 2011 2012 2013 
Area (km2) 330,290  
Population (million)         
  Total 28.59 29.06 29.51 29.92P 
  Male 14.73 14.98 15.22 15.43P 
  Female 13.86 14.08 14.29 14.49P 
Life Expectancy (years)         
  Male 71.9 72.2p 72.4e 72.6e 
  Female 76.6 76.8p 77.0e 77.2e 
Gross Domestic Product (GDP)         
  GDP at current prices (RM million) 797,327 885,339 941,949e 986,733p 
  GDP at constant 2005 prices  (RM million) 676,653 711,760 751,934e 787,611p 
  GDP Growth (%) 7.4 5.2 5.6e 4.7p 
Notes: Between 2011 and 2013, the population estimates were based on the adjusted Population and 
Housing Census of Malaysia for 2010.  P Preliminary e Estimate  





1.6.3 Stroke burden in Malaysia 
In 2011, diseases of the circulatory system were the fifth principal cause of hospitalisation and 
the main cause of death (25.6% of all deaths) in all Ministry of Health hospitals in Malaysia 
(Ministry of Health, 2011). 
In 2012, cerebrovascular diseases (ICD-10 Blocks I60–I69) contributed to 28,272 
hospital discharges among all Ministry of Health hospitals, which is equivalent to a 97.6 
discharge rate per 100,000 population, and comprised 17.8% (28,272/158,788) of all diseases 
of the circulatory system (Ministry of Health, 2012). In 2012, the total number of deaths from 
stroke in all Ministry of Health hospitals in Malaysia was 4162, or a 14.4 mortality rate per 
100,000 populations. This was 33.8% (4162/12,312) of all deaths from diseases of the 
circulatory system, second to ischaemic heart diseases (Ministry of Health, 2012). 
Malaysia sits among the low-income and middle-income countries specifically in the 
Southeast Asia region. Based on the estimates made by the Global Burden of Diseases, Injuries, 
and Risk Factors Study (GBD 2010), most of the burden (98.6% incident strokes, 52.2% 
prevalent strokes, 70.9% stroke deaths, and 77.7 DALYs lost) exerted by the low-income and 
middle-income countries (central, east, south, and southeast Asia; eastern Europe; Andean, 
central, southern, and tropical Latin America and the Caribbean; and North Africa and the 
Middle East, Oceania, central, east, southern, and west sub-Saharan Africa) (Feigin et al., 
2014). The Southeast Asia region had the highest mortality (age-standardized stroke mortality 
above 136.7 per 100,000 people) in 2010 (Figure 1-8).  
We used Pubmed Advanced Search Builder (www.pubmed.com) to review all the 
studies on stroke ever conducted in Malaysia. We set the title as ‘Malaysia’ and ‘Stroke’ in the 
search builder fields. . The search yielded only fifteen articles with the latest publication 
published in May 2016 in Neurology Research. There was one study each on stroke registry, 
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on brief review of stroke in Malaysia, on stroke fatality, on longitudinal study (but small 
population covered) and on stroke pattern in Kelantan, Malaysia (Aziz et al., 2015, Loo and 
Gan, 2012, Jaya et al., 2002, Wan-Arfah et al., 2015, Neelamegam et al., 2013). Two studies 
looked at the costing of stroke and two more on ischaemic stroke (Akhavan Hejazi et al., 2015, 
Nor Azlin et al., 2012, Hamidon and Raymond, 2003, Aziz et al., 2016). A total of three studies 
on outcome of treatments (Sudirman et al., 2015, Ali et al., 2015, Aziz et al., 2016) and four 
studies on psychological and functional aspects after stroke (Sahathevan et al., 2014, 
Rameezan and Zaliha, 2005, Khoo et al., 2013, Mohd Zulkifly et al., 2016). Almost all were 
single-centre studies and none was a case-control study. The longitudinal study was conducted 
in a small area in the Northwest of Malaysia (Neelamegam et al., 2013).    
1.6.4 Health care system in Malaysia 
In Malaysia, there are two providers of healthcare:  the government sector (majority) 
and the private sector. The government run two types of public hospital, one is run by the 
Ministry of Health, the other (known as University Hospital) - run by the Ministry of Higher 
Education. Both types of hospital are subsidized by the government. The Malaysian health care 
system consists of mainly tax-funded and government-run universal services. Its public sector 
health services are organized under a civil service structure and are centrally administered by 
the Ministry of Health. The public sector provides about 82% of inpatient care. People can 
choose between public and private services depending on their ability to pay (Safurah et al., 
2012).  
In Malaysia there is no system of family doctors or general practitioners for patients 
as practiced by NHS in the UK. Patients needing the kind of primary healthcare for which one 
might see a GP in the UK, typically visit a public hospital (for example to get initial check-up). 
This decision about where to go is mostly based on patients’ preference and logistics. There 
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are also small private clinics manned by 1 to 3 medical doctors who provide outpatient care 
and minor surgery (Pagalavan, 2011). But again, unlike the NHS, these private clinics do not 
have designated patients (meaning they are not the designated GP for particular patients). 
Patients who come to these clinics pay for the service in full. 
For the outpatient services at polyclinics, district hospital and tertiary hospitals, 
patients need to pay 1.00 RM (Ringgit Malaysia) for the non-specialist treatment and 5.00 RM 
(Ringgit Malaysia) to 30.00 RM (Ringgit Malaysia) for the specialist treatment. If the patients 
are admitted, the charge will be free (3rd class), 5.00 RM (Ringgit Malaysia) (2nd class) and 10.00 
RM (Ringgit Malaysia) for the 1st class. These charges are for Malaysians only. Other costs for 
the special services and investigations can be found on the Ministry of Health website 
(Ministry of Health Malaysia, 2013a, Ministry of Health Malaysia, 2013b). The public but non-
Ministry of Health hospitals such as the university hospitals act as teaching hospitals. These 
type of public hospitals have bigger autonomy than then Ministry of Health hospitals but are 
still managed according to government regulations.     
 Patients can also go directly to emergency departments or smaller government 
hospitals (district hospitals or district health clinics) for treatment and check-ups. At these 
smaller public clinics/hospitals, doctors can examine patients and refer them to hospitals, such 
as HUSM or HRZP in Kelantan, if necessary. The place of referral depends on the distance from 
the referring hospitals/clinics and the availability of expertise at the referred hospitals. People 
generally have good physical access to health facilities (health facilities was available to 95 
percent of the population in 2004) (Merican et al., 2004). And 92% of the urban population 
live within 3km of a health facility and nearly 69% for the rural population. As a signatory to 
the 1978 Alma Ata Declaration, Malaysia affirms health as a fundamental human right, in that 
no one should be denied because of ethnicity, race or religion (Merican et al., 2004, Safurah 
et al., 2012).  
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The private sector provides services used by about up to 25% of population (Zan, 
2016). Their services concentrate mainly in the cities and all hospital charges are borne by the 
patients. All patients receiving treatment from the private hospital pay the charges using 
medical insurances. These medical insurances provide medical plans and the plans are 
different between different insurance companies and they cover treatment and admission at 
the private and government public hospitals. Unlike national health insurance – a legally 
enforced scheme of health insurance that insures a national population against the costs of 
health care – these private insurances are non-compulsory to the general Malaysian 
population.   In 2014, the Ministry of Health hospitals had 2,465,162 admissions and the non-
Ministry of Health hospitals 148,450 admissions, a total of 2,613,612. In the same year, the 
total number of admissions to the private hospitals was 1,083,201 (Ministry of Health 
Malaysia, 2015).  
There has been no study to our knowledge that compares the quality of services and care 
between the public and the private services in Malaysia. But it has been shown that 
privatization increases the drug price in Malaysia (Babar and Izham, 2009). A systematic review 
did not support the claim that the private sector is usually more efficient, accountable, or 
medically effective than the public sector in low- and middle-income countries (Basu et al., 
2012). Malaysia implements the National Referral System to ensure provision of integrated 
health care to the population with the key objective of providing greater equity, accessibility 
and better utilization of resources (Merican et al., 2004). The current healthcare system in 
Malaysia is considered as progressive and equitable to her population (Yu et al., 2008). 
1.6.5 Stroke services in Kelantan, Malaysia 
The study took place in the two largest hospitals in Kelantan, Malaysia: a) Hospital Universiti 
Sains Malaysia (HUSM) and b) Hospital Raja Perempuan Zainab II (HRPZ).  
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In Kelantan, there are two main tertiary hospitals - HUSM (a public hospital run by the 
Ministry of Higher Education) and HRPZ (a public hospital run by the Ministry of Health, 
Malaysia), six kilometres apart at the capital of Kelantan state, Kota Bharu. Both are the two 
largest hospitals in Kelantan and both are owned by the government (public hospitals). The 
public has full and equal access to both hospitals and choosing which hospital depends on the 
preference of the patient. Both hospitals provide advanced medical and surgical services. Each 
of them has its own niche area for example, HUSM is in the neuromedical and neurosurgical 
services and HRPZ for endochrine surgical services and respiratory services. 
HUSM is in Kubang Kerian town, six kilometres (km) from the capital of Kelantan, 
Malaysia. Its centroid coordinates are 6.099 latitude and 102.281 longitude. It is the second 
largest hospital (in Kelantan, Malaysia). And it is also categorised as a public hospital and is 
managed by the Universiti Sains Malaysia. 
HRPZ was previously known as Hospital Kota Bharu. It is the largest public hospital in 
Kelantan. HRPZ is a Ministry of Health hospital and is in the capital of Kelantan. The centroid 
of HRPZ is at the coordinates 6.125 latitude and 102.246 longitude.  
1.6.5.1 Hospital Universiti Sains Malaysia (HUSM)  
Hospital Universiti Sains Malaysia (HUSM) is part of the Health Campus of the Universiti Sains 
Malaysia. It started with 36 beds in 1983 and now in 2008 it has 747 beds.  The missions of 
HUSM are to provide new patient services and to become a full-fledged medical centre. To 
achieve the missions, HUSM acts as the referral hospital and also a teaching hospital to the 










Figure 1-8 Age-standardized stroke mortality per 100,000 people in 2010 (Feigin et al., 2014). Malaysia – comprised of Peninsular Malaysia and East 




Table 1-3 Demography of Kelantan, Malaysia for year 2010, 2011, 2012 and 2013. 
 2010 2011 2012 2013 
Population (million)     
Total 1.59 1.62 1.65 1.68p 
Male 0.8 0.81 0.83 0.85p 
Female 0.79 0.81 0.82 0.84p 
Average Annual Population Growth Rate (%) 1.3 1.8 2 1.9p 
Gross Domestic Product (GDP)     
GDP at constant 2005 prices (RM mil.) 11,991 12,780 13,476 13,963 
GDP per capita at current prices (RM)  9,322 10,363 10,568 10,677 
GDP Growth (%) 4.9 6.6 5.4 3.6 
Employment      
Labour Force ('000) 547.2 554.3 589.2 615.2 
Employed ('000) 534.2 543.5 575.6 598.1 
Unemployed ('000) 13.1 10.8 13.6 17.1 
Labour Force Participation Rates, LFPR (%) 57 56.2 58.2 59.3 
Unemployment Rate (%) 2.4 2 2.3 2.8 
Notes: Between 2011 and 2013, the population estimates were based on the adjusted Population and 
Housing Census of Malaysia for 2010.  P Preliminary e Estimate  
Source: (Department of Statistic, 2015) 
 
 
1. Outpatient service 
2. In-patient service 
3. Clinical support service 
4. Laboratory service 
5. Pharmaceutical service 
HUSM has two CT scanning machines: 
1. GE LightSpeed Plus 4-Slice CT (acquired in 2000) 
2. Siemens Somatom Definition AS+ 128-Slice (acquired in May 2009) 
The neuroscience service is a part of in-patient services and was initiated in 1984 and 
was formally run by the Neuroscience Unit in 2001. In 2006, the neuroscience service did a 
major revamp to provide a much better service combining experts from the neurological, 
neurosurgical, neurophysiological, radiosurgical and neuroradiological teams. It is one of the 
most active neuroscience unit in the field of traumatic brain injury, haemorrhagic stroke and 




1.6.5.2 Hospital Raja Perempuan Zainab (HRPZ) II  
HRPZ is the oldest hospital in Kelantan. It began operating in the 1920s. It has 16 clinical 
departments, 9 clinical support services and 8 non-clinical support services. HRPZ provides, 
among many others, outpatient and in-patient services.  
The Department of Medicine is one of the clinical departments in HRPZ. This 
department is the tertiary referral centre serving the population of Kelantan and North 
Terengganu (the neighbouring state). It provides general medicine and medical speciality 
services such as the endocrinology, gastroenterology, cardiology and neurology specialty 
services. The neurology speciality service is run by neurologists and medical officers. They 
provide in-patient and out-patient care for patients with neurology problems such as stroke. 
The department has a dedicated unit the Neurophysiology Unit. The Department of Medicine 
is the largest department in HRPZ with it has 238 total number of beds.   
1.7 Risk factors for stroke 
Risk factors, also known as risk markers, for stroke are the characteristics of an individual or 
population that are associated with an increased risk of stroke as compared with those 
without these characteristics (Lindley, 2008, Arboix, 2015, Jia et al., 2011, Adams, 2007). 
Understanding the risk factors for stroke is important because if these risk factors can be 
controlled in the general population, it could lead to reductions in the risk for stroke incidence 
and mortality (Hata and Kiyohara, 2013, O'Donnell et al., 2010a, O'Donnell et al., 2010b). 
Traditionally, the risk factors can be divided into: a) non-modifiable risk factors, and 




1.7.1 Non-modifiable risk factors 
The non-modifiable risk factors are factors that are not changeable and they include factors 
or variables such as age, sex, family history of stroke, geography and ethnicity. 
Advancing age is the main non-modifiable risk factor for stroke (Ovbiagele and 
Nguyen-Huynh, 2011). Age is probably the single most important forecaster of a high risk for 
stroke (Adams, 2007). Age rapidly increases the likelihood of stroke after a certain age, such 
as 55 years (Rosamond et al., 2007, Rosamond et al., 2008). Age was reported to double the 
risk for stroke in those aged 65 years and above (Ovbiagele and Nguyen-Huynh, 2011). The 
risk for stroke is seven times higher among persons older than 70 years than in younger 
persons (Brott et al., 1997, Brott et al., 1986). 
Although haemorrhagic and ischaemic stroke affect people from all ethnic groups in 
all parts of the world (Sudlow and Warlow, 1996, Sudlow and Warlow, 1997, Poungvarin, 
1998), the rates vary between ethnicities. The variation could result from different diets and 
lifestyles, smoking prevalence, accessibility to health care and public health resources and 
different reporting quality (Adams, 2007, Asplund, 1996, Truelsen et al., 2006). 
A positive family history of stroke is also a risk factor for stroke. This indicates that 
stroke is perhaps an inherited disease (Adams, 2007). For example, intracranial aneurysms and 
vascular malformations—components of multi-system genetic diseases—occur in family 
clusters, and stroke patients with a positive family history of stroke have approximately three 
to five times increased risk of aneurysmal rupture (Adams, 2007). First-degree relatives also 
have almost twice the risk for stroke (Ovbiagele and Nguyen-Huynh, 2011). 
In some studies, sex is a risk factor for stroke but the findings are inconclusive in all 
studies. Some studies have found that women, in particular those with atrial fibrillation (AF) 
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(Wagstaff et al., 2014) and an older age (after 70 or 75 years old) (Bhattacharjee et al., 2011, 
Wagstaff et al., 2014), have a higher risk of stroke compared to men. The higher risk of stroke 
among women could be the result of pregnancy, preeclampsia or use of oral contraceptive 
pills before menopause (Bushnell, 2008) or could be due to increased cardiovascular risk after 
menopause (Lisabeth and Bushnell, 2012). Others have found that men have 20–30% higher 
risk of stroke compared to women (Ovbiagele and Nguyen-Huynh, 2011). 
1.7.2 Modifiable risk factors 
Studies have found that hypertension (Hata and Kiyohara, 2013, Ovbiagele and Nguyen-
Huynh, 2011, O'Donnell et al., 2010b), diabetes mellitus (Ovbiagele and Nguyen-Huynh, 2011, 
Hata and Kiyohara, 2013, O'Donnell et al., 2010b), hypercholesterolaemia (Hata and Kiyohara, 
2013, Ovbiagele and Nguyen-Huynh, 2011), smoking (Hata and Kiyohara, 2013, Ovbiagele and 
Nguyen-Huynh, 2011, O'Donnell et al., 2010b), alcohol intake (Ovbiagele and Nguyen-Huynh, 
2011, O'Donnell et al., 2010b) and socioeconomic status (Ovbiagele and Nguyen-Huynh, 2011) 
are among the important modifiable risk factors for stroke. 
Recently, there have been interests in the other modifiable risk factors for stroke such 
as social and economic status, weather, season, day of the week as well as biochemical and 
environmental factors and geography (Adams, 2007, O'Donnell et al., 2010b, Pedigo et al., 
2011, Yang et al., 2015, Yadav, 2015, Storhaug et al., 2013, Howard et al., 2013, Maheswaran 
et al., 2005). Populations from a lower socioeconomic class have a higher risk of stroke 
compared to the more affluent and educated populations (Cox et al., 2006, Kumar et al., 2015). 
In addition, the incidence of stroke and in particular the incidence of intracranial haemorrhage 
correlates with cold weather. It also occurs more frequently on Mondays than other days of 
the week (Adams, 2007). Other new risk factors that have been identified and investigated 
include inflammation, infection, renal disease, dietary habit (Ovbiagele and Nguyen-Huynh, 
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2011), ratio of apolipoprotein B (ApoB) to ApoA (O'Donnell et al., 2010b) and homocysteine 
(Sacco et al., 1998). 
Hypertension is the most important modifiable risk factor for all stroke subtypes and 
is a more potent risk factor for intra-cerebral haemorrhage (ICH) than for ischaemic stroke (IS) 
(O'Donnell et al., 2010b). A large multi-centre case–control study showed that five risk factors 
account for more than 80% of global risk for all stroke: a) hypertension, b) current smoking, c) 
abdominal obesity, d) diet and e) physical activity and with the addition of apolipoprotein, 
they account for up to 90% of the risk for stroke (O'Donnell et al., 2010b). 
Among studies looking at risk factors for stroke such as cholesterol and body mass 
index (BMI), the findings have been inconclusive. For example, the independent positive 
relationship between total cholesterol and stroke mortality was reportedly absent in middle 
age (after allowing the effect of systolic blood pressure) and in those with systolic blood 
pressure below 145 mmHg (Prospective Studies et al., 2007). The finding from previous large 
studies on the relationship between body mass index (BMI) and stroke risk is not consistent 
(Song et al., 2004, Kurth et al., 2005). A large study shows that higher mortality for stroke 
(about 40%) was associated with each five kg/metre2 in the upper BMI range (25 to 50 kg/m2) 
with no evidence of a positive association between BMI and stroke in the lower BMI range 
(Prospective Studies et al., 2009). The positive relationship between BMI and stroke risk can 
be largely attributed by the effect of BMI on blood pressure (Prospective Studies et al., 2009). 
1.7.3 Risk factors for ischaemic stroke  
Ischaemic stroke is positively associated with hypertension and homocysteine but is inversely 
associated with apolipoprotein and high-density lipoprotein (HDL) cholesterol (O'Donnell et 
al., 2010b, Gorgui et al., 2014, Sacco et al., 1998). Other risk factors include low socioeconomic 
status (Kumar et al., 2015) and cystatin C (Yang et al., 2015). In young Caucasian adults 
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(younger than 50 years old), the most common risk factors are dyslipidaemia, smoking, 
hypertension and patent foramen ovale (a heart valve defect) (Renna et al., 2014).  
In INTERSTROKE study, however, it was reported that the increased concentration of 
total cholesterol was not associated with risk of ischaemic stroke but the ratio of non-HDL to 
HDL cholesterol was (O'Donnell et al., 2010b). The non-association between total cholesterol 
and ischaemic stroke is consistent with a finding from a large prospective observational studies 
(Prospective Studies et al., 2007).  
1.7.4 Risk factors for haemorrhagic stroke  
The risk factors for haemorrhagic stroke include: a) hypertension b) anticoagulant (blood 
thinning), c) cerebral aneurysms (enlargement of the blood vessels), d) substance abuse, e) 
family history of stroke, f) smoking, g) diabetes, h) high cholesterol, i) obesity and j) sedentary 
lifestyle (Torpy et al., 2010). 
For intra-cerebral haemorrhage (ICH), the investigators in the United States of 
America (USA) reported that in the their populations, the risk factors were: a) race (non-whites 
are at higher risk for stroke), b) interaction between race and age, c) systolic blood pressure 
(but not hypertension status), d) male sex and warfarin use, e) cholesterol levels and f) 
triglyceride levels (Howard et al., 2013, Sturgeon et al., 2007). In European populations, the 
risk factors for ICH were: a) hypertension, b) diabetes, c) triglyceride levels, d) short stature, 
e) history of psychiatric morbidity and f) smoking status (Zia et al., 2006). In the Asian male 
population, a pooled analysis showed that the risk factor for haemorrhagic stroke was systolic 
blood pressure, and to a lesser extent, smoking (Hyun et al., 2013). Other studies have found 
that total cholesterol levels, non-HDL cholesterol levels and ratio of non-HDL to HDL were 
associated with reduced risk (O'Donnell et al., 2010b, Tziomalos et al., 2009).  
33 
 
A systematic review of 14 longitudinal and 23 case–control studies showed that the 
most important and consistent risk factors for SAH include: a) smoking status, b) hypertension 
and c) excessive alcohol intake (Feigin et al., 2005). 
1.8 Outcomes of stroke 
Depending on when the patient presents and on the underlying causes, the outcome of stroke 
may be stable, progressive or completely resolved. In stroke outcome studies, the 
investigators mainly deal with: a) stroke death and b) the functional health status after stroke. 
Generally, PICH or very large ischaemic strokes contribute to an early mortality rate of 10% 
within the first week. A further 10% die within a month, and after about a year, a third of 
people with stroke will have died (Lindley, 2008). 
Reliable estimates of the population mortality are one of the problems in many 
countries especially those in the low-income and middle income countries. The problems of 
estimating population mortality rates by cause in Malaysia and other countries in the Asian 
region include incomplete vital registration, expertise of certifying specialists and variation in 
mortality data. Inadequate case-ascertainment, incomplete health screening, inaccurate 
diagnosis, lack of investigative equipment and technology and low level of awareness may 
contribute to inaccurate information about stroke mortality in developing countries 
(Venketasubramanian, 1998, Thammaroj et al., 2005, Kim, 2014). Providing specialists is 
important in the less developed countries (Kim, 2014). The stroke workload for Malaysia was 
only 9.1%, much lower than Indonesia, Singapore and Thailand which was most likely due to 
the small number of neurologist; hence, many stroke patients may be attended by non-




1.8.1 Stroke mortality and stroke case-fatality 
Stroke mortality is calculated by dividing the number of all new strokes by the population size 
in a specified time interval (Feigin et al., 2003, Bonita, 1992).  Stroke case-fatality measures 
the proportion of people who die because of stroke within a specified time period (Bonita, 
1992) or the proportion of fatal strokes in all first strokes within a specified time period (Feigin 
et al., 2003, Saposnik et al., 2008).  
The mortality rate from stroke (M), stroke event rate (C), and case-fatality are related 
by M=C times F but in most populations, changes in stroke mortality were principally 
attributable to changes in case-fatality rather than changes in event rates (Sarti et al., 2003).  
The burden of ischaemic and haemorrhagic stroke has increased significantly between 
1990 and 2010. And the absolute number of incident haemorrhagic stroke was twice lower 
that of ischaemic stroke, the overall global burden of haemorrhagic stroke (deaths and DALYs) 
was higher (Krishnamurthi et al., 2013). Stroke is the second leading cause of death worldwide; 
contributing to 10% of all deaths and 4% of all DALYs worldwide. If the current trend continues, 
there will be almost 12 million stroke deaths, 70 million stroke survivors and more than 200 
million DALYs lost globally by 2030 (Feigin et al., 2014). 
The Global Burden of Disease (GBD) study estimated that in 2001, ischaemic heart 
disease (IHD) and cerebrovascular disease (stroke) were the leading causes of death for low- 
and middle-income countries and for high income countries, responsible for 12 million deaths 
globally, or almost one-quarter of the global total (Mathers et al., 2006). In the South-East Asia 
(SEA) countries alone, stroke had caused 6.6% of total deaths in the region (World Health 
Organization, 2014). Figure 1-10 shows the geographic distribution of relative mortality from 
stroke and ischaemic heart diseases worldwide. 
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Worldwide estimates for the year 2002 (based on data from 192 WHO member states) 
showed that the age- and sex-adjusted mortality rates for cerebrovascular disease vary 10-
fold between countries, from 24.5 per 100,000 population to 251 in 100,000 population 
(Johnston et al., 2009). Stroke mortality rates appear to be higher than ischaemic heart disease 
mortality in much of Africa and Asia and lower in North America, Western and Northern 
Europe and Australia (Kim and Johnston, 2011). 
The Global Burden of Disease Study in 2010 reported that the highest overall, male 
and female mortality rate in SEA countries was 90.1, 105.0 and 77.5 per 100,000 people, 
respectively (Krishnamurthi et al., 2014).  
Country-specific studies show that in India, 28-day stroke mortality in a community study 
was 27.2% (24.5% for urban populations and 37.1% for rural populations; 72.1% of these 
deaths occurred within 10 days of stroke) (Sridharan et al., 2009). In-hospital mortality in 
Singapore was 3.4%, 2.5% and 9.1% among Chinese, Malays and Indians, respectively (Sharma 
et al., 2012). In Malaysia, the estimated annual age-standardised mortality rates from stroke 
(per 100,000 population) was 79 for males and 82 for females based on WHO estimates, and 
higher—103 and 97 for males and females, respectively—based on more reliable adjusted 
local data (Hoy et al., 2013). 
Two studies in Malaysia looking primarily at PICH reported that overall hospital-based 
fatality (2002–2003) was 43.9% (Sia et al., 2007) and 32.5% (2007–2009) (Yousuf et al., 2012). 
The stroke fatalities in PICH that occurred during the first 24 hours, first 2 days and first week 






Figure 1-9 Worldwide geographic distribution of relative mortality from stroke (Kim and Johnston, 2011). 
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In Kelantan, a hospital-based study reported that the overall stroke mortality was 
37.3% (January 1997 to December 1998), with a majority of patients (91.5%) dying during the 
first month, 62.7% of patients dying while in the ward (stroke fatality) and the rest dying at 
home (Jaya et al., 2002). A study in Kuala Lumpur, Malaysia, based on 2000–2001 data showed 
that the in-hospital case–fatality rate within 30 days after admission for ischaemic stroke was 
11.7%; that for haemorrhagic stroke was 27.3% (Basri and Azman Ali, 2003). 
1.8.2 Predictors for stroke mortality and stroke case-fatality  
The risk for death in stroke patients is determined by multiple factors such as sex, age 
(Appelros et al., 2003, Olsen et al., 2011, Liu and McCullough, 2012, Nedeltchev et al., 2010), 
socioeconomic status (Eriksson et al., 2013, Cox et al., 2006, Lindmark et al., 2013), education 
(Lindmark et al., 2013), co-morbidities such as diabetes (O'Donnell et al., 2010a, Delbari et al., 
2011, Fernandes et al., 2012), hypertension (Delbari et al., 2011), diastolic blood pressure on 
admission (Sharma et al., 2012), diet (Scarborough et al., 2011), stroke severity (Saposnik et 
al., 2008, Andersen et al., 2005, Appelros et al., 2003, Basri and Azman Ali, 2003, Sharma et 
al., 2012), drug treatment and availability and experience of stroke teams and physicians 
(Saposnik et al., 2008, Kita et al., 2009), time of admission (weekday versus weekend) (Ogbu 
et al., 2011), anaemia (Li et al., 2013), location of the infarction (Basri and Azman Ali, 2003), 
quality of primary care (Lee et al., 2011) and stroke subtype (Shigematsu et al., 2013). 
In the Asian populations, the AASAP study (a multi-centre study based in 36 hospitals 
all over Asia) reported that the risk factors for early death in ischaemic stroke were age, 
diabetes mellitus, smoking, AF, ischaemic heart disease and previous anti-platelet treatment, 
and the risk factors for death in ICH were age and hypertension, which mirror the risk factors 
in Europe and North America (Wong, 1999). 
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In Malaysia, the predictors for ischemic stroke mortality were infarction of the mid-
cerebral artery (MCA) area, AF, diabetes mellitus, Barthel Index and Glasgow Coma Scale (GCS) 
score (Basri and Azman Ali, 2003). The predictors of intracerebral mortality in Malaysian stroke 
patients were GCS score, ICH score, volume of haemorrhage, presence of intraventricular 
extension, presence of midline shift on CT images and posterior fossa bleeding among others 
(Yousuf et al., 2012, Sia et al., 2007). 
1.8.3 Predictors of functional health status after stroke  
Studies have shown the functional status, as well as other outcomes, after stroke are 
associated with age (Sohrabji et al., 2013, van Almenkerk et al., 2013, Khan et al., 2012, Kong 
and Lee, 2014), stroke severity, size of the stroke (van Almenkerk et al., 2013) and stroke type 
(Di Carlo et al., 2006, Paci et al., 2011, McNaughton et al., 2001). 
One the best-known measures of functional status after stroke is the Barthel Index. It is 
the most-cited measure of disability in stroke rehabilitation trials in the published literature 
(Sangha et al., 2005). It was developed initially to act as a simple index of independence post-
stroke and a useful scoring assessment in rehabilitation (Quinn et al., 2011). It has excellent 
reliability (Duffy et al., 2013), and the most popular version of the Barthel Index is the 10-item 
Barthel Index (scores from 0 to 100 with 5-point increments) (Shah et al., 1992, Tibaek and 
Dehlendorff, 2011, Balu, 2009). The maximal score is 100 (total independence) and the lowest 
score is 0 (totally dependent bedridden state) (Tibaek and Dehlendorff, 2011, Uyttenboogaart 






1.9 Modelling binary outcome: Logistic regression model 
1.9.1 Logistic regression model  
Linear logistic regression is the commonest statistical method with which to model data with 
a binary outcome variable, (Hosmer et al., 2013, Hosmer et al., 2011). The other less used 
method is binary probit model; both – the linear logistic and probit models – are jointly known 
as the binary regression model (Long and Freese, 2006).  
Logistic or logit models are popular in health and medical studies because: a) the 
common linear regression is not appropriate for binary data as the fitted values 𝑥𝑇 𝛽 may be 
less than zero or greater than one (Katz, 2011, Dobson, 2002), b) the logistic regression is 
mathematically flexible, c) the logistic model parameters provide the basis for clinically 
meaningful estimates of effect (Faraway, 2006, Hosmer et al., 2013) and lastly, d) they are 
computationally easier to model (Dobson, 2002). 
Logistic regression produces linear predictor, which is the weighted combination of 
the independent, predictor or prognostic variable (Nashef et al., 1999, Roques et al., 1999, 






The quantity 𝜋(𝑥) = 𝐸(𝑌|𝑥) represents the conditional mean of Y given x when the 
logistic distribution is used. A transformation of 𝜋(𝑥) is known as the logit transformation (or 
the linear logistic model) and it is a special form of the general logistic regression model 









= 𝛽0 + 𝛽1  
The logit is the natural logarithm of the odds of the outcome. It can take on any value 
from minus to plus infinity. This means that in a regression analysis when the outcome variable 
is dichotomous, the model for the conditional mean (the probability) of the regression 
equation extents from zero to one (Katz, 2011, Hosmer et al., 2013). 
1.9.2 Model fitting for a logistic regression 
If Y is coded 0 or 1 the expression for 𝜋(𝑥) given in equation (1) provides the conditional 
probability that Y is equal to 1 given x. This is denoted as 𝜋(𝑥). It follows that the quantity 1 - 
𝜋(𝑥) gives the conditional probability that Y is equal to zero given x, Pr(Y = 0|x).  
The general method for estimating parameters in the logistic model is via the 
maximum likelihood. The contributions to the likelihood function for the pair (𝑥𝑖 , 𝑦𝑖) of data 
when Y is coded as zero (0) or one (1), is through this expression: 
𝜋(𝑥𝑖)
𝑦𝑖[1 − 𝜋(𝑥𝑖)]
1−𝑦𝑖  (3) 
 
As the observations are assumed to be independent, the likelihood function is defined 
as: 







However, it is easier mathematically to work with the log of the equation using the 










To find the value of β that maximises L(β), we differentiate L(β) with respect to β0 and 
β1 by using the likelihood equations:  
∑[𝑦𝑖 − 𝜋(𝑥𝑖)] = 0 (6) 
 
∑ 𝑥𝑖[𝑦𝑖 − 𝜋(𝑥𝑖)] = 0 
 
(7) 
 In equation (6) and equation (7), it is understood that the summation is over i 
varying from 1 to n.  
1.9.3 Model checking for a logistic regression model 
In a logistic model, model checking includes the assessment of: a) summary measures of 
goodness of fit (a single number that summarises the overall model) and b) regression 
diagnostics (numbers that summarise the fit of individual subjects in data forming the overall 
model) (Hosmer et al., 2013, Dobson, 2002). 
There are three general summary measures of goodness of fit in logistic regression: a) 
the Hosmer–Lemeshow statistics, b) the Pearson chi-square test and c) the receiver operating 
characteristic (ROC) (Hosmer et al., 2013). 
The Hosmer-Lemeshow statistics measure the overall model fitness and is the 
commonest measure of fit in logistic regression (Dobson, 2002). It compares the probabilities 
of the outcome occurring (predicted by the logistic model) against the observed data. 
Similarly, another overall model fitness test, i.e. the Pearson chi-square test, also compares 
the difference between the expected probability of the outcome occurring (predicted by the 
logistic model) and the observed outcome in the data (Long and Freese, 2006). 
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The third measure of the overall goodness of fit is the area under the ROC curve, also 
known as the c-index (Royston and Altman, 2010, Hanley and McNeil, 1982). The ROC curve 
quantifies the ability of a logistic model to discriminate between patients having or not having 
the outcome of interest (Royston and Altman, 2010). Although there has not been any 
consensus for values for a model to classify the ROC curve based on its performance, it is 
generally accepted that for a logistic model, an ROC curve greater than 0.7 indicates good 
discrimination for the fitted model (Brown et al., 2007, Burd et al., 2006). 
As many logistic data contain individual rather than grouped observations, logistic 
model checking uses covariate patterns derived from the data. Covariate patterns are 
observations containing the same values of all the explanatory variables (Dobson, 2002). 
The residuals (the difference between the predicted outcome calculated from the 
model and the observed outcome) are calculated based on these grouped observations in the 
model (Long and Freese, 2006). 
1.10  Modelling time-to-event outcome: Survival analysis and the Cox 
proportional hazard regression  
In some epidemiological studies, researchers observe subjects until a certain time using the 
cohort study design. In a cohort study, there are at least two end points for each subject, 
where: a) the subject develops an event during the period of follow-up; this is also known as 
failure, or b) the subject does not develop an event at the end of the follow-up. Under these 
circumstances, the subject is said to be censored. In a cohort study, all participants either have 
the same follow-up time, or each participant has his or her own follow-up time (including 
different starting and end points). In the latter circumstance, survival or duration analysis is 
the method of choice for data analysis. 
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Survival analysis generally comprises three methods: a) non-parametric, b) semi-
parametric and, c) parametric. Non-parametric analysis includes the Kaplan-Meier method 
useful to describe the survival probability. Semi-parametric analysis such as the Cox 
proportional hazard regression is the most commonly used method for analysing survival data 
in an epidemiological study. The parametric analysis include exponential, Weibull and log-
normal survival models (Hosmer et al., 2011, Kleinbaum and Klein, 2012, Katz, 2011). 
The Kaplan-Meier method and the Cox model are widely used in clinical studies with 
time-to-event data. In such studies, all subjects who do not develop the outcome of interest 
are grouped together, and they are known as the censored observations. Both the Kaplan-
Meier and the Cox model require these assumptions about censoring: a) Independent 
censoring, b) Random censoring, and c) Non-informative censoring (Kleinbaum and Klein, 
2012). The reasons for subjects being censored can be used to help properly assess the nature 
of the missing data. For example, if the subjects were censored because of a lack of response 
or side effects, then this will give rise to –  in statistical terms – informative missing data. 
Outcome-related censored subjects are informative and should not be disregarded in an 
analytical study without careful thought. Sections 1.10.4, 1.10.5 and 1.10.6 will provide further 
details about the censoring mechanism, the implications of informative censoring and the 
methods of handling informative censoring. In Appendix H of this thesis, two recent 
imputation methods, a) the Gamma imputation method and b) the Risk Score imputation 
method, are described in greater length.    
1.10.1  Descriptive method for survival analysis 
The initial analysis for survival data includes describing the survival function of the subjects. 
The survival function is defined as ‘the fraction of individuals who does not have the event at 
any given time’ (Glantz, 2005). 
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The default estimator of survival function in most statistical software is the Kaplan–
Meier estimator or product limit estimator. This estimator incorporates information from all 
observations, both uncensored and censored (Hosmer et al., 2011). Assume we have a sample 
of n independent observation denoted (ti, ci), i = 1,2,..,n of the underlying survival time 
variable T and the censoring indicator variable C. assume that, among the n observations, 
there are m ≤ n recorded times of failure and n – m censored values. Let the number at risk of 
dying at t(i) be denoted ni and the observed number of deaths be denoted di. The Kaplan–Meier 








With the convention that ?̂?(𝑡) = 1 if t < t(i).  di is denoted as the number of deaths observed 
at the first failure time and ni the number of subjects alive at any specified time point (number 
at risk of dying or simply the number at risk).  
1.10.2  The Cox proportional hazard regression 
Semi-parametric survival analysis is adequate for comparing survival between different groups 
(levels) of a categorical covariate, but a fully parametric hazard function, which requires the 
specification of a baseline hazard function, yields more information from the data (Kleinbaum 
and Klein, 2012, Hosmer et al., 2011). 
Semi-parametric Cox proportional hazard regression allows the incorporation of 
subjects with differing lengths of follow-up and censoring, either the result of loss to follow-
up or of death due to other causes (Katz, 2011). One advantage of using Cox proportional 
hazard regression for statistical non-specialists is that it is more intuitive to interpret hazard 
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ratios than regression parameters estimated as effects on a time scale in parametric models 
or accelerated failure time models (Hosmer et al., 2011). 
The form of the Cox regression model (hazard function) is specified as:  
ℎ(𝑡, 𝑥, 𝛽) = ℎ0(𝑡)𝑟(𝑥, 𝛽) (9) 
 
where ℎ0(𝑡) is the hazard function that changes as a function of survival time, while 
𝑟(𝑥, 𝛽) characterises how the hazard function changes as a function of subject covariates. The 
ratio of the hazard functions for 2 subjects with a covariate denoted as x1 and x0 is:  





hence, the model can be written as (Cox, 1986):  










With this parameterisation (equation (11)), the hazard function becomes: 
ℎ(𝑡, 𝑥, 𝛽) = ℎ0(𝑡)𝑒
𝑥𝛽  (12) 
 
and the hazard ratio is: 
𝐻𝑅(𝑡, 𝑥1, 𝑥𝑜) = 𝑒
𝛽(𝑥1−𝑥0)







1.10.3  Model fitting for the Cox proportional hazard regression 
It is not possible to use the log-likelihood function in survival analysis because the error 
component must be specified; alternatively, an expression—the partial likelihood function—
is proposed (Cox, 1986). 
This partial likelihood function depends only on the parameter of interest and is given 
by the following expression (Hosmer et al., 2011) on page 75:  









where the assumption is: no tied times and it is often modified to exclude terms when 
ci = 0, yielding: 
𝑙𝑝(𝛽) =  ∏
𝑒𝑥𝑖𝛽
∑ 𝑒𝑥𝑗𝛽 𝑗𝜖𝑅(𝑡)






Where the product is over m distinct ordered survival times and x(i) denotes the 
value of the covariate for the subject with ordered survival time t(i). The log partial likelihood 
is:  








We obtain the maximum partial likelihood estimator by differentiating the right hand 
side of the equation with respect to  (beta), setting the derivatives equal to 0 and solving 




1.10.4  Censoring mechanism and informative censoring 
 Survival analysis becomes complicated because the failure times are unobserved for a 
proportion of individuals and the data only provide the last time that the subjects were under 
observation, known as censoring time. Also, there is always a possibility that the hazard of 
failure in those subjects at risk at a given time and who have not yet failed or been censored 
is different from the hazard at that time in those with the same values of all relevant 
covariates, but who have been censored. This contradicts the standard assumption that if an 
observation is censored at time C, the contribution to the likelihood is just the probability that 
lifetime T exceeds C. The fact that the censoring has occurred when it did has not altered the 
distribution of T, hence the censoring mechanism is irrelevant for inference about the 
distribution of T (Siannis et al., 2005).  
In survival analysis, the censoring mechanism can be classified as (Shih, 2002): 
1) Non-informative censoring (ignorable missing) 
a. Missing completely at random (MCAR): the censoring mechanism 
is independent of both observed and missing data 
b. Missing at random (MAR): the censoring mechanism is 
conditionally independent of missing data given observed data.  
2) Informative censoring (non-ignorable missing)  
a. Missing not at random (MNAR): the censoring mechanism is 
conditionally dependent on missing data given observed data 
The critical distinction is between 1) and 2) because under 1), likelihood-based 
inferences correctly address properties of the uncensored process, which is often what is 
wanted.  Standard survival analysis methods assume that censoring is non-informative.  
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One of the most important assumptions of censoring is that censored patients are 
considered to have survival prospects similar to the participants who continued to be followed 
(Ranganathan and Pramesh, 2012, Bland and Altman, 1998). In practice, censoring is almost 
invariably assumed to be non-informative or ignorable. 
1.10.5  Implication of informative censoring: An example in stroke setting 
Here, we consider an example using a study of stroke mortality to illustrate the relationship of 
censoring and the survival time. A survival analysis that uses the Kaplan–Meier method and 
Cox model assumes that censoring is non-informative. In this setting, ICU patients discharged 
alive from the hospital are assumed to be representative of all other individuals who have 
survived to this time of discharge but who are still in hospital. In this case, the distribution of 
the censoring time is unrelated to the distribution of the survival time.  
This censoring assumption is 'non-informative' about the mortality pattern of the 
population. This is perhaps true if the censoring process operates at random (which is usually 
the case when mortality is assessed at a point in calendar time), provided that this time point 
is selected before the study is initiated (Resche-Rigon et al., 2006). However, this assumption 
is false if, for example, censoring is a result of a deterioration or an amelioration in the 
patient’s health status. This is probably the case in neurology wards where patients are 
discharged in relatively good health, and thus potentially censored informatively. This can 
happen when the patient needs no more stroke care (due to amelioration or deterioration of 
their vital conditions). Patients are therefore discharged alive (censored) because they have a 
lower or higher risk of hospital death (due to stroke) than the average. These patients are 
therefore not the same patient population as those who stayed within the hospital. The  
censoring is therefore  'informative', and carries information about the remaining survival time 
(Resche-Rigon et al., 2006).  
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1.10.6 Methods to handle informative censoring 
Several methods have been described to deal with the problem of informative censoring. 
These include imputation techniques for missing data, often together with sensitivity analyses 
to mimic best and worst-case scenarios, and considering the censoring event itself as an 
important end-point (Shih, 2002, Ranganathan and Pramesh, 2012).  
By conceptualizing the censored failure times as missing data, the problem of non-
independent censoring becomes a missing data problem. Using multiple imputation in such 
cases provides a natural context for also accommodating missing covariates (Jackson et al., 
2014). It was developed to: a) remove bias in standard survival analysis when it is thought that 
the censoring may be informative and b) improve efficiency by imputing events times for 
individuals who were censored (Burkoff et al., 2016b, Hsu and Taylor, 2009). 
 A procedure has been developed to quantify the sensitivity of the conclusion from 
fitted Cox proportional hazards model when the independent censoring in in doubt, rather 
than focusing on the reasons why the assumption of independent censoring may be false 
(Jackson et al., 2014). This procedure uses intuition that censoring associates with either a 
harmful effect or protective effect. By modelling such association between censoring and 
failure, investigators gain an informed view of the model’s assumptions and the plausible 
range of sensitivity parameter or parameters to investigate.  In this approach, the censored 
observations provide unobserved failure times and multiple imputation is used to impute 
censored failure times (Burkoff et al., 2016a). Estimation proceeds via multiple imputation 
where censored failure times are imputed by the users. Users can define that censoring may 
be associated with either a harmful effect or protective effect. The basic idea is to assume a 
step-change in the hazard at the censoring time. The size of this step-change cannot be 
estimated from the available data, but instead is used as a sensitivity parameter.  The censored 
observations provide missing (unobserved) failure times and the user then imputes multiple 
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censored failure times. The user can also set different parameter or parameters that quantify 
the departure from independent censoring. From there, a sensitivity analysis can be 
performed to explore the implications of a range of possible values of sensitivity parameters. 
Once the imputed datasets have been created, the user can estimate the model parameters 
of interest by fitting an analysis model to each of the imputed datasets. At the end, the 
resulting parameter estimates are combined using Rubin’s rules (Jackson et al., 2014). For 
further details, see Appendix H. 
 Another procedure that utilises multiple imputation is known as the risk score 
imputation. It uses non-parametric multiple imputation. The risk score imputation procedure 
creates multiple imputated event times for those subjects whose event times were censored 
(Burkoff et al., 2016b). In this procedure, auxiliary variables were used to compare survival 
distributions.  Covariates which are known or believed to be related both to the hazard of 
failure and the hazard of censoring should be included in the imputation process. To increase 
the efficiency of the imputation, the user can include covariates which are only related to the 
hazard of failure. This procedure assumes that each subject provides other information that is 
informative about the health condition of the subjects and can be used for prediction of both 
event and censoring times. In risk score imputation, to improve robustness, two proportional 
hazard (PH) models are used: a) a PH model for the event times and b) a PH model for the 
censoring times. Each risk score is a linear combination of auxiliary variables. it is centred and 
scaled by subtracting the mean and dividing by the standard deviation of the risk scores. Based 
on the imputing risk set, a non-parametric multiple imputation, Kaplan-Meier imputation, 
imputes a future event or censoring time for each censored observation (Hsu and Taylor, 
2009). In risk-score imputation, the event time is drawn from a Kaplan-Meier estimator of the 
distribution of event times calculated from the observations in the imputing risk sets. (Hsu and 
Taylor, 2009). Once the data sets have been imputed, the user can perform standard time-to-
event statistical analyses on the augmented datasets and the results are then combined to 
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produce parameter estimates and hypothesis tests. In this case, the correctness of the analysis 
relies on the correctness of the imputation model. For further details, see Appendix H.  
1.10.7 Residuals and proportionality assumption for the Cox proportional 
hazard regression  
An examination of model adequacy provides a measure of its validity and examining the 
residuals does this. The Cox proportional hazard model produces residuals that are not 
obvious. Residuals (the difference between the predicted and observed outcome) generated 
from the Cox model include: a) Schoenfeld residuals, b) scaled Schoenfeld residuals and c) 
Martingale residuals or Cox–Snell residuals  (Kleinbaum and Klein, 2012, Hosmer et al., 2011, 
Cleves et al., 2010).     
The proportional hazard assumption is vital in the interpretation of the estimated Cox 
regression parameters. It has a log-hazard function of the form (15)(Hosmer et al., 2011): 
ln[ℎ(𝑡, 𝑥, 𝛽)] = ln [ℎ0(𝑡) + 𝑥′𝛽 (17) 
 
where the left part is the log of the baseline hazard function, and on the right, the 
linear predictor. 
Methods to assess proportionality include: a) a plot of the log-hazard over time and 
b) a plot of scaled Schoenfeld residuals over time. A plot that fits the proportionality 
assumption will have the residuals lying ‘randomly’ scattered about the zero (Cleves et al., 
2010, Hosmer et al., 2011). A plot of the log-hazard over time would produce two continuous 





1.11  Modelling longitudinal data analysis: Linear mixed models 
Data with measurements taken repeatedly from a subjects is known as a wave are called 
longitudinal data or panel data (Diggle et al., 2002, Rabe-Hesketh and Skrondal, 2012). In this 
type of data, the analysis of choice must reflect the presence of correlation between 
successive measurements (Dobson, 2002, Diggle et al., 2002, Rabe-Hesketh and Skrondal, 
2012). 
There are two approaches to modelling longitudinal data: a) drop the usual 
assumption of independence between outcomes 𝑌𝑖  and model the correlation explicitly, or b) 
consider the hierarchical structure of the study design, where the outcomes are assumed to 
be independent but with the presence of correlation between a subject’s measurements 
(Dobson, 2002). Problems in longitudinal data analysis can be grouped into: a) where 
regression of the dependent variable (Y) on independent variable (x) is the scientific focus, and 
b) where correlation is the main interest (Diggle et al., 2002). 
Different statistical models in longitudinal data include: a) random-effect models, b) 
fixed-effect models, c) dynamic models, d) marginal models (Rabe-Hesketh and Skrondal, 
2012, Diggle et al., 2002), e) transition models and f) analysis of variance (Diggle et al., 2002). 
1.11.1  Naïve analysis for the correlated data 
Naïve analysis, sometimes called pooled analysis, utilises all observations from the subjects 
(assuming independence between subjects) with: 
𝐸(𝑦𝑖𝑗𝑘) = 𝛼𝑖 + 𝛽𝑡𝑘 + 𝑒𝑖𝑗 (18) 
where 𝑌𝑖𝑗𝑘 is the score at time 𝑡𝑘(𝑘 = 1, . . , 𝑛)  for patient 𝑗(𝑗 = 1, … , 𝑛)  
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One way of fitting a model with naïve analysis is by using a generalised estimating 
equation (GEE), assuming independence between observations for the same subject, which 
can estimate the population-averaged coefficients (Diggle et al., 2002). 
1.11.2  Multi-level models for longitudinal data 
The multi-level approach is an alternative to analysing longitudinal data. Repeated 
observations on the same units are also clustered data (Rabe-Hesketh and Skrondal, 2012). 
For example, suppose a model is specified as: 
𝑌𝑗𝑘 =  𝜇 + 𝑎𝑗 + 𝑒𝑗𝑘 (19) 
where 𝑎𝑗  is the effect of time j.  It is independent, identically distributed random 
variables with 𝛼𝑗~𝑁(0, 𝜎𝛼
2) . Similarly, the terms are independent, identically distributed 
random variables with 𝑒𝑗𝑘~𝑁(0, 𝜎𝑒
2). In this case, 
𝐸(𝑌𝑗𝑘) =  𝜇 (20) 
𝑣𝑎𝑟(𝑌𝑗𝑘) = 𝐸[(𝑌𝑗𝑘 − 𝜇)






𝑐𝑜𝑣(𝑌𝑗𝑘 ; 𝑌𝑗𝑚 ) =   𝐸[(𝛼𝑗 − 𝑒𝑗𝑘) ((𝛼𝑗 − 𝑒𝑗𝑚)] =  𝜎𝛼
2 (22) 
 
for the times in the same subjects, and 
𝑐𝑜𝑣(𝑌𝑗𝑘 ; 𝑌𝑗𝑚 ) =   𝐸[(𝛼𝑗 − 𝑒𝑗𝑘) ((𝛼𝑗 − 𝑒𝑙𝑚)] =  0 (23) 
 
for different patients (Dobson, 2002). 
In a linear model where longitudinal data with 𝑌𝑗𝑘  is the measurement at time 𝑡𝑘 on 
subject j, it can be written as:  
𝑌𝑗𝑘 =  𝛽0 +  𝑎𝑗 + (𝛽1 +  𝑏𝑗)𝑡𝑘 + 𝑒𝑗𝑘 (24) 
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The parameter 𝜇 is a fixed effect and the term 𝑎𝑗 is a random effect (an example of 
mixed model with both fixed and random effects). The parameters of interest are 𝜇, 𝜎𝛼
2 and 
𝜎𝑒
2. 𝛽0 and 𝛽1 are the intercept and slope parameters for the population, 𝑎𝑗  and 𝑏𝑗  are the 
differences from these parameters specific to subject j, 𝑡𝑘  denotes the time of the kth 
measurement and 𝑒𝑗𝑘 is the random error term (Dobson, 2002). 
In general, mixed models for normal response can be written in the form: 
𝐲 = 𝐗𝛃 + 𝐙𝐮 + 𝐞 (25) 
 
where 𝛃 is the fixed effects, and u and e are the random effects. The matrices X and Z 
are the design matrices. Both u and e are assumed to be normally distributed.  
1.11.3  Model checking for the linear mixed models 
We invoke statistical assumptions whenever we fit a statistical model. In a mixed model, the 
assumptions involve the structural and stochastic parts. The assumptions include checking the 
functional form, normality and homoscedasticity. A fundamental assumption of the mixed 
model is that the level-2 residuals or Ui (a sample of independent unobservable variables from 
random effects distribution) are independent of the explanatory variable (Diggle et al., 2002). 
Checking the functional form involves looking at the plot of ‘outcome’ against 
‘predictor’; for normality checking, visualising residual distribution is adequate; and to check 
for homoscedasticity assumption, we plot the residuals against the predictor (Singer and 





1.12 Issues in model building 
1.12.1  Effect of the third variable  
In epidemiology, model building serves to: a) produce a prediction model and b) adjust for 
confounding variables (Neter, 1996). When prediction is the aim, model fit and mean square 
prediction error are the main criteria used to evaluate model adequacy. Adjustment for 
confounding variables is important in clinical epidemiology to minimise bias. To achieve this, 
any ‘third’ predictors thought to be influential are identified and included in the model (Jewell, 
2004). The adjusted model provides insight into the relationship between the predictors and 
the outcome through the model structure. 
1.12.1.1 Confounders 
In epidemiological analysis, there are three types of effect exerted by the ‘third’ variable: a) 
confounding, b) mediation and c) suppression. Confounding does not necessarily imply a 
causal relationship among the variables as opposed to mediation. The presence of this third 
variable affects the relationship between a risk factor and an outcome (Kleinbaum and Klein, 
2012). Due to this ‘confounding’ effect, the third variable is more often known as a confounder 
(Katz, 2011, Szklo and Nieto, 2007). 
In confounding, the association between variables has these essential features: a) the 
confounding variable is causally associated with the outcome, b) the confounding variable is 
causally or non-causally associated with the exposure and c) the confounding variable is not 
an intermediate variable in the causal pathway between exposure and outcome (Szklo and 
Nieto, 2007, Jewell, 2004). 
Several assessments identify a particular variable as an important confounder: a) the 
application of automatic variable selection, b) the comparison of adjusted and unadjusted 
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effect estimates and c) the combination of statistical association from the data with some 
background knowledge about the causal network (Hernan et al., 2002). A variable has a 
considerable effect on the model if the coefficient of at least one of the explanatory variables 
changes by more than 10% (Hernan et al., 2002) or 20% by the inclusion or removal of a 
suspected third variable (Hosmer et al., 2011, Hosmer et al., 2013). Conversely, relying only 
on statistical significance to identify confounding is not recommended but if unavoidable, use 
a larger p-value than the traditional 0.05 during model building (Szklo and Nieto, 2007).   
1.12.1.2  Interaction 
In interaction, at least two explanatory variables (predictors) interact with each other and 
influence the parameter estimation during model building. The product of the two 
‘interacting’ variables is known as the two-way interaction term (Katz, 2011, Hosmer et al., 
2011, Hosmer et al., 2013). In interaction, the effect of a covariate in the model may differ 
depending on the level of the other covariate in the same model (Kleinbaum and Klein, 2012). 
Interaction can be described as instances in which potential intervention on secondary 
exposure is in view. It is often used interchangeably with effect modification (Hosmer et al., 
2011, Hosmer et al., 2013, Katz, 2011). In contrast to interaction, effect modification is merely 
conditioning of a secondary variable (VanderWeele, 2009, Knol and VanderWeele, 2012). 
Unlike a suspected confounder variable, the interaction term is tested for its statistical 
significance before keeping or removing it from the model using the likelihood ratio (LR) test. 
A variable in a model that has a p-value of less than 0.05 from a chi-square test suggests the 





1.12.2  Modelling the functional form of continuous covariates  
In developing a regression model,𝑥 = (𝑥1, … , 𝑥𝑘) denotes the vector of predictor variables 
under consideration and 𝑔(𝑥) = (𝛽1×1 + ⋯ + 𝛽𝑘×𝑘) is their linear function. 
For a logistic model (binary outcome), the relevant model is 𝑙𝑜𝑔𝑖𝑡 Pr(𝑌 = 1|𝑥) =
𝛽0 + 𝑔(𝑥) . In a Cox proportional hazards model (time-to-event outcome), the effect of 
predictors is modelled through the hazard functionℎ(𝑡|𝑥) = ℎ0(𝑡) exp[𝑔(𝑥)](Sauerbrei et al., 
2007). 
For generalised linear regression models, if the covariates or predictors are 
continuous, they must fulfil the assumption of linearity in the logit (Hosmer et al., 2013) or log 
hazard (Hosmer et al., 2011).  
1.12.2.1  The functional forms of continuous covariates   
The shape of the relation between the numerical or continuous predictor variables and the 
outcome in the model should be correctly specified. 
One of the many ways to represent the effect of continuous predictor variables on the 
outcome is categorise the continuous predictor. It is grouped into about four or five groups at 
‘suitable’ cut-off points. The products of this approach—the corresponding dummy 
variables—are used as a predictor in the model. Unfortunately, the use of cut-off points is 
problematic because: a) the resulting step function is a poor approximation of the true 
relationship, b) cut-off points almost always fit the data much less well than a suitable 
continuous function, c) it is hazardous because effect estimates are biased, d) p-values are 
much too small and unlikely to be reproducible (Royston et al., 2006, Sauerbrei et al., 2007), 
e) the number of cut-off points and where they are placed is arbitrary and f) results are not 
necessarily robust (Royston et al., 2006, Wong et al., 2011). 
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The use of splines is the next alternative. To use splines, a continuous predictor 
variable can be fitted by generalised additive models (Hastie and Tibshirani, 1990, Sauerbrei 
et al., 2007, Wong et al., 2011). The limitations when using spline-based estimation include: a) 
susceptibility to erroneous fitting of local noise (Sauerbrei et al., 2007) and b) instability, with 
very ‘wiggly’ fitted function, render an analysis less useful and difficult to reproduce 
(Rosenberg et al., 2003). 
Other options such as quadratic polynomials, or less frequently, cubic polynomials, 
have been used in the past. The problem with these two methods is that the range of curve 
shapes afforded by polynomials is limited (Royston and Altman, 1994, Sauerbrei et al., 2007).  
1.12.2.2  Fractional polynomials (FP) and other methods 
The functional relationship between numerical predictors and the outcome can be non-linear 
(J-shaped or U-shaped), which more accurately represents the risk than a straight-line linear 
relationship does (Wong et al., 2011). In addition, modelling numerical predictors correctly to 
represent non-linearity in a multivariable model will improve model fitting (Hosmer et al., 
2011, Hosmer et al., 2013, Wong et al., 2011). 
Fractional polynomial (FP) function and various types of spline are two of the most 
commonly used methods to represent the non-linear relationship between numerical 
predictors and the outcome variable (Sauerbrei et al., 2007). The spline method has not gained 
wide acceptance (Sauerbrei et al., 2007, Wong et al., 2011) because spline modelling, though 
extremely flexible, generates fitted curves with uninterpretable ‘wiggles’ hence is problematic 
to many readers (Sauerbrei et al., 2007, Royston and Sauerbrei, 2005). 
In FP, the transformation is applied to the numerical covariates. The power for the 
transformation function of 𝑥𝑝  , with p coming from a set, 𝑆 = {−2, −1, −0.5, 0, 0.5, 1, 2, 3}. In 
the case of 𝛽0 + 𝛽1𝑥
𝑝with p in S, the model is known as FP model of degree 1, or FP1. FP1 
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can be extended to degree 2 or FP2 (generalisations of quadratics) (Royston and Altman, 
1994). In multivariable modelling, use of degree 3 or FP3 or higher order functions is rarely 
sensible, as instability is greatly increased (Royston and Sauerbrei, 2005). 
1.12.2.3  Software to model the functional form of the continuous covariates 
In Stata (StataCorp., 2010), the multivariable FP (MFP) function can produce various functional 
forms of continuous (numerical) covariates to best represent the relationship between a 
predictor variable and an outcome variable. The advantage of using MFP is that in both 
univariable and multivariable model building, MFP will fit data using a simple method with 
interpretable and transportable results (Royston and Sauerbrei, 2005, Sauerbrei et al., 2007). 
In MFP, a ‘linear’ model for a numerical predictor x assumes a risk score or linear 
predictor of the form. Similarly, a non-linear model denotes non-linearity in x in the risk score. 
For example, in Cox regression models of the form, ℎ(𝑡|𝑥) = ℎ0(𝑡)exp 𝛽(𝑥) and ℎ(𝑡|𝑥) =
ℎ0(𝑡) exp(𝛽√𝑥)respectively represent the linear and non-linear form in x (Sauerbrei et al., 
2007). 
MFP uses the closed test procedure (Royston et al., 2006, Royston and Sauerbrei, 
2013, Sauerbrei et al., 2007, Wong et al., 2011). During the procedure, these algorithms take 
place: 
1. Determine the best-fitting second-degree polynomial by choosing power 
transformations from the set {-2, -1, -0.5, 0, 0.5, 1, 2, 3}, where 0 denotes the log-
transformation. 
2. The best-fitting FP2 is then compared against the null model using a deviance 
difference test with 4 degrees of freedom to determine whether the continuous 
covariate should be included in the model. 
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3. If the first test is statistically significant, a second deviance difference test with 
3 degrees of freedom is applied to compare the best-fitting FP2 against the linear 
model. 
4. If the second test is significant, a final deviance difference test with 2 degrees 
of freedom is used to compare the best-fitting FP2 with the best-fitting FP1. 
5. If the final test is significant, FP2 is included; otherwise, FP1 is chosen. 
1.12.3  Variable selection 
Subject matter knowledge should guide model building whenever possible (Sauerbrei et al., 
2007). Throughout the process of model building, variables that are extraneous, redundant, 
have a lot of missing data, or intervene between the risk factor and the outcome should be 
excluded (Katz, 2011). A predictor that is not significant statistically can remain in the model 
if it is important in practice and if it confounds the effect of the other predictors. On the other 
hand, predictors that are systematically biased can be excluded (Sauerbrei et al., 2007). 
In model building, predictor variables are added into the model or are removed from 
it. This addition and removal of a variable changes the regression parameters, and the newly 
developed model and the previous one must be compared to indicate the magnitude of 
change due to its addition or removal; all is done using logic, theory, prior research, hypothesis 
testing and model fit comparison (Singer and Willet, 2003). The degree of change can be 
checked using the LR test or the Wald test. Between the two, the LR test is preferred; 
unfortunately, there has been no statistical theory that provides clear evidence to support this 





1.12.4  Goals of model building  
In epidemiology, regression methods have become an integral component for modelling the 
relationship of risk factors and the disease or outcome of interest. Generalised linear models 
for example can describe the relationship between a response variable and one or more 
explanatory variables (Hosmer et al., 2013, Hosmer et al., 2011)—multifactorial conditions or 
risk factors (Katz, 2011). 
One of the goals of disease modelling is finding the best-fitting and most 
parsimonious, clinically interpretable model which describes the relationship between the 
response variable and explanatory variable (Hosmer et al., 2013, Hosmer et al., 2011). When 
the aim of model building is to explore important predictors or independent variables, it is 
recommended to approach model building by: a) data collection and preparation, b) reduction 
of explanatory or predictor variables, c) model refinement and selection and d) model 
validation (Neter, 1996). This approach requires a combination of substantive theory, research 
questions and statistical evidence (Singer and Willet, 2003). 
Methods to reduce the number of predictors include: a) manual selection and b) 
automatic selection. Automatic selection such as stepwise procedures perform better than 
literature-based assessment (Sauerbrei et al., 2007) unless the number of predictors or 
independent variables is large. With a large number of predictors, a parsimonious model is 
preferred. A parsimony model contains a subset of ‘important’ predictors whose regression 
coefficients differ from zero. For this task, sequential strategies include forward selection, 
stepwise selection or backward elimination procedures or all-subset selection with different 
optimisation criteria. In practice, the criteria for assessing the model after these strategies are 
Mallows’ Cp, the Akaike information criteria (AIC) or the Bayesian information criteria (BIC) 
(Burnham and Anderson, 2002, Sauerbrei et al., 2007). 
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1.13  Thesis overview 
This thesis focuses on the use of current and established epidemiological and statistical 
methods to develop a model of the risk factors for stroke, to explore the prognostic factors 
for stroke fatality, to compare the prognostic effect of the two main stroke subtypes: a) 
cerebral infarction and b) haemorrhagic stroke and lastly to model the longitudinal functional 
health status of stroke patients over 3 months. The information provided by this project would 
be useful for improving the overall understanding of the natural history of stroke, particularly 
in stroke prevention and control, the management of acute stroke in the hospital and finally, 
in post-stroke assessment, specifically in Kelantan and generally in Malaysia, where data on 
stroke are very scarce. 
First, I investigated the risk factors for stroke using a case–control study design. I 
included individual- and area-level risk factors (Paper I). Using binary logistic regression and 
in-hospital case and control patients, I developed an epidemiological risk factor model to 
predict the risk for stroke. The independent risk factors for stroke in Kelantan are: a) age, b) 
sex, c) race, d) population density and e) average number of household members. The model 
was complicated by the interaction of the variables age and sex and by the non-linear 
relationship between age and the odds for stroke. 
Next, using similar hospital-based stroke data, I extracted data from a cohort of stroke 
patients admitted to HUSM. Using the time-to-event data, I developed a prognostic model 
based on Cox proportional hazard regression to predict in-hospital stroke fatality. The 
independent prognostic factors of in-hospital stroke fatality were age and the GCS score—a 
well-known scale that quantifies the severity of a coma (Paper II). 
Based on the information from Paper II, the focus in the subsequent study was to 
compare the clinical presentation (on admission), fatalities and prognostic effect of stroke 
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fatality between two main stroke subtypes: a) haemorrhagic stroke and b) cerebral infarction) 
(Paper III). 
Lastly, to understand the impact of stroke on functional status after acute stroke 
(post-stroke), I recruited 98 stroke patients admitted to HUSM and HRPZ. I collected their 
baseline information and scored each patient using the Barthel Index—a well-known 
functional status questionnaire in stroke—at discharge then at 1 and 3 months after discharge 
(Paper IV).  
1.13.1 Draft Paper 1 
Individual and area-level risk factors for stroke in Kelantan, Malaysia: A hospital-based case–
control study by Kamarul Imran Musa, Peter J Diggle, and Thomas J Keegan is a study in which 
we investigated the risk factors for stroke using in-hospital patient data from two major 
hospitals in Kelantan: a) HUSM and b) HRPZ. Our general objective was to explore the 
relationship of the individual- and area-level variables (risk factors) with the outcome (stroke 
or no-stroke) using a case–control study design. We defined the cases (stroke) and the controls 
(no-stroke) using the ICD-10. We requested the hospital data containing the individual-level 
data for the cases and controls. The Department of Statistics, Malaysia, provided the area-
level data. We performed binary logistic regression to model the risk factors and during the 
modelling, we used MFP to correctly specify the non-linear relationship between the 
continuous variables and the outcome. We plotted a variogram to assess the presence of 
significant spatial correlation (whether the geographical locations of stroke patients are 
related with the risk for stroke). In this paper, we analysed 3118 patients (1369 cases and 1749 
controls) and found that the variables age, population density, average number of household 
members and race and a 2-way interaction term between transformed age and sex were 
significant in the final model. The final model also passed the goodness of fit test. There was 
64 
 
no strong evidence to suggest the presence of spatial correlation, hence justifying the use of 
traditional binary logistic regression. We concluded that a model with age, race, population 
density and an interaction term between age and sex predicts stroke but that locations do not. 
 Dr Thomas Keegan and I designed the study. I requested data from the hospitals and 
the Department of Statistics and cleaned and analysed the data. Professor Peter Diggle 
critically reviewed the analysis and improved the results. I drafted the manuscript and Dr 
Thomas Keegan performed the review and final editing of the overall manuscript.  
1.13.2  Draft Paper 2 
Glasgow Coma Scale and age as independent prognostic factors for in-hospital stroke fatality 
by Kamarul Imran Musa, Peter J Diggle, and Thomas J Keegan is a study with the following 
objectives: a) to compare the on-admission variables between stroke patients who were alive 
and dead at discharge, and b) to identify the prognostic factors for stroke fatality. In this study, 
we recruited 226 consecutive stroke patients admitted to HUSM. Stroke patients were eligible 
if they had been discharged with the ICD-10 Chapter IX Blocks I60–I69 (cerebrovascular 
diseases). We used an independent t-test and the Pearson chi-square test to compare the on-
admission variables between stroke patients who were alive or dead on discharge. We 
performed Cox proportional hazard regression analysis to identify the prognostic factors for 
stroke fatality. In this study, 57.1% (129/226) of stroke patients were female and 42.9% 
(97/226) were male. On admission, the overall mean age and GCS score were 60.8 years and 
12.4, respectively. Overall, 65.4% (148/226) and 32.7% (74/226) had high blood pressure and 
diabetes mellitus, respectively. Two models were considered: a) age and GCS score, and b) age 
and stroke subtype. Model (a) was considered the best prognostic model for stroke fatality 
because it is more practical in clinical settings. 
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Dr Thomas Keegan and I designed the study. I requested the patient files and extracted 
the relevant data from each patient file. I entered, cleaned, analysed and interpreted the data. 
Professor Peter Diggle critically reviewed the analysis and improved the results. I drafted the 
manuscript and Dr Thomas Keegan performed the review and final editing of the overall 
manuscript. 
1.13.3  Draft Paper 3 
Comparing cerebral infarction and haemorrhagic stroke in Asia: case–fatality and prognostic 
effect for in-hospital survival by Kamarul Imran Musa, Juhara Haron, Peter J Diggle, and 
Thomas J Keegan is a study in which our aims were to: a) describe the on-admission variables 
for patients with cerebral infarction and haemorrhagic stroke, and b) compare stroke fatalities 
(3 days, 7 days and 14 days) and the prognostic effect for case–fatality between cerebral 
infarction and haemorrhagic stroke. We collected data from two groups of consecutive stroke 
patients admitted to HUSM: a) cerebral infarction (n = 150) and b) haemorrhagic stroke (n = 
142). We extracted patient variables from the hospital medical records and patient clinical 
folders and reviewed all CT scan images and reports. The overall stroke fatality and fatalities 
at 3 days, 7 days and 14 days were described. The survival probability and prognostic effect 
were estimated using Kaplan–Meier survival estimates and Cox proportional hazard 
regression, respectively. We found that patients in the haemorrhagic stroke group were 
younger, had poorer GCS scores and had a higher mean diastolic blood pressure than those in 
the cerebral infarction group. The median survival time for patients with cerebral infarction 
was 28 days; that for patients with haemorrhagic stroke was 14 days. Haemorrhagic stroke 
patients had more than twice the risk for stroke fatality than those in the cerebral infarction 
group. We concluded that haemorrhagic stroke patients had less favourable clinical 
presentation on admission, higher 3-, 7- and 14-day fatalities and more than twice the risk for 
stroke fatality than those with cerebral infarction while in hospital. 
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Dr Thomas Keegan and I designed the study. I requested the patient files and extracted 
the relevant data from each patient file. Dr Juhara Haron verified the case note diagnosis with 
CT scan images archived at HUSM or the CT reports of each patient. I entered, cleaned, 
analysed, interpreted the data and drafted the manuscript. Professor Peter Diggle critically 
reviewed the analysis and improved the results and Dr Juhara Haron reviewed the methods. 
Dr Thomas Keegan performed the review and final editing of the overall manuscript. 
1.13.4  Draft Paper 4 
Barthel Index scores over three months are related to age and stroke subtype in Asian stroke 
patients by Kamarul Imran Musa, Peter J Diggle, Thomas J Keegan is a study with the following 
objectives: a) describing the change in the Barthel Index at baseline (discharge) to 1 month 
and then 3 months post-baseline, and b) estimating the relationship of age, sex and stroke 
subtype with the change in Barthel Index scores over the 3-month period. We recruited 98 
stroke patients from HRPZ and HUSM when they were admitted for stroke. I scored the Barthel 
Index for all patients at baseline (discharge) and then at 1 and 3 months after discharge. We 
used the random intercept model to account for the individual subject random effect. In this 
study, the mean age of the patients was 60.7 years, 65.3% (64/98) were female and 73.7% 
(70/95) had ischaemic stroke. The unadjusted Barthel Index for all patients increased from 
baseline (mean score = 35.1) to 1 month (mean score = 64.4) and 3 months (mean score = 
78.0). Between discharge and 3 months, 13 patients had died and the distribution of scores 
between patients who died and who were alive during the study period were statistically 
different (p-value from Kolmogorov–Smirnov test = 0.048). Using a linear mixed effect (lme) 
model, the significant predictors for the change in Barthel Index over the 3-month period were 
measurement occasions, age and stroke type. Over the 3-month period, the adjusted mean 
score—from lme—for the Barthel Index increased from 35.1 to 68.7. We reported that with 
increasing age, the Barthel Index score decreased and that haemorrhagic stroke patients had 
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lower Barthel Index scores than ischaemic stroke patients. We concluded that, overall, the 
Barthel Index scores increased from discharge to 3 months and that measurement occasion, 
age, and stroke type, but not sex, were related with the change in Barthel Index score.  
Dr Thomas Keegan, Professor Peter Diggle and I designed the study. I interviewed all 
patients at baseline (discharge) and at 1 and 3 months after the baseline interview. I entered 
and cleaned the data and analysed the results. Professor Peter Diggle critically reviewed the 
analysis, helped in the interpretation and improved the results. I drafted the manuscript and 
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Aims To identify the risk factors for stroke using the individual-level and the area-level 
variables among in-hospital patients in Kelantan, Malaysia. 
Methods A case-control study using in-hospital patients was undertaken. The individual-level 
data were retrieved from the hospital records. The area-level data were derived from the 2010 
Malaysia nationwide census. The cases and controls were defined based on the International 
Classification of Diseases 10th Revision (ICD-10). Logistic regression was used to model the risk 
factors and multivariable fractional polynomials (MFP) to capture non-linear associations of 
numerical variables with stroke risk. The sample variogram and envelopes were simulated 
after fitting the model and plotted to explore the residual spatial correlation at the level of 
sub-sub districts (n=288).   
Results A total of 3,118 patients (1,369 cases and 1,749 controls) were analysed. At univariable 
logistic regression analysis, variables age, sex, race, marital status and population density were 
significantly associated with stroke admission. After fitting multivariable logistic regression, 
variables age, population density, average household and race and two-way interaction 
between age and sex were significantly related with stroke. The area under the Receiver 
Operating Characteristic (ROC) curve was 0.733 and the final model passed Hosmer-Lemeshow 
and Pearson goodness of fit tests. The sample variogram showed no evidence of residual 
spatial autocorrelation. 
Conclusion Age, sex, race, population density and average household are independent risk 
factors for stroke in Kelantan, Malaysia. A quantitative description of the odds for stroke is 
complicated by the non-linearity and by the interaction of age and sex.  
Keywords: Stroke, Risk factors, Logistic regression, Fractional polynomials 
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2.2 Introduction  
Stroke is defined as a clinical syndrome of permanent brain dysfunction having an improving 
or worsening temporal profile commonly due to a brain infarction, brain ischaemia or brain 
haemorrhage (Tegos et al., 2000). It is ‘a clinical syndrome characterized by rapidly developing 
clinical symptoms and/or signs of focal, and at times global, loss of cerebral function, with 
symptoms lasting more than 24 hours or leading to death, with no apparent cause other than 
that of vascular origin’ (Hatano, 1976). The World Health Organization (WHO) reported that in 
2008 stroke was the second commonest cause of death worldwide. (Lopez et al., 2006, Sarti 
et al., 2000).   
 Knowing the risk factors for stroke is important for its control and prevention. 
Customarily, the risk factors for stroke are categorized into modifiable risk factors, such as 
biochemical profiles or smoking status, and the non-modifiable risk factors such as sex and 
age (Adams, 2007, Lindley, 2008). Alternatively, risk factors can also be categorized into 
traditional (such as smoking status or blood pressure) and novel risk factors (such as 
geographical location) (Romero et al., 2008).    
 As research in stroke progresses, new domains of social and environmental risk factors 
have been studied in addition to the big three risk factors for stroke - hypertension, diabetes 
mellitus and cigarette smoking (Adams, 2007). These new domains include; environmental risk 
factors such as geographical locations (Havulinna et al., 2008, Pedigo et al., 2011) and ethnic 
background (Carson et al., 2012, Pullicino et al., 2009). Geographical locations and improved 
computation enable spatial analysis and these has proven useful to track system progress of 
stroke management and to act as a tool in stroke surveillance (Gropen et al., 2009). In the 
United States of America, studies such as the REasons for Geographic And Racial Differences 
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in Stroke study (REGARDS) allowed for the creation of a national cohort to address geographic 
and ethnic differences in stroke (Howard et al., 2006).  
 The majority of stroke studies has taken place in high-income countries (O'Donnell et 
al., 2010a). We used Pubmed Advanced Search Builder (www.pubmed.com) and set the titles 
as ‘Malaysia’ and ‘Stroke’. The search yielded fifteen articles, with the latest publication 
published in May 2016, in Neurology Research. Only one was a longitudinal study and it was 
about a small population in the Northwest Malaysia. None was a case-control study. Eleven 
articles came from studies based on single-centre study (Mohd Zulkifly et al., 2016,  Wan-Arfah 
et al., 2015, Sudirman et al., 2015,  Ali et al., 2015, Akhavan Hejazi et al., 2015, Sahathevan et 
al., 2014,  Khoo et al., 2013, Nor Azlin et al., 2012,  Rameezan and Zaliha, 2005, Hamidon and 
Raymond, 2003, Jaya et al., 2002b), three articles were from multi-centre studies 
(Neelamegam et al., 2013, Aziz et al., 2015, Aziz et al., 2016) and one article is a review article 
(Loo and Gan, 2012).   
 Motivated by the need to improve the understanding of risk factors for stoke in 
Malaysia, and with the availability of the latest census tract from 2010 nationwide census, we 
have carried out a hospital-based case-control study. To our knowledge, the study is the first 
of its kind in Malaysia to investigate the incidence of stroke, traditional risk factors using 
census tract data. The current study would be a valuable resource for healthcare providers 
and policy makers in the control and prevention programme for stroke in Malaysia specifically 
and in Asia generally. We examined the relationship between two groups of risk factors 
variables – the traditional individual-level variables and the census area-level variables – and 




2.3 Methods  
2.3.1 Study design and setting  
We performed a hospital-based case-control study in the state of Kelantan, in the north-east 
of Malaysia. Kelantan, is bounded by Thailand in the north, the South China Sea in the 
northeast, the state of Terengganu in the east, the state of Pahang in the south and the state 
of Perak in the west. It covers 15,099 km square, and in 2011 had a population of 1.6 million.  
 Our study was set in the two public hospitals in Kelantan that offer a neurology service. 
These were a Ministry of Health hospital, Hospital Raja Perempuan Zainab II (HRPZ) and a 
public university teaching hospital, Hospital Universiti Sains Malaysia (HUSM). 
 In this study, the individual-level data were obtained from the hospital records and 
the area-level data were provided by the Department of Statistics, Malaysia (in shapefile 
format). There are 288 administrative districts sub-sub districts (known as ‘mukim kecil’) in 
Kelantan, Malaysia, and we received area-level data for each. The area-level data consisted of 
data on: surface area (square km2), average household size and population size for each sub-
sub district.   
2.3.2 Selection of cases and controls  
Cases and controls were selected from in-patients at both study hospitals.  
 A patient was eligible to be recruited as a case for the study if they met all the following 
criteria; at least 18 years old, a Kelantan resident, a Malaysian citizen and was treated in either 
Hospital Universiti Sains Malaysia (HUSM) or Hospital Raja Perempuan Zainab II (HRPZ) as in-
hospital patients within the study period, June 2010 - June 2011.  
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 Cases were patients who had been discharged with the diagnosis of cerebrovascular 
disease (ICD-10) Blocks I60 to I69 (Cerebrovascular diseases) in the Chapter IX (Diseases of the 
Circulatory Systems). The discharge diagnosis had to have been made by either the neuro-
medical or the neuro-surgical team at HUSM and HRPZ, Kelantan.  
 Controls were selected from patients who had been discharged from either one of the 
study hospitals with the ICD-10 diagnoses of other than cerebrovascular disease Blocks I60-
I69. This means we selected patients as controls even though they have circulatory problems 
such as ischaemic heart diseases (ICD-10 I10-I15), hypertensive diseases (ICD-10 I10-I15), 
pulmonary heart diseases and diseases of pulmonary circulation (ICD-10 I16-I28) and other 
circulatory problems that share many of the risk factors with cerebral infarct (Table 2-1). In 
other case-control study, these type of controls were excluded (O'Donnell et al., 2010a). Our 
intention is that our study will be able to identify risk factors that are more related to stroke 
than other cardiovascular diseases. We excluded a patient as a control if the discharge 
diagnoses was either ICD-10 Chapter XV Pregnancy, Childbirth and the Puerperium (O00-O99) 
or ICD-10 Chapter XVI Certain Conditions Originating in the Perinatal Period (P00-P96) (Table 
2-1). 
 Case-control studies in which the cases are drawn from a tertiary referral centre (such 
as ours) can be prone to selection bias as the cases are a selection of all possible stroke cases 
(in particular they are the cases that have survived to get to hospital). We used hospital 
controls which raises the possibility of bias being introduced, in that the controls may differ in 
some way from the population from which the cases were drawn and this itself may be related 
to exposure. Limitations in resources prevented us from selecting controls from the 
community, as has been the practice in other studies (O'Donnell et al., 2010a, O'Donnell et al., 




Table 2-1 Diagnostic categories for controls 
Diagnostic categories for controls Conditions 
Included ICD-10 categories:  




Excluded ICD-10 categories:  
ICD-10 Chapter IX I60-I69 Cerebrovascular diseases 
ICD-10 Chapter XV Pregnancy 
 Childbirth 
 Puerperium 
ICD-10 Chapter XVI Certain Conditions Originating in the 
Perinatal Period (P00-P96) 
 
2.3.3 Statistical analysis  
All data analyses were carried out using Stata version 11.2 (StataCorp., 2010) except for the 
variogram analysis for which we used R version 3.11. (R Development Core Team, 2013). 
Summary descriptions were means and standard deviations for numerical variables, 
frequencies and percentages for categorical variables. 
 We performed univariable logistic regression followed by multivariable logistic 
regression using as the outcome variable admission to hospital for stroke, coded as 1 for ’yes’ 
and 0 for ’no’.  
 We used  purposeful manual variable selection whereby independent variables were 
added one at a time (Hosmer et al., 2013). Briefly, during the selection process, we performed 
these steps: 
1) we began our analysis with careful univariable analysis of each independent variable. 
Through the use of these analyses, we identified, as candidate variables for the first 
multivariable model, any variable whose univariable test has a p-value less than 0.25 
or 0.20, or whose has clinical importance. 
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2) we fitted the multivariable model containing all the covariates identified for inclusion 
in Step 1.  We assessed the importance of each covariate using the p-value of its Wald 
test or the likelihood ratio test.  
3) We compared the reduced model against the full model. In particular, we were 
concerned with any variables whose coefficients has changed markedly 
4) We checked the assumption that the logit had increased/decreased linearly as a 
function of the covariate. 
5) We checked for interaction among the variables in the model.  
6) We assessed the model fitness.    
 At each step of adding or removing a variable in the model, the likelihood ratio test 
was performed and the degree of change in the beta coefficients of the variables was checked 
for the presence of significant confounding effects.  
 We checked all the numerical variables to determine whether they should enter our 
model linearly or transformed using the Multivariable Fractional Polynomials (MFP) function 
in Stata (Royston and Sauerbrei, 2004, Sauerbrei et al., 2007, Hosmer et al., 2013). Based on 
MFP, variable age was transformed to two terms of age1=age/10 and age2= (age/10)2 
(quadratic function).   
 The interaction between transformed age and sex was significant (p-value <0.05 on 
two degrees of freedom) and included in the model accordingly. Goodness of fit was assessed 
using the Hosmer-Lemeshow test, C, Pearson chi-square test (Hosmer et al., 2013) and area 
under the Receiver Operating Characteristics (ROC) curve (Zelmanovitz et al., 1997).   
 We used the sample variogram of the residuals to check for spatial autocorrelation 
between stroke risk and location. A significant spatial autocorrelation would indicate a 
significant relationship between stroke and location after allowing for the effects of all 
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independent variables included in the model. Standard statistical regression models often 
assume independence of the observation and these models are not appropriate for analysing 
spatially dependent data (Auchincloss et al., 2012). The availability of geographic coordinates 
in our data enabled the assumption of independence of the observation to be checked.  
 To perform the variogram analysis, we needed the geographical coordinates of each 
patient in the study. Unfortunately, neither hospital recorded the address coordinates for 
patients. Hence, we obtained coordinates (geocoded) addresses by matching each patient’s 
address with the database of villages provided by the Malaysian Centre for Geospatial Data 
Infrastructure (MaCGDI) at  http://1malaysiamap.mygeoportal.gov.my/ website. This 
database contains the names of villages in Malaysia with the corresponding geographical 
coordinates. These geographical coordinates are the latitude and longitude coordinates 
pointed at the centre of each of the village. Alternatively, we utilized the open-source mapping 
service providers: a) Wikimapia ( http://wikimapia.org/ ) and, b) Google map ( 
https://www.google.com.my ) to locate the villages that are not available in the MacGDI 
database.  Using ArcGIS, we determined the geographical coordinates of these villages. These 
village geographical coordinate (the geographical centroid) acted as the coordinates for 
patients address in this study. To prevent ‘stacking’ of multiple geographical coordinates of 
the villages, we used R software to slightly ‘jitter’ the coordinates. 
 We calculated the spatial residuals as the difference between the observed number 
of strokes in a sub-sub district and the expected number of stroke in a sub-sub district (n=286) 
after fitting the logistic model. We measured the distances between each pair of centroids of 
the sub-sub districts and calculated the sample variogram up to a maximum distance of 50,000 
metres (50km).  
In the plot of the sample variogram, the rising curve indicates positive spatial 
correlation. Conversely, a plot that is confined within the envelopes of variograms after 
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random permutation of the residuals indicates absence of spatial autocorrelation (Diggle and 
Ribeiro, 2007).  
 On completion of model building and model checking, the final estimated logit model 
for our stroke data is given in the following equation: 
?̂?(𝑥) =  −6.575 + 1.501(𝑎𝑔𝑒1) − 0.086(𝑎𝑔𝑒2) + 0.130(𝑝𝑜𝑝) − 1.332(𝑠𝑒𝑥)
+ 0.596(𝑟𝑎𝑐𝑒) + 0.179(𝑎𝑣𝑒𝑟ℎℎ)  + 0.582(𝑎𝑔𝑒1)(𝑠𝑒𝑥)
− 0.058(𝑎𝑔𝑒2)(𝑠𝑒𝑥) 
 where: 1age  is /10)(age , 2age  is 
2/10)(age , pop  is population density - every 
increase in 1,000 population per 1 km square, sex  is male vs female (reference), race  is 
Malay vs non-Malay (reference), and averhh is average number of household , 5 or more 
household vs less than 5 household (reference). 
2.3.4 Ethical approval  
We received the ethical approvals from the Medical and Research Ethics Committee (MREC), 
Ministry of Health, Malaysia (NMRR-12-471-12139), the Human Research Ethics Committee 
USM (HREC),Universiti Sains Malaysia (JEPEM[242.4.(1.4)]) and Lancaster University Ethics 
Committee. 
2.4 Results  
We analysed data on 3,118 patients from two hospitals, Hospital Universiti Sains Malaysia 
(HUSM) and Hospital Raja Perempuan Zainab 11 (HRPZ), Kelantan, Malaysia. Of these, 1,369 
were cases and 1,749 were controls. Sixty-four percent of cases and controls came from HRPZ 
and the rest from HUSM. 
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 Table 2-2 shows the individual and area-level variables (characteristics) of the cases 
and controls. There were more males (54.8%) than females (45.2%). A majority of patients 
(75.9%) were married at the time of admission and 94.2% of all patients were Malays. The 
mean age for all patients was 55.2 years old (SD = 17.9) and the cases were older than the 
controls (63.1 years vs 49.0 years).  
In Table 2-3 we show the final logistic model containing the independent variables and their 
adjusted odds ratios for stroke. These individual-level variables; age1 and age2 (both 
transformed from age), race (Malay vs Non-Malay), sex (Male vs Female) and the interaction 
term for age1 and age2 with sex;  and population density and the average household size from 
area-level variables were significant the final model. 
Table 2-2 also shows the area-level variables obtained from the Malaysia 2010 census. The 
mean population density was 1328.2 people per km square and was higher in cases (1427 
people per km square) than in controls (1252 people per km square). Of all, 29.8% of the 
census-tracts had the average household size of 5 or more.   
In Table 2-2, we show the results from the univariable or simple logistic regression. 
The independent variables were; age, transformed variable age, age1 and age2, sex, race, 
marital status, population density, average household size and were analysed one at the time. 
The outcome variable was admission to hospital for stroke. Significant relationships with the 
outcome of stroke were seen with all independent variables except race and average 
household size. In the last column of   
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Table 2-3, we show values for the log likelihood of each of the independent variable. 
The lowest value for the log likelihood the model with the best fit, so the model with 2 terms 
(age1 and age2) transformed from age has a better fit (log likelihood = -1843.72) than the 
model using the untransformed age (linear form) (log likelihood = -1879.28).     
In Table 2-3 we show the final logistic model containing the independent variables and 
their adjusted odds ratios for stroke. These individual-level variables; age1 and age2 (both 
transformed from age), race (Malay vs Non-Malay), sex (Male vs Female) and the interaction 
term for age1 and age2 with sex;  and population density and the average household size from 
area-level variables were significant the final model. 
Table 2-2 Individual and area-level variables of cases and controls. The outcome was coded 
as a binary variable either as a case (has stroke) or a control (does not have stroke). 
Variables 
 
Cases, n=1,369 Controls, 
n=1,749 
All,  n=3,118 
  
n % n % n % 
Sex Male 723 52.8 987 56.4 1,710 54.8  
Female 646 47.2 762 43.6 1,408 45.2 
Marital Status  Married 1,148 83.9 1,225 70.0 2,377 75.9  
Others 221 16.1 524 30.0 98 3.1 
Race Malay 1,300 95.0 1,637 93.6 2,937 94.2  
Other 69 5.0 112 6.4 181 5.8 
Household size ≥5 430 31.4 499 28.5 929 29.8  
< 5 939 68.6 1,250 71.5 2,189 70.2 
  Mean SD Mean SD Mean SD 
Age Years 63 12.9 49 18.8 55 17.9 
Population 
density 
Pop/ km 2 1,427 1405.4 1,252 1355.5 1,329 1,380.2 
Note: Age: Mean and SD, Pop density: Population density. Pop density and average household are area-
level variables  
  
 A sensitivity analysis, in which the observed status of the patients was compared to 
the predicted status using the final model, showed that the final performs acceptably. The 
results show that the overall rate of correct classification: sensitivity, specific, positive 




Two goodness-of-fit tests, the Pearson and the Hosmer-Lemeshow goodness of fit 
tests show that our model has good fit. The former test shows no significant difference 
between the observed and fitted value (chi-square p-value=0.215) and the latter, which 
compares the observed and estimated frequency in different group of probabilities, was also 




Table 2-3 Simple logistic regression results showing the estimated regression coefficients, 












Constant only model 
3118 
-0.24 
-0.32 -0.17 <0.001 
-
2138.02 
Untransformed age  
3118 
0.05 
0.05 0.06 <0.001 
-
1879.28 
Transformed age 3118  
    
Age1  1.80 1.47 2.12 <0.001 -




















(1,000 per km2) 
3118 
0.09 







-0.02 0.29 0.08 
-
2136.50 
a,c are the unadjusted parameters and p-values. b Confidence interval. d are the log-likelihood values. 
Age1 and Age2 are the transformed variables from age generated by Multivariable Fractional 
Polynomials (MFP) in Stata. Age1=Age/10, Age2=(Age/2)2  
 
 
Table 2-4 The final model developed from multiple logistic regression analysis (n=3118) 
showing the estimated odds ratios, respective 95% confidence intervals and p-values. 





age1 4.49 2.76 7.29 <0.001 
age2 0.92 0.88 0.96 <0.001 
Malay v. non Malay 1.81 1.30 2.54 0.001 
Male v. female 0.26 0.04 1.71 0.162 
age1*male 1.79 0.93 3.46 0.084 
age2*male 0.94 0.89 1.00 0.044 
Population density (1000 per km2) 1.14 1.07 1.21 <0.001 
> 5 household size v. < 5 1.20 1.01 1.42 0.043 






Figure 2-1 The estimated log-odds from the final model (n=3118) are plotted against the 
variable age. The estimated age effects for males (circles) and females (crosses) shows that 
the log odds for stroke in men are lower than women at ages up to 35 years, slightly higher 
between ages 40 years and 60 years, and increasingly lower starting at the age of 65 years.  
 
Figure 2-2 The adjusted odds ratios (OR) from the final model (n=3118) are plotted against 
the variable age. Though the log odds show different age effect for men and women in 
throughout the age as shown in Figure 2-1, but based the 95% confidence intervals (CI) for 
the odds ratio, they only reached statistical significance at the age of 75 years and beyond 
(as 95% CIs are below 1). 
 
Figure 2-1 and Figure 2-2 show the relationship between age (independent variable) 
and log odds and odds ratios of having stroke by sex, respectively. In Figure 2-1 the curves for 
the log odds of stroke in men and women intersect around 40 years for men and 65 years for 
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women. Before the age of 65, the odds of stroke in both men and women increase with age. 
From the age of 65, the odd of stroke in women increases slightly whereas the odd of stroke 
in men decreases.  
 In Figure 2-2, we plotted the odds ratios (OR) from the final model (n=3118) against 
age (between the age of 20 years to 95 years old with 5-year intervals). In the analysis, women 
were grouped in the reference group. The plot shows that between the age of 20 years old 
and 35 years old, the odds of having stroke in men were lower than the odds of stroke in 
women (odds ratio < 1) albeit non-significant (95% confidence intervals cross 1). However, as 
all patients aged, the difference in odds decreased. Between 35 years to 65 years of age, the 
odds for having stroke in men surpassed than that of in women (odds ratio > 1) but the 95% 
confidence intervals still cross 1. The biggest difference in the odds between sexes was around 
the age 50 years old. From then on, the difference in the odds progressively decreased and 
around 75 years, the odds for having stroke in men are now being surpassed by the odds of 
having stroke in women. All the 95% confidence intervals between the age of 75 years to 95 
years are below one (1).  
In Figure 2-3, the sample variogram to check for spatial autocorrelation taken from 
the centroids of the sub-sub districts (n=286) is shown. The flatness of the ordinates indicates 
absence of strong relationship between the spatial residuals and locations of stroke patients 
measured by the distance a case lives far from one another. This justifies the use of 
conventional logistic regression – excluding locations (coordinates) of patients – in our model 




Figure 2-3 Sample variogram and envelopes generated by simulating the semivariance 
against the distance (in metre). The variances come from the final fitted multiple logistic 
model. The variogram was based on observed residuals generated by the logistic model and 
the ordinates were taken from the centroid coordinates of the sub-sub districts (’mukim 
kecil’), n=286. 
2.5 Discussion 
In this case-control study, we explored the individual-level and area-level risk factors for stroke 
using data from in-hospital patients in the state of Kelantan, Malaysia. We found that the 
important individual-level risk factors for stroke were age, race and sex, and the area-level risk 
factors for stroke were population density and average household size. There was also no 
evidence that a patient’s location and stroke risk were correlated, hence, use of a ‘traditional’ 
logistic regression was adequate.  
It is generally accepted that as people age, the risk of chronic diseases such as stroke, 
increases (Schaller, 2007). It has been shown that the incidence of stroke doubles every 
decade in both females and males after the age of 55 years (Rojas et al., 2007). This study 
confirms such a relationship in stroke. But, it is also important to consider if age should be one 
of the important risk factors in the model rather than as a nuisance variable (Sanderman et 
al., 2006, Joffe, 2003). In this study, we assessed the role of age to try to understand its role in 
the ‘aging process’ in our populations, hence the requirement to model age as one of the 
covariates in our model. 
85 
 
 We transformed the variable age into two new variables because the odds for stroke 
with age was not linear. We used the fractional polynomials method for the transformation. 
The non-linearity in the risk for cardiovascular diseases in numerical variable such as age is 
consistent with other epidemiological studies (Drefahl et al., 2012, Driver et al., 2008, Modig 
et al., 2013a). The implications for our analysis of non-linearity are two-fold: a) firstly, the need 
to transform the variable age to better fit the statistical model, and b) the relationship 
between age and risk stroke is not a straight line so is best presented in a graph.  
In addition to nonlinearity, our model was also complicated by the interaction 
between age and sex. We showed the odds for stroke in male and female patients following 
two different trajectories. In males, odds of stroke increased in a curvilinear fashion with age 
and plateaued around age 65. And after age 75, the odds for stroke in men decreased. In 
females, however, the odds of stroke increased and plateaued only at the age 80 years and 
with no subsequent decrease. This result suggests that women were protected from stroke 
compared to men until certain age and this is consistent with studies in the US (women were 
protected until the age of 80 years old) (Sealy-Jefferson et al., 2012) including results from the 
Framingham Heart Study (Petrea et al., 2009). Unfortunately, the reason for the protective 
effect is still not known (Sealy-Jefferson et al., 2012) but social and medical factors could be 
the contributing factors (Petrea et al., 2009). We acknowledge that in our study, it is possible 
that the age result may have been driven by selection bias. This bias could have resulted from 
differences in the referral pattern by the sex of controls, such that at younger ages male 
controls may have been younger than male cases because the nature of the conditions for 
which they were in hospital. 
 In general, there is no consensus in the literature over whether either men or women 
have a higher risk for cardiovascular disease. It has been postulated that as a result of various 
biological, environmental and social factors, men have a higher risk for stroke than do women, 
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possibly in the range from 30-40% (Roger et al., 2012). The National Health and Nutrition 
Examination Surveys (NHANES) from 1999-2004, has reported that women were more than 
twice as likely to have had a stroke than men and earlier; from the age of 45 to 54 years 
(Towfighi et al., 2011, Towfighi et al., 2007). Some age-matched studies show that women had 
higher stroke incidence (Appelros et al., 2009). Our study suggests the odds for stroke were 
higher in men than in women between the age range of 35 and 65. Outside this range, our 
data suggests the odds for stroke were higher in women. Our model shows that after the age 
of 65, the risk for stroke in women levelled off, though still at a rate consistently higher than 
in men.  
 The age when the risk for stroke is higher in females differs between studies. For 
example, we reported that women started to have higher risk for stroke than in males at the 
age of 65. In Argentina, the risk for stroke in females increased higher than males at the age 
of at least 80 years old (Rojas et al., 2007).  
 We also found that ethnicity was significantly associated with risk of admission for 
stroke. Malay patients had higher odds for stroke admission compared to non-Malay patients. 
Ethnicity has been shown to play a role in the development of cardiovascular disease, for 
example, a study in Singapore has shown different disease rates between members of Malay, 
Chinese and Indian ethnic groups (Lee et al., 2001). More generally, Asian ethnic groups have 
higher risk for stroke compared to white Caucasian men (Eastern Stroke Coronary Heart 
Disease Collaborative Research Group., 1998) and in America, African Americans have a higher 
risk of ischaemic stroke compared to other ethnic groups (Ohira et al., 2006). The difference 
in risk could be related to different health status and lifestyles between ethnicities, for 
example in Singapore, obesity rates in Malays were higher than in other ethnic groups (Hong 
et al., 2004).  
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 On possible reason, why people of Malay ethnicity may be at higher risk of overweight 
and cardiovascular disease is in adhering to different diet. It is known that Malay people 
consume less daily fruits than the people of Chinese or South Asian ethnicity, another risk 
factor for cardiovascular disease (Yen and Tan, 2012). Further studies looking at ethnic 
disparities will help in the planning of practical preventive strategies (Hong et al., 2004).  
In this study, the population density and average size of household are significantly 
related to the risk of hospital admission for stroke. An increase in population density was 
associated with an increase in odds of stroke – a 14% increase in odds for every additional 
1,000 populations per km2. Areas in which the average household contained more than 5 
people had a 20% higher odd of stroke compared to smaller households. Our results perhaps 
suggest that these population density and average household size are proxies for the degree 
of urbanization, crowdedness, air pollution and the greater pressure of life – all of which 
contribute to increased stroke prevalence (Lin et al., 2007). In developing countries, 
urbanization has been shown to improve socio-economic but at the same time, increases the 
prevalence of cardiovascular risk factors (Nakibuuka et al., 2015).   
 We avoided categorizing numerical variables to avoid losing statistical information and 
power (Royston et al., 2006, Royston and Altman, 2010) and instead, used fractional 
polynominal method to model them. Fractional polynomial is a robust method which can 
improve the model fit (Wong et al., 2011). One of the advantages of using STATA software is 
that it has the most functions for performing fractional polynomials in comparison to other 
software (Sauerbrei et al., 2007, Royston and Sauerbrei, 2013, Royston and Sauerbrei, 2004). 
Using a parametric Multivariable Fractional Polynomials (MFP) function in STATA, we show 
that the odds for stroke were not linear in both male and female at different age. MFP also 
allowed us to show graphically the interaction between the variables age and sex.  
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 Studies have recently reported that location of patients is a risk factor for stroke (Hunt 
et al., 2014, Lee et al., 2014). The relationship between a location and an event, a phenomenon 
known as spatial correlation, can be explored using a variogram (Diggle and Ribeiro, 2007) or 
alternatively, can be treated as a covariate in a more complex generalized linear geostatistical 
model (Stanton and Diggle, 2013). In our study, the absence of spatial autocorrelation – 
geographical relationship between stroke patients – means that logistic regression was 
adequate. In future studies, we would recommend using individual-level coordinates in stroke 
spatial studies rather than the coordinates of the centroid of an area. This will increase the 
power of study and minimize the risk of ecological bias.  
 The strength of our study includes the use of multivariable fractional polynomials 
(MFP). MFP allowed us to: a) assess the non-linear relation between age and odds for stroke 
and b) developed an improved logistic model. This finding is consistent with other 
cardiovascular studies (Drefahl et al., 2012, Modig et al., 2013a, Modig et al., 2013b). We did 
not categorize age, as doing so would reduce statistical information and power (Wong et al., 
2011, Sauerbrei et al., 2007, Royston and Sauerbrei, 2013). Next, we used the nationwide 
census data, which is conducted every 10 years in Malaysia. Thirdly, we used semi-variogram 
to justify the use of ‘conventional’ logistic regression. 
 The use of in-hospital patients limits the generalizability of the findings. Our findings 
are on the population of stroke patients who reach hospital. It is likely that there are many 
patients with less severe stroke who may not attend the emergency departments and many 
stroke victims will die before reaching hospital. The introduction of a stroke register in 
Malaysia would improve population level studies of the outcome and risk factors for stroke in 
the country. Secondly, the use of the disease classification (ICD-10) without a secondary 
clinical review from the neurologist may introduce selection bias. The recommended case 
ascertainment would be the verification of the ICD-10 diagnosis by a neurosurgeon or 
89 
 
neurologist, using the CT scan or MRI imaging taken during hospital admission, and without 
this inaccuracies in diagnosis and coding may occur. Thirdly, two biases could present in our 
study. The selection bias which was mentioned earlier occurred especially in the retrospective 
case-control study such as ours because by design it requires both the cases and the controls 
are representative of the same population (Geneletti et al., 2009). The use of only hospital-
based controls would introduce hospitalization bias, also known as Berkson’s bias (Geneletti 
et al., 2009). 
 In this study, we were aware of the limitation caused by the hospitalized controls and 
understood that selecting controls in case-control studies tends to be more problematic. The 
controls would satisfy two requirements; a) within the constraints of any matching criteria, 
their exposure to risk factors and confounders should be representative of that in the 
population "at risk" of becoming cases, and b) also, the exposures of controls should be 
measurable with similar accuracy to those of the cases (Coggon et al., 2003, Bandera et al., 
2013).  
 Efforts have been made to reduce bias that may result from control selection, however 
it is possible that our control selection methods may introduce bias. Hospital control may be 
drawn from a population that differs from the cases in terms of their likelihood of exposure. 
Both our cases and controls were drawn from hospitals. People admitted to hospital for a 
reason other than stroke may still be likely to be exposed to inherent risk factors for stroke, 
such as age, or modifiable ones such as high blood pressure. While we were restricted to using 
hospital controls we did take care to use controls from a variety of wards, and with a variety 
of diagnoses because exposure measurement using patients a range of control diagnosis 
rather than single group is a better strategy (Coggon et al., 2003). The effect of the bias may 
can vary: if cases have a higher frequency of the risk factor of interest than do the controls, 
then a more positive association may emerge. On the other hand, if the prevalence of risk 
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factors is higher among the controls, a protective association may occur (Grimes and Schulz, 
2005).  It is possible that the probability of CVD-risk factors may be higher in hospital controls 
compared similar community controls, which could bias risk estimates towards the null.  But 
a study in China comparing the hospital (out-patients) controls and population controls have 
found that the hospital out-patient controls performed only little different from population 
controls for most exposures (Li et al., 2011). 
 Unfortunately, we do not have exposure variables such as age, body mass index and 
blood pressure from our data (due to our data came from limited hospital electronic record) 
that we can compare our controls with the Malaysian general population. Perhaps, because 
we used hospital (in-patients) controls (whom in our opinion has more co-morbidities), this 
could have attenuated the relationship between the exposure and the outcome as shown in 
elsewhere (Neupane et al., 2010). Had we used the population controls, we would have seen 
a more positive relationship between the risk factors and the outcome (stroke). In the future, 
when it is possible, we propose taking two controls (from both the hospital and the 
population) to better assess the relationship between the risk factors and the outcome (Li et 
al., 2011).       
 Despite these limitations, in this region, where the studies on stroke are still scanty, 
and our study has provided additional knowledge on the risk factors for stroke.  
 
2.6 Conclusion 
In conclusion, the variables age, race and sex are important predicative individual-level factors 
for hospital admission with stroke. The interaction between age and sex and the non-linearity 
relationship between age and the odds for stroke complicates the quantitative description of 
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the odds for stroke in the final model. The population density and average size of household 
were the area-level risk factors for stroke. Based on exploratory use of variogram, the spatial 
correlation between locations and stroke were deemed not important, hence indicative that 
where people lived in relation to one-another was not a risk factor for admission with stroke.  
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Aims To compare the on-admission variables for stroke patients who were alive or dead at 
discharge and to identify the prognostic factors for in-hospital stroke fatality. 
Methods A total 226 consecutive in-hospital stroke patients admitted to Hospital Universiti 
Sains Malaysia were recruited between January 2011 and June 2012. All patients matched the 
International Classification of Disease 10 Chapter IX Blocks I60–I69 (cerebrovascular diseases) 
codes. The on-admission variables were compared using the independent t-test and Pearson 
chi-square test. Cox proportional hazard regression was used to identify the prognostic factors 
for stroke fatality. 
Results On admission, the variables Glasgow Coma Scale (GCS), haemoglobin level, total white 
cell count, sex, type of referral and abnormal lipid profile were significantly different between 
patients who were alive or dead at discharge. Based on univariable Cox proportional hazard 
regression, only age and GCS were significantly related with stroke fatality. Multivariable Cox 
proportional hazard regression showed that 2 models predicted in-hospital stroke fatality: 
model 1 involving age and GCS, and model 2 involving age and stroke subtype. Between the 
two, model (a) was practical because it is easier and quicker to use in clinical settings. There 
was no significant 2-way interaction term in the models. 
Conclusion Age and GCS are two independent prognostic factors for best predicting in-hospital 
stroke fatality. More recent clinical assessment methods, however, could be added to improve 
acute stroke assessment predictive of stroke fatality. 




The World Health Organisation (WHO) defines stroke as ‘rapidly developed signs or focal (or 
global) disturbances of cerebral function lasting longer than 24 hours (unless interrupted by 
death), with no apparent non-vascular cause’ (Hatano, 1976, Feigin et al., 2009, Thorvaldsen 
et al., 1995). 
Stroke case fatality rates vary markedly (28-day fatality ranges from 15% to 57%) 
between populations (Thorvaldsen et al., 1995), but are higher in most of the Asian countries 
than in any other region in the world (Kim and Johnston, 2011). In the low- to middle-income 
countries, the mean total stroke case fatality rate was 35.2% (1980–1989), falling to 23.0% 
during 1990–1999 and then increasing to 26.6% during 2000–2008 (Feigin et al., 2009). 
The predictors for stroke fatality include demographic variables such as sex (Reeves et 
al., 2008, Appelros et al., 2003, Appelros et al., 2009, Olsen and Andersen, 2010), age 
(Andersen et al., 2005, Olsen et al., 2011, Fernandes et al., 2012), socioeconomic status (Cox 
et al., 2006, Eriksson et al., 2013, Lindmark et al., 2013) and education (Lindmark et al., 2013). 
Clinical variables include co-morbidities such as diabetes (Delbari et al., 2011, O'Donnell et al., 
2010b, Fernandes et al., 2012, Basri and Azman Ali, 2003), hypertension (O'Donnell et al., 
2010b, Delbari et al., 2011), diet (Scarborough et al., 2011, O'Donnell et al., 2010b) and stroke 
severity (Saposnik et al., 2008, Andersen et al., 2005, Appelros et al., 2003, Basri and Azman 
Ali, 2003, Yousuf et al., 2012). Other variables include drug treatment and the availability and 
experience of stroke teams and physicians (Saposnik et al., 2008), time of admission (weekday 
versus weekend) (Ogbu et al.), anaemia, location of the infarction (Basri and Azman Ali, 2003) 




To date, there has been no consensus on the most important prognostic factors for 
stroke fatality, although understanding of the factors is important (Shigematsu et al., 2013). 
To the best of our knowledge, there have been only 4 published papers indexed by PubMed 
(http://www.ncbi.nlm.nih.gov/pubmed/ ) on stroke fatality in Malaysia (Jaya et al., 2002, Basri 
and Azman Ali, 2003, Yousuf et al., 2012, Sia et al., 2007). All of them were hospital-based 
studies and two had been published more than 10 years ago. One paper reported that in 2002, 
the overall in-hospital stroke case fatality rate was 37.3% and that it was more common among 
male stroke patients  (Jaya et al., 2002) . The other discussed the stroke case–fatality rate for 
acute ischaemic stroke in Hospital Kuala Lumpur (situated in Kuala Lumpur, the capital of 
Malaysia) (Basri and Azman Ali, 2003, OECD/World Health Organization, 2014) but did not 
explore the prognostic factors for stroke fatality. The remaining two papers described the 
fatalities among intracerebral haemorrhage (ICH) patients in the East Coast of Malaysia and 
Kuala Lumpur, respectively, and concluded that the predictors of fatality among Malaysian ICH 
patients include stroke type, location of haemorrhage and bleeding volume but not sex or age 
(Yousuf et al., 2012, Sia et al., 2007). 
In view of the scarcity of published papers on stroke fatality in Malaysia and with 
Malaysia being a country in the Asian continent—a region with a serious burden of stroke, 
high stroke mortality, prevalence and poorly controlled risk factors (Kim, 2014)—more studies 
on stroke fatality are necessary. This study will add to the body of knowledge on the prognostic 
factors for stroke fatality and will be useful for improving hospital performance and quality of 
care for stroke patients (Donabedian, 1988, Saposnik et al., 2008). 
In this study, we first aimed to compare the on-admission variables between stroke 
patients who were alive or dead at discharge using data recorded on admission. Next, we 
developed multivariable models to identify variables important as prognostic factors for in-




3.3.1 Study design and data source 
We obtained data from consecutive stroke patients admitted to Hospital Universiti Sains 
Malaysia (HUSM), in Kelantan, Malaysia, between 1 January 2011 and 30 June 2012. HUSM is 
one of the largest tertiary hospitals in Malaysia, serving as one of the three referral centres for 
stroke in the East Coast of Malaysia. HUSM has a dedicated team of neurologists, 
neurosurgeons and neuroradiologists who work with all neurology cases. The team also 
services a neuro-intensive care unit and two neurology wards. 
At HUSM, the medical record unit stores databases containing admission and 
discharge information, including patient basic demographic profiles, date of admission and 
discharge, survival status on discharge and final diagnosis. HUSM records the discharge 
diagnosis of each patient in its own electronic hospital registration system (administrative 
diagnosis) and uses the International Classification of Diseases 10th Revison (ICD-10) for this 
purpose. The final diagnosis is made by the medical specialists at discharge, then a trained 
coder inserts the appropriate codes into the registration system. 
3.3.2 Case definition  
We extracted data from eligible records based on the patient discharge diagnosis (cold pursuit 
method) (Thorvaldsen et al., 1995). The diagnosis had to match ICD-10 Chapter IX Blocks I60–
I69 (cerebrovascular diseases) criteria. 
The haemorrhagic stroke patients matched the ICD-10 Block I60, I61 or I62 criteria or 
any combination thereof. The non-haemorrhagic stroke patients were expected to match the 
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ICD-10 Block I63 (cerebral infarction) or other type of stroke (Blocks I64–I69) criteria. All the 
patients in our study had CT scan done for the stroke diagnosis and stroke subtypes.  
At HUSM, all patients with suspected stroke will undergo CT scan examination at the 
emergency department, neuromedical unit or neurosurgical unit as early as possible. Based 
on the CT scan images and clinical presentations, the treating physicians will confirm the stroke 
diagnosis and proceed with further management. The radiologist will review the CT scan 
images usually on the same day, to provide further detailed diagnosis including the stroke 
subtypes.  
The patients had to meet the following eligibility criteria for inclusion in the study: a) 
stroke as the primary reason for admission, and b) of Malaysian nationality. We excluded 
patients with: a) shock and hypertensive encephalopathy, as these conditions are not caused 
directly by cerebrovascular events, and b) discharge diagnosis of transient ischaemic attack 
(TIA) because the symptoms of TIA resolve within 24 hours (Shigematsu et al., 2013, Devries 
et al., 2013, Thorvaldsen et al., 1995). 
3.3.3 Variables  
Through the electronic hospital registration system, the records office administrator at HUSM 
provided the following demographic and administrative variables in electronic format: a) sex, 
b) age, c) race, d) marital status, e) date of admission, f) date of discharge, g) discharge 
diagnosis and h) survival outcome on discharge (dead or alive). 
The neurology team gave the final diagnosis of stroke (discharge diagnosis) and the 
coder at the records office coded it based on the ICD-10 criteria. This type of diagnosis is 
known as administrative diagnosis. 
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KIM extracted abstracted the biophysical, medical history and biochemistry data from 
the case notes. The biophysical data contained the variables a) systolic blood pressure (SBP, 
mmHg), b) diastolic blood pressure (DBP, mmHg), c) Glasgow Coma Scale (GCS) score and d) 
capillary blood sugar (mmol/l). The medical history data provided the variables a) history of 
high blood pressure (yes or no), b) diabetes mellitus (yes or no) and c) abnormal lipid profile 
(yes or no). The biochemistry data contained the variables a) total white cell (TWC) count, b) 
haemoglobin (Hb) level (mg/dl), c) platelet count, d) sodium level (mmol/l), e) potassium level 
(mmol/l) and f) urea level (mmol/l). These variables, especially the biophysical and 
biochemistry data, are taken as standard diagnostic tests for all patients suspected with acute 
stroke. Their predictive role in stroke should be assessed to indicate their usability in early 
stroke care in HUSM setting.   
The GCS is used in the acute setting to measure the level of consciousness and is 
predictive of stroke outcome (Chen et al., 2011, Stroke Unit Trialists, 2007). The GCS score 
consisted of the best eye, motor and verbal responses, and ranged from a minimum of 3 
(worst) to a maximum of 15 (best).  
The outcome variable was the time (in days) until an event (death due to stroke during 
admission). Other outcomes were considered censored observations.   
3.3.4 Statistical analysis 
We used EpiData Entry (Lauritsen, 2000) for data entry and Stata version 11.2  (StataCorp., 
2010) for data cleaning and analyses. 
We described the variables on admission using mean (SD) and frequency (%) where 
appropriate based on the overall patients’ data and then based on survival status at discharge 
(alive or dead). For comparisons, we used the independent t-test and Pearson chi-square test. 
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In assessing survival, the outcome variable was time-to-stroke fatality (event = death) 
after admission to HUSM. The time was calculated in days (the difference of days between the 
date of admission and the date of discharge). The event was defined as either failure (death 
due to stroke, coded as 1) or censored (alive at discharge or death from causes other than 
stroke, coded as 0).  
We used Cox proportional hazard regression—a widely used semi-parametric survival 
analysis method in medicine—to explore the important prognostic factors for in-hospital 
stroke case fatality (Hosmer et al., 2013, Hosmer et al., 2011). During model building, we 
performed the following: a) univariable Cox proportional hazard regression, b) manual 
selection of variables, c) checking of the functional form of numerical variables, d) checking of 
interaction between prognostic factors and lastly, e) checking of the assumptions for the 
hazard proportionality of the chosen model. 
Based on univariable analysis (crude), blood pressure, blood count, blood urea, serum 
electrolytes, capillary blood sugar and marital status were selected for multivariable selection. 
In multivariable analysis, each candidate variable was added to the model individually. At each 
step of adding or removing a variable, we performed the likelihood ratio (LR) test, retaining 
variables with a significance level of less than 2-tailed 0.05. Simultaneously, we examined any 
change in the coefficient, as a change of 20% or more indicates important confounding effects 
(Hosmer et al., 2013). 
We used fractional polynomials to estimate the relationship between numerical 
covariates (age and population density) and the outcome (case or control). We did not 
categorize the numerical covariates because to do so would have reduced the power of 
analysis and provide less information on the relationship between the covariates and the 
outcome (Royston and Sauerbrei, 2004, Royston and Sauerbrei, 2005). Fractional polynomials 
also improve model fit and provide more realistic non-linear relationship if the model (Wong 
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et al., 2011, Royston and Sauerbrei, 2013, Royston and Sauerbrei, 2005, Royston and 
Sauerbrei, 2004, Royston and Altman, 1994). We checked the functional form of two 
numerical variables: a) age and b) GCS score, using fractional polynomial (FP) analysis (Wong 
et al., 2011, Hosmer et al., 2011, Hosmer et al., 2013, Royston and Altman, 1994, Sauerbrei et 
al., 2007, Royston et al., 2006). FP determines whether the variables age and GCS score should 
enter the model in their linear or transformed form. In Stata, the mfp function executes FP 
analysis. Three models were analysed: 1) the null model, 2) the untransformed model (age and 
GCS score in linear form) and 3) transformed model (age and GCS score transformed by mfp). 
In our model, both GCS score and age were best presented in their untransformed (linear) 
form. 
We generated a 2-way interaction term between age and GCS score but the product 
term was not statistically significant (p = 0.294), hence it was excluded from the model. 
We tested the proportionality assumption—the estimated hazard does not depend on 
time—for Cox hazard regression using Schoenfeld residuals. Using these residuals, we 
performed two tests: a) the ‘global test’ (the overall model test), and b) the ‘detail test’ (test 
for each numerical covariate in the model). Our chosen model passed both tests.  
When performing survival analysis for our data, we assumed our data fulfilled these 
three assumptions about censoring (for examples to those censored because they were 
discharged well) : a) independent censoring, b) random censoring and, c) non-informative 
censoring (Resche-Rigon et al., 2006, Kleinbaum and Klein, 2012). The common analyses of 
survival data using the Kaplan-Meier method and the Cox regression model will provide bias 
results when these assumptions are violated. Specifically, in the case of informative censoring, 
censored observations provide important relationships between censoring and the outcome 
of interest (the remaining survival time). When informative censoring is suspected, the 
imputation method for missing observations and sensitivity analysis to estimate the models in 
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various scenarios can be performed. Further details of imputation and sensitivity analysis are 
provided in Appendix H.  The presence of shared dependencies between the covariates and 
the outcomes is one of the ways to support the presence of non-informative censoring. The 
methods to assess it and the results obtained from the assessments are shown in Appendix H.             
3.3.5 Ethical approval 
We received ethical approval from the Medical and Research Ethics Committee (MREC), 
Ministry of Health, Malaysia (NMRR-12-471-12139), the USM Human Research Ethics 
Committee (HREC), Universiti Sains Malaysia (JEPEM [242.4.(1.4)]) and the Lancaster 
University Ethics Committee.  
3.4 Results 
In this study, a total 226 consecutive in-hospital stroke cases at HUSM were analysed. Table 
3-1 shows that the mean age of the whole cohort was 60.8 years (SD = 14.0). Stroke patients 
who died when in hospital were older (mean age = 62.2 years, SD = 15.0) compared to those 
who survived (mean age = 60.4 years, SD = 13.6) but the difference was not statistically 
significant at p = 0.05. The mean GCS score for the whole cohort was 12.4 but patients who 
were alive at discharge had a significantly higher mean GCS score than those who died (mean 
GCS score = 13.7 vs. 8.4; p < 0.001). A higher GCS score indicates a higher level of 
consciousness. The difference in the mean SBP and DBP between patients who were alive and 
dead at discharge was small (SBP, 163.1 mmHg vs. 163.3 mmHg, p = 0.971; DBP, 91.6 vs. 92.8, 
p = 0.705).  
Table 3-1 also shows that patients who were alive at discharge had a significantly 
higher mean Hg level than those who were dead at discharge (13.3 g/dl vs. 12.4 g/dl, p = 
0.010), but there was no difference in mean platelet levels between the two groups (238.5 × 
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109/l vs. 229.5 × 109/l, p = 0.474). The mean TWC count was higher in patients who died during 
admission (12.5 × 109/l vs. 9.8 × 109/l, p < 0.001). The mean serum potassium, serum sodium, 
blood urea and capillary blood sugar levels were not significantly different between patients 
who were dead and alive at discharge (potassium = 3.9 mmol/l vs. 3.8 mmol/l, p = 0.251; 
sodium = 137.5 mmol/l vs. 138.6 mmol/l, p = 0.178; urea = 7.6 mmol/l vs. 8.7 mmol/l, p = 
0.201; capillary blood sugar = 9.6 mmol/l vs. 10.5 mmol/l, p = 0.274). The mean length of stay 
(LOS, in days) between patients who were alive or dead at discharge were not statistically 
different (p=0.210).   
Table 3-2 shows that 93.3% (211/226) of patients in our study cohort were Malay, 
which is consistent with the racial demographics of the state of Kelantan. A nationwide 
population survey in 2010 showed that 92.7% of the Kelantan population was Malay. Married 
patients on admission represented 90.7% (205/226) of the cohort, and 57.0% (129/226) of 
patients were female. Of the total subjects, 38.5% (87/226) had been referred from either 
tertiary hospitals or district hospitals. Based on self-reporting, 32.7% (74/226) of the cohort 
had a history of diabetes, 65.5% (148/226) had a history of high blood pressure and 11.9% 
(27/226) had an abnormal lipid profile. 
Of all the categorical variables, types of referral were the most significant variable (p-
value < 0.001) associated with the survival status at discharge, followed by abnormal lipid 
profile (p-value = 0.010) and sex (p-value = 0.014). More referred patients, female patients 






Table 3-1 On-admission numerical variables for all patients (regardless of survival status at 
discharge) and for patients based on survival status at discharge, n=226 













Age (years) 60.8(14.0) 60.4(13.6) 62.2(15.0) 0.412 
Glasgow Coma Scale 12.4(3.8) 13.7(2.7) 8.4(4.0) <0.001 
Systolic BP (mmHg) 163.2(34.4) 163.1(32.0) 163.3(41.7) 0.971 
Diastolic BP (mmHg) 91.9(20.0) 91.6(18.2) 92.8(25.2) 0.705 
Heart rate (per min) 82.7(20.9) 81.9(20.3) 85.4(22.6) 0.293 
Haemoglobin (g/dl) 13.1(2.2) 13.3(2.1) 12.4(2.4) 0.010 
Platelet count (per 
mm3) 
236.3(74.6) 238.5(72.7) 229.5(80.5) 0.474 
Total white cell count 
(per microlitre) 
10.5(3.9) 9.8(3.5) 12.5(4.2) <0.001 
Natrium (mmol/l) 137.8(5.2) 137.5(3.6) 138.6(8.5) 0.178 
Potassium (mmol/l) 3.9(0.6) 3.9(0.5) 3.8(0.7) 0.251 
Urea (mmol/l) 7.9(5.5) 7.6(4.8) 8.7(7.2) 0.201 
Capillary Blood Sugar 
(mmol/l) 
9.8(4.9) 9.6(5.1) 10.5(3.9) 0.278 
LOSb 6.5(7.8) 6.1(7.5) 7.8(8.7) 0.210 
a Independent t-test      b Length of stay (days) 
 
For the risk of dying in hospital from stroke, age and GCS score were the only 
significant prognostic factors in simple Cox regression analysis, as shown in Table 3-3. The 
unadjusted risk for in-hospital stroke fatality decreased by 17% with a 1-point increase in the 
GCS score. A 1-year increase in age increased the unadjusted risk for in-hospital fatality by 
2.4% (95% confidence interval [CI]: 1.002, 1.047); a 10-year increase in age increased the crude 
risk for stroke fatality by 26.7%.  
When we examined the relationship between categorical variables and stroke fatality 
using Cox proportional hazard regression, we found that stroke subtype (haemorrhagic/non-
haemorrhagic stroke) was the only significant variable in the simple Cox proportional hazard 
regression. Others, such as sex, types of referral and abnormal lipid profile that had been 
shown to be statistically significant (based on Pearson chi-square analyses) in Table 3-2 were 
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no longer significant. The likely reason for these results to differ is because the Pearson chi-
square examines the independence of distribution, i.e. how well the observed distribution of 
data fits with the distribution expected were the variables to be independent, while the Cox 
proportional hazard regression method models the incidence or hazard rate per population 
at-risk per unit time.   
Table 3-5 shows the two models that predict in-hospital stroke fatality at HUSM: 
model 1 (n=225) contains age and GCS score and model 2 (n=226) contains age and stroke 
subtype. We propose that the best model is model 1 (age and GCS score) based on subjective 
assessment. We felt that model 1 is more practical in daily clinical practice. Even though model 
1 seems to have has a better fit (log-likelihood = -205.60, LR chi-square = 40.1, degree of 
freedom [dof] =2) than model 2, the quantitative comparison could not be done especially 
using the likelihood ratio test because of different sample sizes (however, the sample sizes are 
only different by 1; n=225 vs n=226). Being practical means that the GCS score can be assessed 
very quickly even by non-clinicians at almost no extra cost. With model 2, computed 
tomography (CT) scan images to assist clinicians are needed. It is also a poorer fit than model 
1 (log-likelihood = -223.33, LR = 12.9, dof = 2). The need for CT scans translates into extra cost, 
extra time and more training for clinicians. When the model has stroke subtypes, GCS and age 
together as the covariates, the adjusted hazard ratios become 1.52 (p-value = 0.181), 0.83 (p-
value < 0.001) and 1.03 (p-value = 0.006), respectively. Based on the level of significance at 
10% for the Wald statistic, the covariate stroke subtype can be dropped from the model. In 
addition to that, the confounding effect between stroke subtypes and GCS is very likely, hence 
only one of them should be the covariate at one time.     
Based on the ‘global test’ and the ‘detail test’ in Stata, our model does not violate the 
proportional hazard assumption in Cox regression. The p-value for the global test was 0.855 
and for the specific test, the p-value for GCS score and age was 0.986 and 0.576, respectively. 
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Based on the non-significant p-values, we could not reject the null hypothesis that both the 
hazard for age and GCS score were proportional (slopes of residuals against time were zero). 
3.5 Discussion 
In this study of 226 consecutive stroke patients at HUSM, sex, history of abnormal lipid profile, 
referral type, GCS, Hg level and platelet count were significantly different between patients 
who were alive and dead at discharge. Cox proportional hazard regression showed that age 
and GCS score are independent prognostic predictors for in-hospital stroke fatality. 
 Identifying early prognostic factors for stroke fatality is useful for classifying stroke 
patients based on possible outcome. This will then help clinicians anticipate the risk for fatality 
among patients with acute stroke. In our study, we have shown that the GCS score and age 
are independent prognostic predictors for stroke fatality at discharge. Every 1-unit increase in 
the GCS score corresponded with a decrease in fatality risk of about 18% (hazard ratio [HR] = 
0.82). 
The reduction could be as small as 12% or as large as 23% (95% CI of adjusted HR from 
0.77 to 0.88) when adjusted for age. The GCS is an easy and quick physical assessment of 
neurological status and can be performed quickly in the emergency setting by clinicians or 
paramedics. Regarding age, our best model (model 1) showed that with a 1-year increase in 
age, the risk for in-hospital stroke fatality increased by 3% (95% CI from 1.01 to 1.05) when 






Table 3-2 On-admission categorical variables for all patients (regardless of survival status 
at discharge) and for patients based on survival status at discharge, n=226 









Race Malay 211(93.4) 163(94.2) 48(90.6) 0.350 
 Non-Malay 15(6.6) 10(5.8) 5(9.4)  
Sex Male 97(42.9) 82(47.4) 15(28.3) 0.014 
 Female 129(57.1) 91(52.6) 38(71.7)  
Marital status Married 205(90.7) 158(91.3) 47(88.7) 0.561 
 Not-married 21(9.3) 15(8.7) 6(11.3)  
Types of referral Hospital 87(38.5) 55(31.8) 32(60.4) <0.001 
 GP/Home 139(61.5) 118(68.2) 21(39.6)  
Diabetes mellitus Has diabetes 74(32.7) 60(34.7) 14(26.4) 0.262 
 No diabetes 152(67.3) 113(65.3) 39(73.6)  
High blood pressure 
(BP) 
Has high BP 148(65.5) 113(65.3) 35(66) 0.924 
 No high BP 78(34.5) 60(34.7) 18(34)  
Abnormal lipid profile Abnormal 
lipid 
27(12.0) 26(15.0) 1(1.9) 0.010 
 Normal lipid 199(88.0) 147(85.0) 52(98.1)  
a Pearson chi-square p-value 
 
Table 3-3 Numerical variables, crude hazard ratios (HR) with 95% confidence intervals (CI) 
and the respective p-values. The outcome variable was a time-to-event variable; where the 
event was status at discharge (dead or alive) and the time was the numbers of days of 
hospitalization.     
Variable n Crude HRa Lower 95% CIb Upper 95% CIb p-value 
Age (per year)  226 1.02 1.00 1.05 0.034 
Glasgow Coma Scale (GCS) 225 0.83 0.78 0.88 <0.001 
Systolic BP (mmHg) 225 1.00 1.00 1.01 0.720 
Diastolic BP (mmHg) 225 1.00 0.98 1.01 0.678 
Haemoglobin (g/dl) 220 0.96 0.85 1.08 0.504 
Platelet count (per mm3) 220 1.00 1.00 1.01 0.466 
White cell count (per microlitre) 220 1.06 0.99 1.12 0.088 
Natrium (mmol/l) 225 1.02 0.98 1.06 0.373 
Potassium (mmol/l)  225 0.93 0.57 1.52 0.774 
Blood Urea (mmol/l) 225 1.03 0.99 1.07 0.189 
Capillary Blood Sugar (mmol/l) 209 1.03 0.97 1.09 0.329 
a Hazard ratios (HR) were obtained from the simple Cox proportional hazard (PH) regression 







Table 3-4 Categorical variables, crude hazard ratios (HR) with 95% confidence intervals (CI) 
and the respective p-values. The outcome variable was a time-to-event variable; where the 
event was status at discharge (dead or alive) and the time was the numbers of days of 
hospitalization     
Variables Category  
 










Sex Female 129 1    
 Male 97 0.66 0.36 1.21 0.180 
Race Non-Malay 15 1    
 Malay 211 0.48 0.19 1.22 0.122 
Marital  Not married 21 1    
 Married 205 1.12 0.48 2.64 0.795 
Diabetes No diabetes 152 1    
 Have diabetes 74 0.64 0.35 1.18 0.152 
High BP Normal BP 78 1    
 Have high BP 148 0.98 0.55 1.74 0.936 
Abnormal lipid Normal lipid 199 1    
 Abnormal lipid 27 0.25 0.03 1.80 0.168 
Types of 
referral 
GPc/Home 139 1    






1    
 Haemorrhagic 77 2.17 1.18 3.97 0.012 
a hazard ratios obtained from simple Cox proportional hazard (PH) regression 
b confidence interval (CI)        c General Practitioner 
 
Table 3-5 Two prognostic models for in-hospital stroke fatality. The best model (Model 1, 
n=225) contains two independent predictors: age (years) and Glasgow Coma Scale (range of 
score is from 3 to 15). The alternative model (Model 2, n=226) has age (years) and stroke 
subtypes (haemorrhagic stroke vs non-haemorrhagic stroke) as the independent predictors. 
The parameters shown are the adjusted hazard ratios (HR), standard error (SE), lower and 
upper 95 confidence intervals (CI) for adjusted hazard ratios (HR) and the respective p-values   
 
Adj HR a SE b Lower 95% CIc Upper 95% CIc p-value 
Best model (Model 1) 
 







n=225      
Glasgow Coma Scale (GCS) 0.82 0.03 0.77 0.88 <0.001 
Age (years) 1.03 0.01 1.01 1.05 0.011 




n=226      





Age (years) 1.03 0.01 1.01 1.05 0.014 
a hazard ratios obtained from multivariable Cox PH regression  b standard error for hazard ratio 





Our finding replicates the findings of at least two previous studies—both involved 
patients with ischaemic stroke—which had shown only age and stroke severity as the 
prognostic factors for stroke case fatality rates in their models. The first study was in Denmark 
(n = 26,818), and reported that age and the Scandinavian Stroke Scale (SSS) score predicted 
stroke fatality within the first week post-stroke (Andersen et al., 2011). The second study (n = 
479), done in Switzerland, showed that advanced age and the National Institute of Health 
Stroke Study (NIHSS) were both independent predictors of early stroke mortality (Nedeltchev 
et al., 2010). Other studies have found that in addition to age and stroke severity, the 
important prognostic factors of stroke fatality include diabetes, sex and history of previous 
stroke (Andersen et al., 2005, Saposnik et al., 2008, Koton et al., 2009). 
A review has reported that the relationship between sex and stroke fatality varies 
between studies (Reeves et al., 2008). In our results, sex was not a predictor of stroke fatality, 
consistent with the findings from other studies (Wahab et al., 2008, Appelros et al., 2003, 
Nedeltchev et al., 2010). Studies with positive relation between sex and stroke fatality results 
have shown that, in general, women had either: a) a greater risk than men for stroke fatality 
(Devries et al., 2013, Niewada et al., 2005) or b) a lower risk for stroke fatality than men (Sheikh 
and Bullock, 2007, Koton et al., 2009). 
 Our findings also showed that co-morbidities and physical profiles were not 
significantly related to stroke fatality. However, others have demonstrated that blood 
pressure status was a significant predictor of fatality in all major types of stroke (Johnston et 
al., 2009, Okumura et al., 2005). Besides blood pressure, diabetes mellitus (Koton et al., 2009, 
Wong, 1999, Okumura et al., 2005), abnormal heart rate such as atrial fibrillation (Appelros et 
al., 2003, Andersen et al., 2005), temperature and glucose (Koton et al., 2009), body mass 
index (Johnston et al., 2009) and anaemia (Hao et al., 2013) also predict fatality in certain types 
of stroke.  
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 The GCS is widely used to assess stroke severity in the acute setting. However, newer 
measurement tools such as the SSS and the NIHSS can improve assessment of stroke severity 
if used alongside the GCS. The SSS (Andersen et al., 2005), level of consciousness (Andersen et 
al., 2005, Saposnik et al., 2008) and NIHSS (Teasdale and Jennett, 1974) are predictive of stroke 
outcome. Our study suggests that the roles of these new tools for assessing stroke severity 
should be investigated in Malaysia, as both of these tools are not standard clinical assessment 
tools in the emergency setting here. 
 Age has been found to be a significant predictor of morbidity and mortality (Devries 
et al., 2013, Fernandes et al., 2012, Saposnik et al., 2008, Wong, 1999). In our study, we found 
that the risk for fatality with age increased linearly. Studies looking specifically at the 
relationship between age and stroke fatality risk have found that the relationship can be non-
linear (Olsen et al., 2011). 
 There are several limitations to this study. First, we used stroke patients from only one 
centre (HUSM). Furthermore, HUSM is an advanced university hospital providing one of the 
best stroke care in Malaysia, and the population who attend this hospital may not be a random 
subset of the whole population of those at risk of stroke. Because of this, it limits the 
generalisability of our results to all patients treated at other hospitals in Malaysia. Second, 
because of the unavailability of a stroke registry, data were abstracted from patient electronic 
medical registration information, which might create bias due to poor standardisation in data 
entry and quality control. Thirdly, many important stroke fatality predictors were not routinely 
collected at HUSM thus limiting the number of covariates in our model. We also used in-
hospital patients who have different characteristics from out-of-hospital stroke patients 
(Shigematsu et al., 2013).  
In the survival analysis, we assumed the censoring processes to be non-informative. This 
is based on the shared dependency between the covariates (for example, stroke subtypes and 
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Glasgow Coma Scale) and the outcome as shown by the Cox regression and the reversed Cox 
regression in Appendix H. This evidence has allowed the use of Kaplan-Meier and Cox 
proportional hazard models in this study. However, in the case when this evidence is regarded 
as inadequate, and thus informative censoring poses a limitation to the numerical estimation 
by the Kaplan-Meier and the Cox regression models in this study, multiple imputation methods 
and sensitivity analysis can be performed. Multiple imputation methods, such as the Gamma 
imputation and the Risk Score imputation methods, impute observation to the missing 
observations, and sensitivity analysis allows – for examples – the Cox estimation to be done in 
different scenarios (see Appendix H).  Next, in this study, data consisted of 226 patients with 
only 53 of them deceased at discharge. There were also ‘thin cells’ (cells with small 
frequencies), for example, for the variables of race, marital status and abnormal lipids (Hosmer 
et al., 2011). These, too, would reduce the power of our Cox proportional models.  The 
strengths of the study include the use of CT scan images or radiological reports for case 
confirmation. A CT scan is the diagnostic test of choice for stroke imaging (Falcone et al., 
2013a) and improve the validity of the study because: a) CT scan images help provide accurate 
stroke subtyping, (Kalantri and Kalantri, 2010, Runchey and McGee, 2010), and b) CT scan 
images provide more objective assessment of severity than physical examination alone 
(Thorvaldsen et al., 1995, Andersen et al., 2011, O'Donnell et al., 2010a, Keir et al., 2002). 
3.6 Conclusion 
Sex, type of referral, history of abnormal lipid profile, GCS, Hg level and TWC count are 
significantly different between in-hospital stroke patients who were alive and dead at 
discharge. A Cox proportional hazard model for predicting in-hospital stroke fatality contained 
two independent prognostic factors: age and GCS score. Both variables are easy and quick to 
perform in an emergency setting. However, clinicians in Malaysia should consider newer 
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clinical assessments for stroke severity such as the SSS or NIHSS to complement current stroke 
assessment on admission.  
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4.1 Abstract  
Aims To describe the on-admission baseline demographic and clinical variables for patients 
with cerebral infarction or haemorrhagic stroke and to compare the stroke case–fatalities and 
the prognostic effect between them in an Asian population. 
Methods Data from two groups of consecutive stroke patients: a) cerebral infarction (n = 150) 
and b) haemorrhagic stroke (n = 142) were collected from hospital medical records and patient 
clinical folders. The overall stroke fatality and fatalities at 3 days, 7 days and 14 days were 
described. The survival probability was estimated using the Kaplan–Meier estimate. Cox 
proportional hazard regression was used to estimate the crude and adjusted hazard ratio for 
stroke fatality between haemorrhagic stroke and cerebral infarction. The assumption of 
hazard proportionality was checked. 
Results On admission, patients in the haemorrhagic stroke group were younger, had poorer 
Glasgow Coma Scale scores and higher mean diastolic blood pressure than those in the 
cerebral infarction group. The overall stroke case fatality for cerebral infraction was 12.0%; 
that for haemorrhagic stroke was 46.5%. In the haemorrhagic stroke group, patients with 
subarachnoid haemorrhage had the highest fatality. The median survival time for patients in 
the cerebral infarction group was 28 days; that in the haemorrhagic stroke group was 14 days. 
In the crude and adjusted models (adjusted for sex then age, respectively), patients in the 
haemorrhagic stroke group had more than twice the risk for stroke fatality than those in the 
cerebral infarction group. 
Conclusion Patients in the haemorrhagic stroke group had less favourable presentation on 
admission, higher overall stroke fatality and higher 3-day, 7-day and 14-day fatality than those 
with cerebral infarction. They also had much higher risk for stroke fatality than the patients 
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with cerebral infarction. This indicates a need for improved critical care to minimise 
intracranial bleeding.  
Keywords:Cerebral infarction,Haemorrhagic stroke,Stroke case fatality  
4.2 Introduction 
Stroke is the second leading cause of death worldwide (Feigin, 2007). It is a heterogeneous 
disease commonly classified into three major subtypes: a) ischaemic stroke (cerebral 
infarction), b) haemorrhagic stroke and c) subarachnoid haemorrhage (SAH) (Amarenco et al., 
2009). 
Ischaemic stroke constitutes about 70% of all stroke but the overall burden of 
haemorrhagic stroke is significantly higher (Krishnamurthi et al., 2014) because of its severity 
(Testai and Aiyagari, 2008). In 2000–2008, the frequency of haemorrhagic stroke in the low- 
to middle-income countries was twice that in the high-income countries (Feigin et al., 2009) 
and was also greater in the Asian populations (Wong, 1999, Xu et al., 2010, Basri and Azman 
Ali, 2003, Kaul et al., 2009, O'Donnell et al., 2010b, Durai Pandian et al., 2007). 
Much of stroke research carried out to date has tended to focus on cerebral infarction, 
probably because it is more common than haemorrhagic stroke (Fernandes et al., 2012, Basri 
and Azman Ali, 2003, Feigin et al., 2009). Stroke research also largely comes from the 
developed countries despite the greater burden of stroke being in the low- and middle-income 
countries (Johnston et al., 2009), many of which are in Asia. Statistics on stroke also show large 
variations between countries (Ingall et al., 2000). Given these shortcomings, more studies are 
necessary to better understand the differences between stroke subtypes. 
To the best of our knowledge, there have been only 4 published papers on stroke 
fatality in Malaysia. All were hospital-based studies, and two are more than 10 years old. One 
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paper reported that in 2002, the in-hospital stroke case fatality rate was 37.3% (Jaya et al., 
2002). A 2003 paper reported that the 30-day in-hospital stroke case–fatality rate was 11.7% 
for ischaemic stroke and 27.3% for haemorrhagic stroke (Basri and Azman Ali, 2003). The other 
two papers were on primary intracerebral haemorrhage (ICH) studies (Sia et al., 2007, Yousuf 
et al., 2012). In Kuala Lumpur, Malaysia, the fatality rate at discharge was 43.9% (Sia et al., 
2007), while a recent study in Kuantan, Malaysia, showed that among ICH patients, the 24-
hour fatality rate was 32.7% and that the predictors of fatality included stroke subtype, 
location of haemorrhage and bleeding volume but not sex or age (Yousuf et al., 2012). 
We aimed to address these shortcomings in data by studying stroke admissions to a 
large hospital in Malaysia, where the patients are of Asian origin. Our interest was in the 
proportion of strokes that were haemorrhagic and relative survival by stroke type. Access to 
computed tomography (CT) scans for each patient admitted to our study hospital allowed us 
to use accurate and reliable diagnoses to categorise patients by stroke subtype. 
This study had two primary aims: a) to describe the on-admission baseline demographic 
and clinical variables for cerebral infarction and haemorrhagic stroke and b) to compare the 
prognostic effect of haemorrhagic stroke against cerebral infarction for stroke fatality.   
4.3 Methods 
4.3.1 Study venue 
The study took place at Hospital Universiti Sains Malaysia (HUSM), Kelantan, Malaysia. HUSM 
is one of the two largest tertiary hospitals—hospitals with specialists—in Kelantan. At HUSM, 
a neurology team manages all stroke patients. Those admitted to the ward are treated in the 
neurology unit and attended to by a group of specialists consisting of neurologists, 
neurosurgeons and neuroradiologists.  
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4.3.2 Case definition  
Stroke cases were identified from HUSM records. HUSM uses the International Classification 
of Diseases 10th Revision (ICD-10) to code diagnosis at discharge; this coded diagnosis is 
termed ‘administrative diagnosis’. 
Diagnoses eligible for inclusion in our study were ICD-10 Chapter IX Block I60 
(subarachnoid haemorrhage), I61 (intracerebral haemorrhage), I62 (other non-traumatic 
intracranial haemorrhage such as extradural or subdural haemorrhage) and I63 (cerebral 
infarction). Collectively, Blocks I60, I61 and I62 are known as haemorrhagic stroke. Our cases 
were all cases of stroke with ICD-10 Blocks I60, I61, I62 and I63 who had been admitted and 
diagnosed at HUSM between December 2008 and June 2012 (ICD-10 Block I60, I61, I62) or 
between January 2011 and June 2012 (ICD-10 Block I63). 
Data on 150 consecutively admitted stroke patients in the cerebral infarction group 
and 150 consecutive patients in the haemorrhagic stroke group were extracted from hospital 
records. Eight patients in the haemorrhagic stroke group were excluded because three had a 
stroke secondary to trauma and five were misdiagnosed as having had a stroke, resulting in a 
final study sample of 150 patients with cerebral infarction and 142 with haemorrhagic stroke. 
The stroke diagnosis extracted from each medical record was verified by a radiologist 
(JH), who cross-checked the written diagnosis in the medical records with the CT images stored 
by the HUSM picture archiving and communication system (PACS) server. A CT scan is the 
investigation of choice to subtype a stroke based on imaging (Falcone et al., 2013a) to 
differentiate stroke subtypes (Falcone et al., 2013a, Kalantri and Kalantri, 2010, O'Donnell et 
al., 2010b, Warlow, 1998, Runchey and McGee, 2010). In the event where CT scan images were 
not available in the PACS server (e.g. a CT scan was done by the referring centre), we verified 
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the stroke diagnosis based on the radiological diagnosis recorded in the referral letter 
provided by the patient.    
4.3.3 Variables  
For this study, the HUSM medical records office provided data on: a) age, b) sex, c) date of 
admission, d) date of discharge and e) survival status at discharge for each patient. In addition, 
KIM reviewed each patient’s hard copy medical record and extracted the following additional 
data: a) type of referral centre, b) Glasgow Coma Scale (GCS) score, c) systolic blood pressure 
(SBP, mmHg), d) diastolic blood (DBP, mmHg) and e) stroke diagnosis. 
At HUSM, stroke severity is assessed using the GCS. The GCS is a widely-used measure 
of a patient’s state of consciousness. It uses a scale between 3 (the worst) and 15 (the best) 
points. The GCS score is a total of scores from its 3 components: a) best eye response (1–4 
points), b) best verbal response (1–5 points) and c) best motor response (1–6 points) (Singh et 
al., 2000).   
4.3.4 Statistical analysis 
All data were entered into EpiData Entry software (Lauritsen, 2000) and analysed using Stata 
11.2 SE (StataCorp., 2010). 
We calculated the stroke case fatality by dividing the number of deaths from all causes 
after admission by the number of admissions for stroke, and multiplying by 100 (Roberts and 
Goldacre, 2003, Saposnik et al., 2008). Because the calculation was performed for only deaths 
during hospitalization of acute stroke in our study, our stroke fatality is best coined as ‘in-
hospital stroke fatality’ (Roberts and Goldacre, 2003). We calculated the overall stroke case 
fatality and case fatality at 3 days, 7 days and 14 days. Stroke fatality studies differs in; 1) their 
chosen time frame – for example within 28 days, 21 days to one month,  7 days, 30 days, and 
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1 year of stroke admission – and 2) whether the researchers restrict or do not restrict to stroke 
deaths during hospital admission (Thorvaldsen et al., 1995, Feigin et al., 2009, Saposnik et al., 
2008).  
In assessing survival, the outcome variable was time-to-stroke fatality (death) after 
admission to HUSM. The time was calculated in days (date of admission until date of discharge) 
and the event was defined as either failure (death due to stroke, coded as 1) or censored (alive 
at discharge or death from causes other than stroke, coded as 0). Kaplan–Meier survival curves 
were plotted and the survival experience between cerebral infarction and haemorrhagic 
stroke was tested using the log-rank test (Hosmer et al., 2011). Kaplan-Meier estimate 
provided the fraction of subjects (stroke patients) living for a certain amount of time (days) 
after acute stroke and can be formally defined as ‘the probability of surviving in given length 
of time while considering time in many small intervals’ (Goel et al., 2010).     
Cox proportional hazard regression was used to produce hazard ratios (HR) and to 
compare the prognostic effect between stroke subtypes. To facilitate the interpretation of HR, 
the cerebral infarction group was chosen as the reference (baseline) category because the risk 
of death from cerebral infarction is lower than that from haemorrhagic stroke. We compared 
the prognostic effect of stroke subtypes in 3 models: 1) stroke subtypes alone, 2) stroke 
subtypes with age and 3) stroke subtypes with sex. Since the aim of analysis is to look at the 
prognostic effect of stroke subtypes, we felt adding only age and sex covariates, one at a time, 
was adequate.  
 The Schoenfeld residuals generated by the Cox proportional hazard regression were 
used to check for the assumption of hazard proportionality (Hosmer et al., 2011). In Stata, 
‘estat phtest’ tests the hazard proportionality for the overall model (global test) and for each 
covariate (detailed tests). All tests were 2-tailed and p-values of less than 0.05 were 
considered significant.  
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In the Cox regression analysis, three assumptions about censoring (censored because 
they were discharged alive) including the independent censoring, the random censoring and 
the non-informative censoring (Resche-Rigon et al., 2006, Kleinbaum and Klein, 2012) were 
considered not violated. This can happen when there is a presence of shared dependency 
between the covariate (such as stroke subtypes in the model) and the outcome (Figure H.1). 
The results to support the shared dependency in this study are shown in Table H.3 and Table 
H.4. But the independence between time (T) and censoring (δ = 0) to provide non-bias 
estimates in survival analysis requires a strong assumption. In the event that informative 
censoring is suspected, multiple imputation methods can be performed. Two recent methods 
are: a) the Gamma imputation method and b) the Risk Score imputation method. Both 
methods will replace missing observations with imputed values based on different 
approaches. Imputation can be done in different parameters set by users, and this will produce 
different estimates depending on the parameters. Sensitivity analysis can then be performed 
on these different estimates (See Appendix H for further details).          
4.3.5 Ethical approval  
We received ethical approval from the Medical and Research Ethics Committee (MREC), 
Ministry of Health, Malaysia (NMRR-12-471-12139), the USM Human Research Ethics 
Committee (HREC), Universiti Sains Malaysia (JEPEM [242.4.(1.4)]) and the Lancaster 
University Research Ethics Committee.  
4.4 Results 
Data from 150 consecutive patients with cerebral infarction and 142 consecutive patients with 
haemorrhagic stroke treated at the HUSM neurology ward were extracted from the HUSM 
records office and clinical folders. In the haemorrhagic stroke group, 21.1% (30/142) had SAH, 
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59.2% (84/142) had primary ICH and 19.7% (28/142) had other types of intracranial 
haemorrhagic stroke. All patients were of Asian origin. 
Table 4-1 shows the variables age (years), length of stay (days), GCS score, SBP and 
DBP for the two groups as stratified by sex. The haemorrhagic stroke group was further 
grouped into a) SAH, b) primary ICH and c) others. Patients in the haemorrhagic stroke group 
were significantly younger, had poorer GCS scores and had higher DBP (mean age = 57.6 years, 
mean GCS score = 10.1, mean DBP = 94.3 mmHg) than the patients admitted with cerebral 
infarction (mean age = 62.5 years, mean GCS score = 13.5, mean DBP = 91.8 mmHg). 
The distribution of stroke patients based on referral type (centre) is presented in Table 
4-2. A chi-square test showed a significant difference (p < 0.001) in the distribution of referral 
type: a large proportion of patients in the cerebral infarction group (71.3%) had attended as 
self-referral to HUSM but a large proportion of patients in the haemorrhagic stroke group were 
referred from other tertiary or district hospitals (32.4%, 26.8% and 33.3%, 27.5%, 
respectively).  
4.4.1 Stroke fatality  
Table 4-3 shows the overall stroke case fatality by stroke type, and stroke fatalities at 3 days, 
7 days and 14 days. The fatalities were deaths due to all causes while our stroke patients were 
being treated at the HUSM. The overall case fatality rate for cerebral infarction was 12.0% 
(18/150). At 3 days, 7 days and 14 days, the fatalities were 4.0% (6/150), 8.7% (13/150) and 
10.7% (16/150), respectively. The overall case fatality rate in the haemorrhagic stroke group 
was 46.5% (66/142), approximately four times higher than that of the cerebral infarction 
group. At 3 days, 7 days and 14 days, the fatalities were 22.5% (32/142), 33.1% (47/142) and 
39.4% (56/142), respectively. 
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Among the haemorrhagic stroke subgroups, the SAH group had the highest overall 
case fatality 66.7% (20/30). Case fatalities in SAH patients were 6 times higher at 3 days and 
almost 5 times higher at 7 days and 14 days post admission than that in patients admitted with 
cerebral infarction. More than half (56.0%) of patients with ICH died within 14 days of 
admission. The distribution of stroke fatalities at each of the 4 time points differed significantly 
between the haemorrhagic stroke and cerebral infarction groups. The distribution of overall 
fatality differed significantly between the subgroups of haemorrhagic stroke but not the 
distribution of fatalities at 3 days, 7 days and 14 days.   
4.4.2 Prognostic factors between ischaemic and haemorrhagic stroke  
Figure 4-1 shows the Kaplan–Meier survival estimates for the cerebral infarction group (n = 
150) and haemorrhagic stroke group (n = 142). The median survival time was significantly 
shorter (log-rank test p < 0.001) in the haemorrhagic stroke group (median=14 days) than in 
the cerebral infarction group (median=28 days). At 10 days after admission, there were only 
11 patients out of 150 CI patients who were in the ward while the rest (139 patients) have 
been discharged alive by the treating physicians. They were considered as censored patients 
in our analysis. Among the 142 HS patients, there were still 40 patients who were alive and 
being treated in the ward at 10 days. At day 50, none of the CI patients was in the ward but 
two (n=2) HS patients were still being treated.   
Table 4-4 and Table 4-5 show the survival parameters estimated for the Cox 
proportional hazard regression model in a model with stroke subtype as the only covariate 
and for two covariate-adjusted models. 
Table 4-4 shows that the crude and adjusted risks (adjusted for sex) for stroke fatality 
in the haemorrhagic stroke group were both 2.61 times higher than that of the cerebral 
infarction group (95% confidence interval [CI]: 1.53, 4.44). When the model was age-adjusted, 
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the risk for stroke fatality for the haemorrhagic stroke group increased to 2.78 (95% CI: 1.62, 
4.76).  
The risk estimates for stroke case fatality for the haemorrhagic stroke subgroups, i.e. 
SAH, ICH and others, were compared against cerebral infarction, as shown in Table 4-5. The 
univariate Cox regression model shows that all haemorrhagic stroke subtypes posed 
significantly higher risk for stroke fatality than cerebral infarction: the crude HR was 2.88, 2.68 
and 2.17 times greater, respectively, than that for cerebral infarction. When adjusted for age 
then sex in multivariate Cox hazard regression, the risk estimates for stroke fatality of the 
haemorrhagic stroke subgroups remained higher than that of the cerebral infarction group, 
with SAH carrying the highest risk for stroke fatality.  
4.5 Discussion 
Our study describes the on-admission characteristics of stroke patients and compares stroke 
case–fatalities and prognostic effects between patients with cerebral infarction or 
haemorrhagic stroke in an Asian population. We found that haemorrhagic stroke patients 
were younger, more commonly referred from hospital settings than other settings and had 
lower GCS scores and higher DBP on admission than cerebral infarction patients. Overall, 3-
day, 7-day and 14-day stroke case fatalities (in-hospital stroke fatality) were all higher in the 
haemorrhagic stroke group than in the cerebral infarction group. The median survival time 
was shorter in the haemorrhagic stroke group (median=14 days) than in the cerebral infarction 
group (median=28 days). When not adjusted or when adjusted for either age or sex, 
haemorrhagic stroke patients had more than twice the risk for in-hospital stroke fatality than 
cerebral infarction patients. Our findings show that among the haemorrhagic stroke 
subgroups—SAH, ICH and other types of brain haemorrhage—SAH had the highest risk for in-




Table 4-1 The means and standard deviations (SD) for age, length of stay (LOS), Glasgow Coma Scale (GCS), systolic blood pressure (SBP in mmHg) and 
diastolic blood pressure (DBP in mmHg) stratified for sex and stroke subtype 




j  All  
  n Mean(SD) n Mean(SD) n Mean(SD) n Mean(SD) n Mean(SD) n Mean(SD) 
Age M 69 61.9(12.7) 57 59.5(14.1) 6 46.3(20) 36 56.4(13.8) 15 61.6(15.6) 126 59.5(14.1) 
 F 81 63.1(13.9) 85 60.7(13.7) 24 61.9(10.3) 48 56.4(14.6) 13 59.1(11.6) 166 60.7(13.7) 
LOSa M 69 4(4) 57 5.8(7.4) 6 12(9) 36 6(4.8) 15 10.7(16.2) 126 5.8(7.4) 
 F 81 5.4(6.2) 85 7.9(8.5) 24 10.8(9.1) 48 6.2(6.5) 13 9.1(12.3) 166 6.7(7.5) 
GCSb M 69 14(2.6) 57 12.7(3.5) 6 7.7(4.5) 36 11.2(3.7) 15 12.3(3.6) 126 12.7(3.5) 
 F 81 13.2(3) 85 9.4(4.4) 24 10(4) 48 9.3(4.5) 13 9.1(4.6) 166 11.3(4.2) 
SBPc M 69 159.5(26.8) 57 165.4(30.7) 6 151(24) 36 184.4(30.1) 15 150.8(31.6) 126 165.4(30.7) 
 F 81 168.1(36.8) 85 161.5(37.3) 24 156.3(34) 48 167(38) 13 150.5(39.7) 166 164.7(37.1) 
DBPd M 69 90.5(17.8) 57 95.6(22) 6 93.7(19.1) 36 109.3(25.6) 15 86.3(16.8) 126 95.6(22) 
 F 81 92.9(19.2) 85 93.6(22.1) 24 86.8(14.6) 48 99.7(24) 13 83.8(20.6) 166 93.3(20.7) 
a LOS=length of stay (days) b GCS=Glasgow Coma Scale (min=3,max=15), c SBP=Systolic blood pressure d DBP=Diastolic blood pressure e M=male,F=female f CI=cerebral 
infarction g HS=haemorrhagic stroke h SAH=subarachnoid haemorrhage i ICH=intracerebral haemorrhage and j Others=other intracranial haemorrhage .  
Note: HUSM uses administrative diagnosis based on the International Classification of Diseases (ICD) 10. In ICD-10, cerebrovascular diseases were coded in Chapter I60 to I69 
where cerebral infarction is coded as I63, subarachnoid haemorrhage is coded as I60, Intra-cerebral haemorrhage is coded as I61. We grouped stroke patients under ‘other 





Table 4-2 The frequencies and percentages of the type of referral for stroke patients to the 
Emergency Department, Hospital Universiti Sains Malaysia (HUSM) for different stroke 
subtypes 
Referring centrea Cerebral infarction, n(%) Haemorrhagic stroke, n(%) 
From other tertiary hospital 7(4.9) 46(32.4) 
From general practice 4(2.8) 2(1.4) 
From district hospital 29(20.3) 38(26.8) 
Direct from scene (Self-referral) 102(71.3) 52(36.6) 
Not documented 7(4.7) 4(2.8) 
TOTAL 150(100.0) 142(100.0) 
a Pearson chi-sq(dof)=46.4(4), p-value<0.001 
 
 
Table 4-3 The overall stroke case fatality and the 3 days, 7 days and 14 days stroke fatalities 
for patients with cerebral infarction (CI) and haemorrhagic stroke (HS)  
Fatalities for the cerebral infarction (CI) and haemorrhagic stroke (HS) 
   Overall 3-day 7-day 14-day 
 Stroke subtypes All patients  Dead (%) Dead (%) Dead (%) Dead (%) 
CI 150 18(12.0) 6(4.0) 13(8.7) 16(10.7) 
HS 142 66(46.5) 32(22.5) 47(33.1) 56(39.4) 
  292 p-val<0.001 p-val<0.001 p-val<0.001 p-val<0.001 
      
Fatalities for the subtypes of the haemorrhagic stroke (HS) 
  Overall 3-day 7-day 14-day 
 Stroke subtypes All HS patients  Dead (%) Dead (%) Dead (%) Dead (%) 
SAH 30 20(66.7) 8(26.7) 11(36.7) 13(43.3) 
ICH 84 33(39.3) 18(21.4) 37(44.0) 47(56.0) 
Others  28 13(46.4) 3(10.7) 10(35.7) 10(35.7) 
  142 p-val=0.036 p-val=0.301 p-val=0.644 p-val=0.137 
a CI=cerebral infarction b HS=haemorrhagic stroke cSAH=subarachnoid haemorrhage d ICH=intracerebral 





Figure 4-1 Kaplan-Meier survival estimates and curves of overall survival for the cerebral 
infarction (CI) group and haemorrhagic stroke (HS) group. The number at risk shows the 
numbers of patients still alive, and therefore at risk for stroke death at different period of 
time (days). The survival probability indicates the Kaplan-Meier probabilities (conditional 
probabilities) that a patient survives so many days or longer. The median survival time for 
CI was 28 days and for HS was 14 days – meaning that a patient with CI has a 50% probability 
of surviving 28 days or longer and for a patient with HS has a 50% probability of surviving 14 
days or longer.  The log rank test (results not shown) gave the p-value <0.001 
 
Table 4-4 The crude hazard ratios (HR) and adjusted HR (adjusted for age then sex), standard 
errors and 95% confidence intervals for HR estimated using the Cox proportional hazard 
regression model. The haemorrhagic stroke (HS) was compared against the cerebral 
infarction (CI as the baseline group). In all comparisons, p-values yielded were less than 
0.001.   
Covariates   n HR a  SE b  Lower 95% CI c Upper 95% CI c p-value 
stroke subtypes HS d  142 2.61 0.71 1.53 4.44 <0.001 
 CI 
e  150 1.00     
stroke subtypes + age HS 142 2.78 0.76 1.62 4.76 <0.001 
 CI 150 1.00     
stroke subtypes + sex HS 142 2.61 0.71 1.53 4.44 <0.001 
 CI 150 1.00     
a HR=Hazard ratio b SE=Standard error for HR c CI=confidence interval for HR d HS=Haemorrhagic stroke 





Table 4-5 The crude hazard ratios (HR) and adjusted HR (adjusted for age then sex), standard 
errors and 95% confidence intervals for HR estimated using the Cox proportional hazard 
regression model. The haemorrhagic stroke (HS) was compared against the cerebral 
infarction (CI as the baseline group). All p-values were less than 0.050.   
        
Covariates  
 
n HRa SEb 
Lower 95% 
CIc 
Upper 95%  
CIc p-value 
stroke subtypes SAH d  30 2.88 0.97 1.48 5.59 0.002 
 ICH 
e  84 2.67 0.79 1.50 4.77 0.001 
 Others 




0 1.00     
stroke subtypes  SAH d  30 3.11 1.06 1.59 6.06 0.001 
+ age ICH e  84 2.90 0.86 1.61 5.20 <0.001 
 Others 




0 1.00     
stroke subtypes  SAH d  30 2.74 0.93 1.41 5.34 0.003 
+ sex ICH e  84 2.68 0.79 1.50 4.79 0.001 
 Others 




0 1.00     
a HR=Hazard ratio b SE=Standard error for HR c CI=confidence interval for HR d SAH=subarachnoid 
hemorrhage e ICH=intracerebral haemorrhage f Others=intra-cranial haemorrhage (acute non-traumatic 
subdural haemorrhage or non-traumatic extradural haemorrhage) or patients with CT imaging showing 
the combinations of SAH, ICH or CI g CI=cerebral infarction  
 
We also reported differences in on-admission variables between patients with 
haemorrhagic stroke and patients with cerebral infarction. Patients with haemorrhagic stroke 
were younger on admission than those with cerebral infarction were. This reinforces evidence 
from previous research showing that the frequency of haemorrhagic stroke is greater in young 
adults than in the elderly (Subha et al., 2015). In this study, patients with haemorrhagic stroke 
were also more commonly referred from other hospitals rather than from other settings. This 
was also seen in earlier studies. A likely explanation is that it is a more severe condition (Testai 
and Aiyagari, 2008, Andersen et al., 2009, Aronowski and Zhao, 2011) and requires more 
advanced care at a better-equipped centre (Giraldo, 2015c, Giraldo, 2015a).  
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In Kelantan, Malaysia, patients with haemorrhagic stroke are referred to HUSM from 
other hospitals because it is a centre that provides advanced care in the Northeast of Malaysia 
especially for cases requiring neurosurgical procedures. Our results showed these referrals 
were more likely when the stroke was haemorrhagic than for other types. The implication for 
our study of this referral pattern is the possibility of the introduction of two types of bias. a) 
Berkson’s bias and b) centripetal bias. Both are classified under ‘selection bias’ (Delgado-
Rodriguez and Llorca, 2004). Berkson’s bias is produced when, for example, the probability of 
hospitalisation for two different diseases differ and centripetal bias means patients are drawn 
to a specific centre because of its reputation (Delgado-Rodriguez and Llorca, 2004). There is 
also a possibility that the higher fatality in haemorrhagic stroke could be due to the referral 
source or them being in worse clinical condition than those with ischaemic stroke. To provide 
more information on this a further analysis, such as a stratified analysis (stratified Cox or 
stratified logistic regression), could be performed in on each stratum (or level) of the referral 
source (Hosmer et al., 2011, Kleinbaum and Klein, 2012).       
In our study, patients with haemorrhagic stroke had significantly lower GCS scores 
because the intracranial environment has been more severely compromised due to more 
severe pathologies. The pathologies include disruption of the normal brain anatomy due to 
the accumulation of haematoma, increased local pressure, increased blood toxicity and the 
accumulation of oxidative stress after cell death (Aronowski and Zhao, 2011). 
Haemorrhage (bleeding) occurring from a focal blood vessel in the brain parenchyma 
gives rise to a condition known as ICH; if from sudden bleeding into the subarachnoid space, 
it causes a condition known as SAH, commonly due to a ruptured aneurysm leading to more 
global clinical manifestations (Giraldo, 2015c). 
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Our analyses show that all haemorrhagic stroke subtypes—SAH, ICH and other types 
of brain haemorrhage—pose significantly higher risk for fatality because of the extent of brain 
damage due to bleeding and rebleeding (Roos et al., 2000). 
In cerebral infarction, the pathophysiology is more limited (localised) because the 
main culprit is occlusion of the brain arteries resulting in lack of blood supply, which is clinically 
manifested as sudden neurological deficit. In cerebral infarction, thrombolytic therapy is the 
standard treatment and only rarely is surgical intervention necessary (Giraldo, 2015b). 
The mean age on admission for the cerebral infarction patients in this study is similar 
to those in other studies involving Asian populations (Wong, 1999, Basri and Azman Ali, 2003, 
Christopher et al., 2007). Our ICH patients were almost 5 years younger than ICH patients 
reported in a similar study (mean age = 61.3 years) pooled from 36 hospitals all over Asia (the 
Asian Acute Stroke Advisory Panels study) (Wong, 1999). 
In our study, both the cerebral infarction and haemorrhagic stroke patients were 
younger on admission than those in studies in the high-income countries such as Korea (Kim, 
2009), Finland (Huhtakangas et al., 2013), Canada (Saposnik et al., 2008), Sweden (Nedeltchev 
et al., 2010) and Denmark (Andersen et al., 2011). This is in line with the finding reported in a 
well-known review of stroke epidemiology (Feigin et al., 2009), where the younger age groups 
in the low- to middle-income countries were at higher risk of stroke than their counterparts in 
the high-income countries. 
Our analyses show that, based on the GC scores, patients in the haemorrhagic stroke 
group had more impaired consciousness, which is consistent with the findings of others (Singh 
et al., 2000, Giraldo, 2015b, Giraldo, 2015c, Giraldo, 2015a). We also report that on admission, 
patients in the haemorrhagic stroke group presented with higher blood pressure. This 
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supports previous research reporting that blood pressure is an important risk factor for 
haemorrhagic stroke (Suzuki et al., 2011, Truelsen et al., 2007, Del Brutto et al., 2013). 
In this study, the overall stroke case fatality in the cerebral infarction group was similar 
to that in an earlier report in Malaysia (Basri and Azman Ali, 2003) but was higher than that in 
a study based on other Asian populations (only 8.8%) (Wong, 1999). The 3-day, 7-day and 14-
day stroke case fatality rates in the cerebral infarction group were all higher than that reported 
in Denmark (3-day fatality = 1.9%, 7-day fatality = 3.3%) (Andersen et al., 2011), Canada (7-day 
fatality = 6.9%) (Saposnik et al., 2008), Brazil (10-day fatality rates in three of four centres 
studied were between 4.9% and 7.5%) (Fernandes et al., 2012) and in a large international 
study—The International Stroke Trial—where the 14-day stroke fatality rate was only 4.6% 
(Czlonkowska et al., 2002). 
The overall stroke case fatality in the haemorrhagic stroke group in this study matched 
that of a previous local study (Basri and Azman Ali, 2003) but was higher than that in studies 
elsewhere in Asia (Wong, 1999) and in Brazil (Fernandes et al., 2012). Our comparisons with 
other studies are limited because few studies focus on haemorrhagic stroke and because the 
use of different durations of observation (e.g. days) renders comparisons difficult. 
The difference in the results of stroke fatality between our study and other studies 
could be due to: 1) the difference in the baseline characteristics such as age, sex, stroke 
severity and comorbidities, 2) the quality of treatment on admission, 3) the quality of care 
during admission, 4) the variations in the length of observation (e.g. days), and 5)  the use of 
only in-hospital data (limited to only data during admission) or combination of in-hospital and 
out of hospital data (data during admission and after admission) (Saposnik et al., 2011, 
Saposnik et al., 2008, Sridharan et al., 2009, Thorvaldsen et al., 1995, Wahab et al., 2008, Zhou 
et al., 2013, Delbari et al., 2011, Feigin et al., 2009, Feigin et al., 2003, Xu et al., 2010, Yousuf 
et al., 2012). 
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On admission, there were few differences between patients admitted with cerebral 
infarction and haemorrhagic stroke when variables such as SBP or GCS score were examined. 
This highlights possible difficulties in clinical decision-making when there is a need to 
distinguish between cerebral infarction and haemorrhagic stroke (Donnan, 2011, Martins et 
al., 2011). Misdiagnosis may lead to underestimation of haemorrhagic stroke incidence (Keir 
et al., 2002, Shiber et al., 2010). In view of this difficulty, in practice the ability to distinguish 
cerebral infarction and haemorrhagic stroke must be improved at the earliest possible point 
of contact with physicians or emergency workers. The improvement may include the use of 
additional screening tools and advanced neuroimaging services to enable quick and accurate 
identification of stroke subtype and objective quantification of the severity of stroke (Runchey 
and McGee, 2010, Keir et al., 2002). 
To manage stroke patients effectively, especially those with haemorrhagic stroke, 
hospitals should be equipped with easy access to neuroimaging services to enable prompt use 
of at least a CT scan and to provide aggressive interventions to control blood pressure, correct 
the underlying coagulopathy and to obliterate vascular lesions in patients with a high-risk of 
re-bleeding in the case of haemorrhagic stroke (Diamond et al., 2003, Lavados et al., 2005, 
Roos et al., 2000). Policy-makers should make available a stroke unit in every major hospital. 
Studies and systematic reviews have shown that stroke units providing integrated acute stroke 
care through neurologists, neurosurgeons and neuroradiologists have been effective in 
reducing stroke mortality and morbidity (Ingall et al., 2000, Stroke Unit Trialists, 2007, 
Saposnik et al., 2011). In Asia especially, new resources should be directed towards developing 
and implementing stroke training for health care workers (Donnan, 2011). 
The main strength of the study is that we recruited and extracted both the routine 
hospital and clinical data of nearly 300 stroke patients in the setting of a major hospital in a 
region of Southeast Asia, from which such data are sparse. The stroke analysis is also 
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strengthened by the use of CT scan images—the investigation of choice in stroke (Falcone et 
al., 2013a)—or at least formal radiological reports, to establish stroke subtype. This reduces 
the classification bias of stroke subtype. 
We are aware of a few limitations of the study. One of them is the restriction to hospital-
based stroke patients. The severity and fatality in stroke patients in the community and in 
hospitals are likely to be different (Andersen et al., 2011), hence our inferences pertain to 
hospitalised stroke patients only. Second, we cannot generalise these results to stroke patients 
in all types of hospitals because our subjects were treated in a tertiary care hospital equipped 
with a neurology unit. Much of tertiary hospitals in the Asian countries, including Malaysia, 
still lack an integrated neurology care stroke unit. Thirdly, we assumed that one of the 
censoring processes was non-informative. We based this assumption on the evidence that the 
covariate of interest (stroke subtype) shares its dependency with the outcome based on the 
Cox regression and reversed Cox regression analyses (see Figure H.1). In both analyses, the 
estimates of stroke subtype remain plausible and significant as shown in Table H.3 and Table 
H.4. On the other hand, censored observations provide non-negligible information 
(informative censoring) when there is no exact independence between time and censoring. In 
cases where censoring is informative, the numerical estimates from Kaplan-Meier and Cox 
proportional hazards become biased. In this instance, the multiple imputation method can be 
performed, and this method replaces the missing observations. The imputation can be 
performed using different parameters to mimic different scenarios. In Appendix H, we outline 
the principle of multiple imputation for Cox regression and describe two recent methods 
(Gamma imputation and Risk Score imputation) that are available as software packages. A 
sensitivity analysis (a technique used to determine how different values impact a particular 





This study has shown that on admission to hospital, haemorrhagic stroke patients present at 
a younger age and have lower GCS scores and higher blood pressure than cerebral infarction 
patients. Overall, 3-day, 7-day and 14-day in-hospital stroke case fatality are all higher in 
patients with haemorrhagic stroke—especially SAH—than in those with cerebral infarction. 
The median survival time is shorter in patients with haemorrhagic stroke (14 days) than in 
patients with cerebral infarction (28 days). Haemorrhagic stroke subtypes—intracerebral, 
subarachnoid and other type of brain haemorrhage—carry at least twice the risk (crude and 
adjusted) for in-hospital stroke fatality than cerebral infarction. 
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Aims To describe the change in Barthel Index score at baseline (at discharge) to 1 month and 
then 3 months post-baseline and to explore the relationship between age, sex and stroke 
subtype with Barthel Index score over the 3-month period. 
Method A total 98 in-hospital stroke patients were recruited and their Barthel Index scores 
were assessed on 3 measurement occasions (at baseline, 1 month after baseline, 3 months 
after baseline). The Barthel Index was scored by telephone interview. The Barthel Index has 
10 items, with total scores ranging from 0 (worst) to 100 (best). Analysis was done using a 
random intercept model taking into consideration the individual subject random effect. 
Results The mean age of the patients (n = 98) was 60.7 years (SD = 13.6); 65.3% (64/98) were 
female and 73.7% (70/95) had ischaemic stroke. The overall Barthel Index score increased 
from baseline (mean = 35.1, SD = 39.4) to 1 month (mean = 64.4, SD = 39.5) and to 3 months 
(mean = 78.0, SD = 38.9). Over the 3-month period from the baseline, 13 patients died; their 
mean baseline Barthel Index score was different from the mean score of patients at discharge 
(Kolmogorov–Smirnov test p = 0.048). Measurement occasion, age and stroke subtype were 
significantly related with the Barthel Index score. Over the same period, the adjusted Barthel 
Index mean score increased from 35.1 to 68.7. The Barthel Index score decreased as age 
increased, while haemorrhagic stroke patients consistently had lower Barthel Index scores 
than ischaemic stroke patients. There was no significant interaction between the covariates in 
the model. 
Conclusion Overall, the Barthel Index score increases from baseline to 3 months post-baseline. 
Measurement occasion, age and stroke subtype but not sex are related with Barthel Index 
score over a 3-month period.  
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5.2 Introduction  
Stroke is a major public health problem that causes a substantial global burden of health 
(Krishnamurthi et al., 2014). About 10% of all deaths around the world are due to stroke, with 
millions of survivors left disabled (Strong et al., 2007). In 2005 alone, 16 million people suffered 
from a first-ever stroke (Mukherjee and Patil). 
Acute stroke results in neurological, functional and cognitive decline (Lisabeth et al., 
2014). After surviving a stroke, functional status generally improves over time (Rachpukdee et 
al., 2013). It is useful to estimate this change in functional status for 3 principal reasons: a) for 
clinicians to provide effective stroke care, anticipate discharge planning and support patients 
and family (Park et al., 2013), b) for researchers to explore the prognostic factors and 
underlying pathophysiology of stroke (Bhalla et al., 2013), and c) to facilitate comparisons 
between interventions in clinical trials (Harrison et al., 2013). Studies have shown that 
functional status—as well as other outcomes—after acute stroke are associated with age 
(Sohrabji et al., 2013, van Almenkerk et al., 2013, Khan et al., 2012, Kong and Lee, 2014), stroke 
severity, size of the stroke (van Almenkerk et al., 2013) and stroke subtype (Di Carlo et al., 
2006, Paci et al., 2011, McNaughton et al., 2001). 
One of the most well-known measures of functional status after stroke is the Barthel 
Index. It is the most commonly cited measure of disability in stroke rehabilitation trials in the 
published literature (Sangha et al., 2005). The Barthel Index was initially developed to act as a 
simple index for independence of function in patients post-stroke and as a useful scoring 
assessment during rehabilitation (Quinn et al., 2011). It has excellent reliability (Duffy et al., 
2013) and its 10-item version—with scores of 0 to 100 in 5-point increments—is the most 
often used (Quinn et al., 2011). 
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In this study, we aimed to answer the following questions: a) how do Barthel Index 
scores change between baseline and at 1 and 3 months post-baseline? and b) are the 
covariates age, sex and stroke subtype associated with change in the Barthel Index score over 
a 3-month period? Our objectives were first to describe the Barthel Index scores at baseline, 
after 1 month, then 3 months post-baseline. Subsequently, we explored the relationship 
between specific covariates (age, sex, stroke subtype) and the Barthel Index scores over this 
3-month period. 
5.3 Methods 
5.3.1 Patients  
A total of 108 consecutive stroke patients diagnosed and admitted between 1 July 2013 and 
31 October 2014 from two major tertiary hospitals in Kelantan, Malaysia: a) Hospital Universiti 
Sains Malaysia (HUSM) and b) Hospital Raja Perempuan Zainab II (HRPZ) were recruited for 
this study.  
The stroke patients were eligible if they met the following inclusion criteria: a) stroke 
was the primary diagnosis for hospital admission, b) age > 18 years, c) stroke diagnosis was 
established by the neurology team, d) diagnosed and admitted between 1 July 2013 and 31 
October 2014 and e) stroke subtype was limited to: a) ischaemic stroke (infarction of the 
central nervous system) or b) haemorrhagic stroke (spontaneous non-traumatic 
haemorrhage) (Cioncoloni et al., 2012). We excluded stroke patients if: a) the primary 
diagnosis for admission was not stroke, or b) they required intensive care on the day of 
recruitment. 
The clinical definition for stroke in this study was ‘a clinical syndrome characterised by 
rapidly developing clinical symptoms and/or signs, focal, and at times global, loss of cerebral 
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function, with symptoms lasting more than 24 hours or leading to death, with no apparent 
cause other than a vascular one’ (O'Donnell et al., 2010a, Hatano, 1976).  
5.3.2 Barthel Index 
The Barthel Index was designed to be a simple index of a patient’s independence and is also 
used to measure the change in functional status during rehabilitation (Mahoney and Barthel, 
1965). It is a scale that indicates the ability to perform activities of daily living. It has 10 items 
(tasks), with total scores ranging from 0 (worst mobility in activities of daily living) to 100 (full 
mobility in activities of daily living) (Quinn et al., 2011) and it has adequate clinimetric (quality 
of clinical measurements) properties in stroke rehabilitation (Cioncoloni et al., 2012). In the 
index, the 10 items have these scoring combinations: a) 0 and 5, b) 0, 5 and 10, or c) 0, 5, 10 
and 15. 
In this analysis, we treated the scores as numerical as previously done (Nakao et al., 
2010, Shah et al., 1989, Harrison et al., 2013), although treating Barthel Index scores as 
categories: a) score > 80, independent; b) score < 40, very dependent; or a) score of 95/100, 
cut-off point for excellent outcome; and b) score of 75/100, a poor outcome, is also acceptable 
(Harrison et al., 2013). 
5.3.3 Consent and interview 
Informed consent was obtained from the patient, or if the patient was unable to give informed 
consent, from a proxy, usually the next of kin. Following that, one researcher (KIM) conducted 
all Barthel Index assessments. 
Patients were deemed able to participate in the study if they had a Glasgow Coma 
Scale score of ≥15 and were orientated to time, place and person. Additionally, patients had 
to have been assessed as fit and reliable to participate in the interview by a neurologist. 
138 
 
Eliciting information from a proxy, usually the next of kin, in stroke studies has been 
proven to be accurate (Bruno et al., 2010) and has been used in a large multi-centre stroke 
study: the INTERSTROKE study (O'Donnell et al., 2010b). 
Before discharge, Barthel Index scores were elicited in the ward by visual inspection 
and face-to-face interview. There are 10 items in the Barthel Index and it was administered by 
interview by KIM. Subsequently, the data were coded based on scores of 0, 5, 10 or 15 for 
each item. KIM then entered the recorded Barthel Index scores into a database. 
The total 10 items yielded the overall Barthel Index score. The scale of the index ranges 
from 0 (worst mobility in activities of daily living) to 100 (full mobility in activities of daily 
living). The items in the Barthel Index address a patient’s ability in feeding, bathing, grooming, 
dressing, bowel and bladder control, toileting, chair transfer, ambulation and stair climbing 
(Harrison et al., 2013). A full list of the items is included in the appendices (Appendix F (Malay 
version) and Appendix G (English version)). 
For patients who had been discharged, commonly 1 and 3 months thereafter, we 
called the patients or the proxy for a telephone assisted interview. On these two measurement 
occasions, KIM conducted the telephone interview. 
Using telephone interviews for Barthel Index assessment has many advantages: a) it 
is reliable and valid (Della Pietra et al., 2011, Go, 2008), and b) it is valid for proxies—such as 
carers—and lay persons (Korner-Bitensky and Wood-Dauphinee, 1995, Hoffmann et al., 2010, 
Janssen et al., 2010). This is especially true when stroke patients are burdened with cognitive 
impairment (up to 60% if they have intracerebral haemorrhage) (Tveiten et al., 2014) and 




5.3.4 Measurement occasions and covariates   
We conducted the interviews and constructed the Barthel Index at 3 time points: a) at 
baseline, b) at 1-month post-baseline and c) at 3 months post-baseline. 
At baseline, most of the patients in this study were assessed after day 3 of admission 
(usually the day the acute stroke occurs). This was done because any Barthel Index assessment 
performed earlier than 3 days post-acute stroke has limitations (Kwakkel et al., 2010, Quinn 
et al., 2011). 
We chose 3 months as the maximum length of follow-up because it has been reported 
that the greatest recovery from neurological deficits after stroke occurs during the first 3 
months or 10 weeks (Van Peppen et al., 2004, Kwakkel and Kollen, 2013).  
The information on the covariates sex, age and stroke subtypes were abstracted from 
the medical records. The other covariates such as education, income and occupation were 
dropped from the analysis because the information was not available in the medical records 
(because it could only be collected directly from patients, and many were too ill to interview 
for this information).   
5.3.5 Statistical analysis  
Of 108 stroke patients recruited, 10 patients were uncontactable during follow-up. We 
described the patients’ characteristics and Barthel Index score at baseline and at 1 and 3 
months post-baseline were described using mean (SD) and frequency (%) where appropriate 
for the remaining 98 patients. 
To compare if the baseline Barthel Index scores between patients who were alive 
throughout the study and those died within the 3-month period followed the same continuous 
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distribution, the cumulative probabilities for each subject were plotted and compared using 
the Kolmogorov–Smirnov test (‘ks.test’ function in R software) (R Development Core Team, 
2013). 
The relationship between the Barthel Index scores at each measurement occasion—
at baseline, 1 and 3 months post-baseline (treated as a dummy variable)—and other 
covariates: age, sex (male or female) and stroke subtype (haemorrhagic stroke or ischaemic 
stroke) were examined individually using simple linear regression. 
Next, a random intercept model—a type of linear mixed effect (‘lme’) model—
considered the stroke patient as the random component and analysed it using the ‘nlme’ 
package in R software (Pinheiro et al., 2015). The regression parameters were estimated using 
maximum likelihood estimates. First, we fitted a model containing only the main effect 
variables. Next, we tested the addition of the 2-way interaction terms in the model. All 
comparisons between models were performed using likelihood ratio (LR) tests. 
A histogram of the distribution of residuals was plotted to check the assumption of 
normality, as was a plot of the standardised residuals against the fitted values for homogeneity 
of variance. This latter plot was used for model checking.   
5.3.6 Ethical approval 
We received ethical approval from the Medical and Research Ethics Committee (MREC), 
Ministry of Health, Malaysia (NMRR-12-471-12139), the USM Human Research Ethics 
Committee (HREC), Universiti Sains Malaysia (JEPEM [242.4.(1.4)]) and the Lancaster 





Data from 98 stroke patients, with a mean age of 60.7 years, were eligible for analysis. Of the 
patients who were eligible and for whom a Barthel Index had been constructed, 34.7% (34/98) 
were male and 65.3% (64/98) were female. Female patients were slightly older than male 
patients; the mean age of the female patients was 61.2 years; that of the male patients was 
59.8 years. Ischaemic stroke patients comprised of 73.7% (70/95) of all strokes patients in this 
study. The proportion of ischaemic stroke was bigger than the haemorrhagic stroke because 
ischaemic stroke is more prevalent (common) than haemorrhagic stroke.    
Table 5-1 shows that during the entire follow-up period, 13 patients died and two (2) 
were lost to follow-up. Of those who died, 10 did so between baseline and 1 month post-
baseline and 3 patients died between 1 and 3 months post-baseline. Because the number of 
deaths was small, this will limit the power of the subsequent analysis. 
In Table 5-2, we show that the overall Barthel Index mean score at baseline was 35.1 
(SD = 39.4). The mean score then increased to 64.4 (SD = 39.5) at 1 month and to 71.5 (SD = 
38.9) at 3 months’ post-baseline. The Barthel Index score was lower at baseline in females 
than in males (mean = 31.6 vs. 41.8), but at 1-month post-baseline, the scores for females and 
males were almost similar (mean = 63.9 vs. 65.6). The scores for both sexes improved at 3 
months’ post-baseline (with a greater improvement in the male patients). The baseline Barthel 
Index score for haemorrhagic stroke patients was lower than that for ischaemic stroke patients 
(mean = 15.0 vs. 41.9), but then it increased more than 4-fold between baseline and 1-month 
post-baseline (mean = 66.3 vs. 63.0). At 3 months’ post-baseline, the Barthel Index scores were 
almost similar (mean = 72.0 vs. 70.3). The baseline Barthel Index score for those who died 
within the first month (n=10) was 4.0 (SD = 8.43), and those who died within the three months 
(n=13) was 8.46 (SD = 19.9).    
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Our analyses also show that for patients who survived, the Barthel Index score 
increased modestly from baseline until 3 months post-baseline. The mean Barthel Index score 
at baseline of those who survived up to 1 month post-baseline (n = 10) was 4.0 (SD = 8.4) and 
the mean Barthel Index score at baseline of those who survived up to 3 months post-baseline 
(n = 13) was 8.5 (SD = 19.9). 
Figure 5-1 shows that more than 40% of patients had baseline scores of 0. The 
cumulative probability plots show that the distribution of the baseline Barthel Index scores (n 
= 98) was marginally different from the distribution of baseline scores of patients who died 
during the 3-month follow-up (n = 13) (Kolmogorov–Smirnov test p = 0.0484). 
Table 5-3 shows the univariable linear regression parameters. At all measurement 
occasions, age was inversely related to Barthel Index score. The mean Barthel Index scores for 
stroke subtype and sex were not significant (p ≥ 0.05) at every measurement occasion, except 
for haemorrhagic stroke, which had a significantly lower Barthel Index score at baseline. 
In Table 5-4, the regression parameters produced by the lme models, the log-
likelihood values and the p-values are shown. It shows that the best predictors for change in 
the Barthel Index over the 3-month interval come from model 4. The predictors are 1) 
measurement occasion (baseline and 1 month and 3 months post-baseline), 2) age (centred 
at 60.7 years) and 3) stroke subtype (haemorrhagic stroke vs. ischaemic stroke). Model 4 
shows that at baseline the Barthel Index was 39.6, at 1 month after discharge 66.9 and at 3 
months after discharge 73.2. Age has inverse relationship with the Barthel Index: a one-year 
increase in age, the Barthel Index reduces by 0.94 unit, indicative poorer functional health 
status with advancing age. Patients with haemorrhagic stroke (HS) has poorer Barthel Index 
score (16.8 unit lower) than patients with ischaemic stroke. 
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Table 5-5 also shows the results of fitting model 4 (covariate measurement occasion 
+ age + stroke subtype) in Table 5-4 with the products of 2-way interaction: a) age × 
measurement occasion, and b) age × stroke subtype. Based on the LR test, both the interaction 
terms (model 5 and model 6) failed to significantly improve model 4 (p = 0.123 and 0.535, 
respectively).  
Table 5-1 Patient characteristics and distribution of patients at baseline, one month and 
three months’ post baseline  
Variables   n Male Female All 
Stroke subtype Ischaemic Stroke 70 27 (81.8) 43 (69.4) 70 (73.7)  
Haemorrhagic Stroke  25 6 (18.2) 19 (30.6) 25 (26.3) 
Mean Age (SD) Years 98 59.8 (12.6) 61.2 (14.2) 60.7 (13.6) 
At Baseline Alive 98 34 (100.0) 64 (100.0) 98 (100) 
Baseline to 1 month Alive   87 28 (82.3) 59 (93.7) 87 (89.7)  
Dead 10 6 (17.7) 4 (6.3) 10 (10.3) 
Baseline to 3 months  Alive  83 27 (79.4) 56 (90.3) 83 (86.5) 
  Dead 13 7 (20.6) 6 (9.7) 13 (13.5) 
 
Table 5-2  The Barthel Index score at baseline, 1-month post-baseline and 3 months’ post-
baseline by sex, major stroke subtype, and vital status  
Patients n At baseline n At 1 month n At 3 months 
   Mean (SD)  Mean (SD)  Mean (SD) 
All  98 35.1 (39.4) 86 64.4 (39.5) 82 71.5 (38.9) 
Male 34 41.8 (42.4) 27 65.6 (41.3) 27 78.0 (34.6) 
Female 64 31.6 (37.5) 59 63.9 (39.0) 55 68.3 (40.8) 
Ischaemic stroke 70 41.9 (40.7) 61 63.0 (40.6) 57 70.3 (39.3) 
Haemorrhagic Stroke 25 15.0 (27.2) 23 66.3 (38.1) 23 72.0 (39.6) 
 
Figure 5-1 shows that more than 40% of patients had baseline score equalled zero. 
The cumulative probability plots show the distribution of the baseline Barthel Index score 
(n=98) is marginally different from the distribution of baseline scores in patients who died 




Figure 5-1 The cumulative proportions and the baseline Barthel Index scores for all patients 
(n=98) and for patients who died after baseline measurement up to 3 months post baseline 
(n=13). The cumulative proportions for Barthel Index were compared using the two-sample 
Kolmogorov-Smirnov test (2-sided test, D = 0.4027, p-value =0.0484) 
 
5.5 Discussion 
This study has shown that overall, the crude (unadjusted) Barthel Index scores increased from 
baseline (mean = 35.1) to 1 month (mean = 64.4) and to 3 months post-baseline (mean = 71.5), 
implying that recovery had taken place. In particular, recovery took place between baseline 
and 1 month post-baseline (83.5% increase in the mean Barthel Index score). The longitudinal 
trend of the Barthel Index score is predicted by duration after stroke, age and stroke subtype. 
Our analyses show that increased age is associated with decreased Barthel Index score and 
that patients with haemorrhagic stroke have significantly lower Barthel Index scores that those 
with ischaemic stroke. 
In this study, the crude mean Barthel Index score increased by about 83.5% (from 35.1 
to 64.4) and 104% (35.1 to 71.5) from baseline to 1 month and baseline to 3 months, 
respectively, suggesting that substantial recovery had taken place during these periods, 
especially between baseline and 1 month. Early recovery has been shown to be mediated 
145 
 
through spontaneous neurological processes (Tveiten et al., 2014). Other factors such as 
socioeconomic processes can also influence recovery but this is more towards long-term 
recovery (Grube et al., 2012). Our result is consistent with previous studies reporting that the 
mean Barthel Index score in stroke patients improves over time (Rachpukdee et al., 2013, Kong 
and Lee, 2014, Hebel et al., 2014). The period during which the greatest recovery occurs is still 
in question but it has been shown that most recovery occurs by 3 months after stroke (Kong 
and Lee, 2014). Between 6 months and 2 years post–acute stroke, the BartheI Index score 
does not improve considerably (von Vogelsang et al., 2015). 
Our results show that age is negatively associated with Barthel Index score during the 
first 3 months following a stroke. The inverse role of age on the Barthel Index can be due to 
various mechanism which can be grouped into a) selective survival and/or cohort effect, b) 
physiologic are-related phenomenon, and c) increasing level of comorbidity due to aging 
(Volpato et al., 2001, Al-Saeed et al., 2016). It is likely that with increasing age, the body 
becomes weaker, making recovery slower, brain tissue is damaged and the protective effect 
of the endothelium and astrocytes in the brain is dysregulated (Sohrabji et al., 2013) and a 
consequent negative effect on sensory–motor recovery (Coelho and Giraldi-Guimaraes, 2014). 
Our finding provides further evidence that age is a consistent predictor of stroke outcome (van 
Almenkerk et al., 2013), more precisely, it is a negative predictor of functionality, as shown in 
other studies (Gunathilake et al., 2014, Chindaprasirt et al., 2013, Tveiten et al., 2014, Knoflach 
et al., 2012). It has been suggested that negative effect on the functionality could last up to 10 
years after the acute stroke (Bhalla et al., 2013). To understand further the role of age, a few 
strategies can be used in future studies: a) model age of onset as the covariate, b) perform 
follow-up studies and c) use index of comorbidity such as Charlson Index (Al-Saeed et al., 2016, 
Volpato et al., 2001).    
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In this study, our results indicate that patients with haemorrhagic stroke have lower 
Barthel Index scores during follow-up compared to patients with ischaemic stroke. Stroke of 
the haemorrhagic subtype is more severe due to more extensive brain injury as a result of: a) 
the accumulation of blood and b) brain ischaemia following the haemorrhage (Frontera et al., 
2015). In haemorrhagic stroke patients, more complications during in-hospital rehabilitation 
service (Di Carlo et al., 2006), a higher prevalence mental disorders (Li and Chen, 2014) and 
poorer cognitive status (Tveiten et al., 2014) render these patients more vulnerable to slower 
recovery. This result confirms the findings that stroke subtype plays important roles in stroke 
outcome (Paci et al., 2011, Di Carlo et al., 2006). 
In our study, we found that that sex has no significant relationship with Barthel Index 
score. Studies on age and its effect on functionality report conflicting results but one review 
concluded that women have poorer functional outcomes after stroke (Reeves et al., 2008). 
The study has its strengths and limitations. The strengths include the follow-up of up 
to 3 months after stroke—an appropriate period for showing changes in functional status—as 
it has been shown that most motor recovery in stroke is completed within 10 weeks of stroke 
(Kwakkel and Kollen, 2013). We employed the mixed effect model in the analysis instead of 
ordinary least square to the longitudinal data which can severely over- or underestimate the 
variance of the regression parameters, and analysis of variance methods are not feasible for 
longitudinal data analysis (Diggle et al., 2002). The mixed effect model takes into account the 
correlation and dependences of the observation and is an efficient method for estimation 
(Rabe-Hesketh and Skrondal, 2012). 
We acknowledge three major limitations. First, there were only 3 measurements over 
the 3-month period. To better quantify the changes in the Barthel Index score after stroke, 
more than three (3) measurements are probably necessary during the follow-up because 
improvements are extended until 12 months post-stroke (Kong and Lee, 2014). Second, the 
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sample size should be larger to accommodate more covariates in the model. Third, other 
covariates such as psychological and employment variables were not readily available in the 
medical records (Rachpukdee et al., 2013, Haghgoo et al., 2013) . Lastly, the floor effect 
(tendency for minimum scores) and the ceiling effect (tendency for maximum scores) reduce 
the ability of the Barthel Index to detect changes in function during early and late phases of 




Table 5-3 The estimated regression parameters from univariate linear regression. The outcomes are Barthel Index scores at baseline, 1-month post-baseline 
and 3 months’ post-baseline. 
Variables Parameters Baseline  1 month  3 months  
  Beta (SE) p-value Beta (SE) p-value Beta (SE) p-value 
Age (n=98) Constant 78.52 (17.79) <0.001 110.22 (19.02) <0.001 118.03 (19.14) <0.001  
Age -0.72 (0.29) 0.014 -0.76 (0.31) 0.016 -0.77 (0.31) 0.015 
Stroke types (n=95) 
 
 
Constant  41.93 (4.50) <0.001 62.95 (5.12) <0.001 70.26 (5.22) <0.001  
Haemorrhagic Strokea  -26.93 (8.78) 0.003 3.35 (9.78) 0.733 1.69 (9.73) 0.862 
Sex (n=98) Constant 41.77 (6.73) <0.001 65.56 (7.65) <0.001 77.96 (7.48) <0.001 
  Femaleb -10.20 (8.33) 0.224 -1.66 (9.23) 0.858 -9.69 (9.14) 0.292 




Table 5-4  Results from linear mixed models performed using maximum likelihood estimation.  The covariates and the assigned model are shown in the 
first column. The regression parameters estimated from these main effect models are shown with the p-values and log-likelihood.  
Covariates (model) Variable Beta SE p-val LLa  Likelihood ratio  p-value
b 
Occasionc , n=98(1) baseline 35.10 3.95 <0.001 -1289.9    
 1 month  62.44 4.09 <0.001     
 3 months  68.82 4.14 <0.001     
Occasion +  baseline 35.11 3.81 <0.001 -1285.0 vs Occasion (1) 9.68 0.002 
Age, n=98 (2) 1 month  62.37 3.96 <0.001     
 3 months  68.77 4.00 <0.001     
 Age -0.80 0.25 0.002     
Occasion +  baseline 36.86 4.56 <0.001 -1256.6 vs Occasion (1) 0.64 0.424 
Stroke typed , n=95 (3) 1 month  64.21 4.69 <0.001     
 3 months  70.45 4.75 <0.001     
 HS
d -7.66 8.20 0.353     
Occasion +  Baseline 39.64 4.44 <0.001 -1250.7 vs Occasion (1) 10.05 0.007 
Age + 1 month  66.89 4.57 <0.001     
Stroke type, n=95 (4) 3 months  73.18 4.62 <0.001     
 Age -0.94 0.27 0.001     
 HS
d -16.77 8.22 0.044     
a LL=log-likelihood, b p-value obtained from comparing the log-likelihood between the current model and the previous one using complete cases (n=95)  
c Occasion is the three measurement occasions treated as a dummy variable; baseline Barthel Index (BI), BI at 1-month post-baseline and BI at 3 months’ post-baseline. 





Table 5-5 Results from linear mixed models performed using maximum likelihood estimation. The covariates contained the 2-way interaction term from 
the best model in table 4 (model 4). The regression parameters estimated from these main effect models are shown with the p-values and log-likelihood.  
Covariates with interaction  
(model no) Variable beta SE p-val LLa  Likelihood ratio p-valueb 
occasionc + age  baseline 35.11 3.83 <0.001 -1237.7 vs occassion + age  2.38 0.123 
+ age*occasion, n=98 (5) 1 month  62.31 3.97 <0.001  + stroke type (4)   
 3 months  68.69 4.02 <0.001     
 Age -0.72 0.28 0.013     
 1 month * Age -0.13 0.25 0.606     
 3 month * Age -0.15 0.25 0.537     
occasionc + age + stroke type Baseline 39.90 4.43 <0.001 -1250.4 vs occassion + age  0.38 0.535 
+ age*stroke type, n=95 (6) 1 month  67.16 4.56 <0.001  + stroke type (4)   
 3 months  73.46 4.61 <0.001     
 HS
d -14.16 8.93 0.116     
 Age -1.03 0.30 0.001     
  Age * HS 0.51 0.71 0.472         
a LL=log-likelihood, b p-value obtained from comparing the log-likelihood between the current model and the previous one  using complete cases (n=95) 
c Occasion is the three measurement occasions treated as a dummy variable; baseline Barthel Index (BI), BI at 1-month post-baseline and BI at 3 months’ post-baseline. 
d HS=Haemorrhagic stroke vs Ischaemic stroke (reference) 
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Our findings suggest the functional status of after stroke improves and the 
improvement is related with a few predictors. This improvement can be captured by 
instruments such as the Barthel Index. Unfortunately, it is a routine practice in Malaysia to 
monitor the functional status in most hospitals in Malaysia. Our view is that the change in the 
functional status should be monitored and instruments like Barthel Index should be instituted 
as a standard functional outcome assessment to quantify this change.   
We used the telephone interview at 1 month and 3 months after the baseline 
measurement. The limitations of the telephone interview include incomplete information, 
higher level of missing data, greater difficulty in achieving rapport and the lack of visual cues 
(Carr and Worth, 2001) but these limitations were minimised here because the Barthel Index 
questionnaire was concise, short and simple. The advantages of the telephone interview were 
that; 1) it was time-saving, 2) cost-effective, and 3) flexible (Carr and Worth, 2001, Barriball et 
al., 1996).  
The implication of this study results on the clinical practice is that rehabilitation for 
stroke patients should begin early—as early as 48 hours—because early rehabilitation 
improves functional outcome (Liu et al., 2014). 
5.6 Conclusion 
The overall 10-item Barthel Index score increases consistently from baseline to 1 month post-
baseline and then to 3 months post-baseline. The score largely improves between the 
measurement at baseline and at 1-month post-baseline (68.7% improvement) as compared to 
the period between 1 and 3 months post-baseline (9.4% improvement). In addition to 
measurement occasion, age is negatively related with Barthel Index score and haemorrhagic 
stroke patients consistently score lower on the Barthel Index than patients with ischaemic 
stroke over the 3-month period.  
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Chapter 6  Conclusion 
The PhD work undertaken for this thesis was motivated by a general epidemiological research 
question: how can we understand the natural history of stroke in the state of Kelantan, 
Malaysia? Understanding the natural history of a disease requires quantification of the risk, 
prevalence and outcome of the disease, which is important for preventing and controlling the 
disease (Gordis, 2009). 
For this PhD work, we conducted 4 projects to answer 4 specific research questions 
on: a) the risk factors for stroke, b) the prognostic factors for stroke fatality, c) the clinical 
presentation and prognostic effect of cerebral infarction and cerebral haemorrhage and d) the 
functional outcome over a 3-month period after acute stroke. 
The four projects were conducted in the setting of two hospitals in Kelantan: a) 
Hospital Raja Perempuan Zainab II (HRPZ) and b) Hospital Universiti Sains Malaysia (HUSM). 
Both hospitals are the two biggest hospitals and most important tertiary hospitals in Kelantan. 
They are hospitals under the care of the Ministry of Health, Malaysia. HRPZ is a public hospital 
while HUSM is a university hospital. 
To meet the goals of this research, I designed the studies, collected the data, 
interviewed the patients and used a range of statistical modelling methods for the data 
analyses. 
I faced several limitations, including difficulty in obtaining good-quality primary data 
because of: a) the absence of a stroke registry (at the time of the study), b) the limited number 
of variables recorded before and at arrival at the emergency departments of both hospitals, 
which were subsequently stored by the records office, c) the absence of routine stroke 
assessment at the emergency departments of both hospitals and d) the use of hospital-based 
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patients rather than population-based patients as recommended by prominent stroke 
scientists (Feigin et al., 2014). These limitations impeded the generalisability of the results. 
Of equal, if not more, importance to the methodological and analytical issues that 
stemmed from these studies is the experience I have gained: from working with a 
multidisciplinary team, interacting with stroke patients, their treating physicians and nurses 
to the hands-on application of epidemiological and statistical methods to the data collected. 
In this chapter, I reflect upon the challenges, successes and future work associated 
with this thesis and the experience I gained through the undertaking of this work.    
6.1 Limitations and strengths  
The project was motivated by the pragmatic goal of understanding the risk factors, clinical 
presentations, survival and functional recovery from stroke in an Asian population. We chose 
the state of Kelantan, Malaysia, for our project. We collected data personally from the hospital 
records offices and from the patients themselves and later performed the recommended 
epidemiological and statistical modelling. 
All data in our project was obtained from two major hospitals in Kelantan: a) HRPZ and 
b) HUSM. The data collection and analytical methods used in the study required me to: a) 
design a suitable epidemiological study, b) obtain data from the relevant medical records 
offices, c) extract individual patient data from the clinical records, d) interview stroke patients 
over a 3-month period to assess their functional outcome status and lastly, e) apply the 
appropriate statistical analysis to the data obtained. 
The main aim of the thesis was to understand the natural history of stroke—an 
important component in quantifying the risk and outcome of the disease (Gordis, 2009)—in 
Kelantan. This course ranged from: a) identifying the risk factors for stroke, b) assessing on-
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admission characteristics of stroke patients at the emergency department, c) identifying 
prognostic variables for stroke fatality during hospitalisation, d) comparing the prognostic 
effect between cerebral infarction and haemorrhagic stroke, to e) assessing functional status 
using the Barthel Index at discharge (baseline) and at 1 and 3 months thereafter. 
The first major limitation was the scarcity of electronically recorded demographic, 
clinical and outcome variables of stroke patients in both hospitals. In practice, major hospitals 
in Malaysia use the International Classification of Disease version 10 (ICD-10) to code the 
diagnosis at discharge. They record basic baseline demographic variables, on-admission 
variables, and status at discharge. 
HUSM uses an online system they developed to record these data. HRPZ, on the other 
hand, uses a system provided by the Ministry of Health, Malaysia, to record the variables. The 
use of extensive electronic medical records is not available to almost all hospitals in Malaysia—
only 4 hospitals in Malaysia to date have been gazetted as emergency medical record (EMR)-
compliant hospitals (Noraziani K et al., 2013). The limited uptake of EMR is probably due to 
EMR being considered ineffective and that it would escalate the cost of health care in Malaysia 
(Health Technology Assessment Unit, 2006). 
The current practice in Malaysia is that doctors at the emergency department examine 
stroke patients brought in by relatives (brought by own transport or ambulance) or referred 
from other hospitals or clinics (brought by ambulance). In most cases in Malaysia, doctors are 
not present at the scene of an acute stroke. Thus, the care received before reaching a hospital 
(pre-hospital care) could be hampered by inadequate assessment, recording and patient 
stabilisation. In Malaysia, the ambulance services are manned by nursing staff and non-
medical ambulance drivers (Hisamuddin et al., 2007), and the quality of service is limited by 
slow ambulance response times (Shah et al., 2008). 
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Only at the emergency department will the attending doctor obtain the full clinical 
history, perform a physical examination and obtain baseline blood samples. In major hospitals 
in Malaysia, a computed tomography (CT) scan investigation is performed after consulting the 
neurology team on patients brought to hospital with the suspicion of stroke. Unfortunately, 
except for the Glasgow Coma Scale (GCS), other stroke-specific assessments and stroke 
screening tools are not routinely used. These stroke assessment tools include the National 
Institute of Health Stroke Scale (NIHSS) (Seki et al., 2014, Nilanont et al., 2010, Dawodu and 
Danesi, 2008), the Scandinavian Stroke Scale (SSS) (Luvizutto et al., 2012, Christensen et al., 
2009, Barber and Stott, 2004) and the Canadian Neurological Scale (Nilanont et al., 2010, Seki 
et al., 2014, MacKay et al., 2007, Brass and Kernan, 1989), which are sensitive and valid tools 
in the acute stroke setting. Assessment of stroke dependency such as with the modified Rankin 
scale (MRS) (Banks and Marotta, 2007, Balu, 2009, Cincura et al., 2009) and functional status 
such as with the Barthel Index (Quinn et al., Balu, 2009, Cincura et al., 2009) are also not 
included as standard stroke assessments in almost all hospital settings in Malaysia. 
The second limitation is the possibility of informative censoring from the survival data 
in paper 2 and paper 3. In both papers, we analysed data for which the outcome of interest is 
the time-to-event data. In the data, the event was in-hospital fatality, which was defined as 
stroke death (fatality) due to all causes during the period of hospital admission at HUSM. In 
paper 2, stroke patients who were discharged alive from the HUSM were taken as censored 
observations. In paper 3, stroke patients who were discharged alive either by the treating 
doctors or at their own-risk (or discharge) were considered as censored observations. Such 
time-to-event study design has the bias that the censored observations could be informative, 
that is that the censoring process (δ = 0) has significant dependence with time (T). If the 
censoring is informative, the numerical estimates from Kaplan-Meier and Cox regression 
methods are biased. We performed the Cox and reversed Cox regression (outcome was 
reversed) to assess if there are shared dependencies between important covariates and the 
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outcome (see Figure H.1 in Appendix H). Based on the consistent significant effect between 
the covariates, such as stroke subtypes and Glasgow Coma Scale shown in Table H.1, Table 
H.2, Table H.3 and Table H.3, we felt that the assumption of non-informative censoring was 
met. In Appendix H, we also describe the principle to handle informative censoring using two 
multiple imputation methods: a) Gamma imputation and b) Risk Score imputation.                       
The third limitation of this study is that all our study data was from 2 major hospitals 
serving the population of Kelantan and there were no data from smaller hospitals such as 
district hospitals. There are 8 district hospitals in the 11 districts in Kelantan, which act as the 
gatekeepers to primary care service in Kelantan. A portion of patients with acute stroke will 
receive treatment from these smaller hospitals, and when they are suspected of having had a 
stroke, these patients will immediately be referred to larger hospitals such as HRPZ and HUSM. 
The rest, consisting of a very small percentage of patients, either have very mild stroke that 
requires admission and subsequent discharge, or too severe a stroke, to which they will 
succumb or be brought back home at their own risk. 
Using data from major hospitals such as HRPZ and HUSM limits inference of the results 
to stroke patients treated at other major hospitals in Malaysia. To be able to generalise the 
results to all stroke patients in the community, a population-based study with data from all 
hospitals in the community is required (Feigin et al., 2014, Feigin et al., 2003, Feigin et al., 
2009, Burke and Venketasubramanian, 2006). 
The fourth limitation is the small sample sizes for Papers 2, 3 and 4. This was 
unavoidable due to logistic factors and the limited availability of CT scan imaging in hospitals 
in Kelantan. For Paper II and Paper III, we collected data from HUSM because only HUSM, and 
not HRPZ, stores CT scan images in a picture archiving and communication system (PACS). The 
availability of this service permitted our radiologist colleague to review CT scan images to 
verify stroke diagnosis and stroke subtype. For Paper III, given the prospective nature of the 
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study and the fact that only KIM performed the interview—to minimise inter-rater bias—and 
follow-up, only 98 patients who were eligible for analysis were recruited in the space of the 1 
year of follow-up. 
The fifth limitation was that we worked with data collected at the earliest at the 
emergency department by the emergency medical team or the neurology team. There were 
no data from the scene where the acute stroke took place and the medical team recorded no 
data while transporting patients from the scene to the hospital. In addition, the data collected 
at the emergency department lacked many clinical parameters or variables. In Malaysia, most 
hospitals, including HUSM and HRPZ, do not have specific assessment tools, such as standard 
observational and clinical assessment tools, when examining patients with acute stroke. Many 
of the variables specific to stroke and are useful for developing prognostic and risk factor 
models are not collected at the earliest possible time. We would recommend that all hospitals 
in Malaysia, especially the general tertiary hospitals such as HUSM and HRPZ, have routine 
clinical assessments and tools and laboratory tests for assessing the symptoms, signs and 
severity of stroke. The establishment of a stroke registry is paramount to achieving this 
objective (Shigematsu et al., 2013, Sridharan et al., 2009, Burd et al., 2006, Sia et al., 2007, 
Shiber et al., 2010, Hong et al., 2013, Kita et al., 2009, Saposnik et al., 2008). 
The sixth limitation is that we did not have the residential coordinates for the stroke 
patients in Paper I. Unlike developed countries such as the UK and Japan, residential postcodes 
are not yet available in Malaysia. The available postcodes in Malaysia only serve as indicators 
of the servicing post office. The best we could do was perform spatial analysis using the 
centroid coordinates of the sub-subdistricts (n = 288) as the patients’ coordinates. Given this 
approach, it is possible that several patients would share the same coordinates, as these 
patients stay in the same sub-subdistricts, and there would only be 288 points (coordinates) 
eligible for spatial autocorrelation analysis. 
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The seventh limitation is that we did not have information on an acute stroke until the 
patient arrives at the emergency department. Patients are usually brought to the emergency 
department in a private vehicle or an ambulance. From the acute stroke until arrival, we 
presumed that active clinical intervention is given to the patient while in the vehicle. In the 
ambulance, paramedics provide basic life support to prolong and increase the survival of 
stroke patients. This is done using ambulance call. However, there has been no standard data 
recording to collect information on the timing of the stroke, where the acute stroke took place 
and the basic clinical and physical assessment and emergency treatment administered on the 
way to the hospital. Studies have shown that the ambulance response time in Kelantan is far 
slower than the international standard (Shah et al., 2008, Hisamuddin et al., 2007). 
The first strength of this study is that we used the ICD-10—the standard diagnostic 
tool for epidemiology, health management and clinical purposes—for a working definition for 
stroke (World Health Organization, 2015). The use of ICD-10 diagnosis (a type of administrative 
diagnosis) makes our study comparable to other stroke studies elsewhere that use similar ICD-
10 codes in their study design. The ICD-10 is an internationally accepted classification 
developed by the World Health Organisation (WHO). The ICD-10 provides a standard measure 
used by WHO member states. It has several limitations such as errors in the coding process 
(O'Malley et al., 2005), but studies have shown the benefit of using the ICD-10 in stroke 
studies, including its high predictive value (Olson et al., 2014), high detection rate (McCormick 
et al., 2015) and its ability to identify stroke and its risk factors (Kokotailo and Hill, 2005). 
The second strength was that we designed all 4 parts of the project, from data 
collection to data analysis. In designing the study, we considered the local setting of interest, 
international importance and comparability. Working with data from studies we designed 
maximised the utilisation of data in our project. In the process of designing our project, we 
looked at the potential meaningful interpretation of the results and their clinical importance 
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specifically for local physicians, neurologists, neurosurgeons, radiologists and public health 
workers in the management and prevention of stroke. 
The third strength was that we collected, cleaned and analysed the data ourselves. 
The use of primary data is paramount in any research (Verpoorte, 2012), while the use of 
existing data provides little or no hands-on experience in an epidemiologic study (Buring, 
2008). Working with primary data enabled us to match our collected data with our study 
clinical definition and the inclusion and exclusion criteria. Data from Paper 1 were obtained 
first-hand from the medical records office. For Paper 2 and 3, we extracted data from each 
patient’s medical notes. In Paper 4, we also extracted data from the medical notes; in addition, 
we personally interviewed patients on their progress using the valid and reliable Barthel Index 
from admission until 3 months after discharge. 
The fourth strength is that in Paper 2 and Paper 3, we verified the ICD-10 diagnosis (the 
administrative diagnosis) using CT scan images stored in the HUSM PACS server. A CT scan is 
the investigation of choice to verify stroke and further subtype it (Kalantri and Kalantri, 2010, 
Falcone et al., 2013b, Runchey and McGee, 2010). We provided the ICD-10 diagnoses for all 
data used in Paper 2, 3 and 4 and our radiologist colleague reviewed and verified them against 
the radiological diagnosis based on the CT scan images. In cases where CT scan images were 
not available because the CT scan had been performed in the referring hospitals, we verified 
the ICD-10 diagnosis using the radiological diagnosis in the clinical notes that accompanied the 
patient to HUSM during the transfer or referral.  
6.2 Experience gained from collaboration 
The experience I gained from Paper I includes working with the Malaysian Centre for 
Geospatial Data Infrastructure (MaCGDI, http://www.mygeoportal.gov.my/). The centre 
provided a list of all registered villages in Kelantan with the corresponding geospatial 
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coordinates of the villages. The list was presented in the form of spatial data in shapefile 
format. To match the addresses of the stroke patients in our study with the addresses of the 
villages in the database, I used ArcGIS software (ESRI, 2010). 
I also communicated with the Department of Statistics, Malaysia 
(https://www.statistics.gov.my/), the official statistics agency of the government of Malaysia. 
They are responsible for conducting a nationwide population survey every 10 years (a 
decennial survey). For this project, they provided us with spatial data containing area-level 
population data. The data also came in shapefile format readable by ArcGIS software. There 
were 3 levels to the area: a) district (‘jajahan’), b) subdistrict (‘mukim’) and c) sub-subdistrict 
(‘mukim kecil’). Given its sensitivity, the spatial data consisted of: a) population number by 
area, age group, sex and race, and b) the unique identification number for each district, sub-
district and sub-subdistrict. Other socioeconomic indicator data were provided to us because 
these variables might be important factors related to having stroke. 
I also established a connection with each records office manager at HUSM and HRPZ. 
I developed an understanding of the electronic data registration for the patients at each 
hospital. As a university hospital, HUSM perhaps has a superior system. It uses its own 
‘personalised’ electronic registration, but HRPZ, being a government hospital, uses a 
‘standard’ system provided by the Ministry of Health, Malaysia. This helped me understand 
the limitation and quality of data managed by both records offices, and the connection made 
me aware of the limitations of the systems in both hospitals. While the quality of patient data 
based on the ICD-10 is good, the staff who code the diagnosis (coders) need rigorous training 
in the use of the ICD-10 to minimise bias (misclassification bias) (Kokotailo and Hill, 2005, 
World Health Organization, 2010, World Health Organization, O'Malley et al., 2005). 
I also connected with a neurologist at HRPZ and neurosurgeons, a neurologist and a 
radiologist at HUSM. This allowed me to understand their workload and how data can help 
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them understand stroke and manage patients with stroke. The present study helped them 
recognise the importance of stroke as a public health problem in Malaysia (Feigin et al., 2003, 
Feigin et al., 2009), understand the role of stroke prevention and control to reduce its massive 
burden on health (Feigin et al., 2014, Krishnamurthi et al., 2014) and the need to establish a 
stroke registry, especially in the Asian population, where stroke data are very scarce 
(Venketasubramanian et al., 2015).  
6.3 Further research 
To understand stroke among the Asian population in Malaysia, a larger longitudinal study with 
data from the population or community is required. Such study is still lacking in the Asian 
countries (Feigin et al., 2009). The PEARL study was the first and the only stroke population-
based incidence study in Malaysia. But the study was conducted in a much smaller scale and 
focused on the population in the South-Western District of the Penang Island, Malaysia which 
has different socio-cultural practices (Neelamegam et al., 2013). A larger population-based 
study that focuses on the population in the east coast of Peninsular Malaysia is needed. The 
prospective population-based study would be ideal to provide more accurate estimates of the 
incidence, improve our understanding of stroke determinants and burden and help with the 
development and monitoring of the effectiveness of stroke prevention and management and 
rehabilitation strategies (Feigin et al., 2014) . Such a study can be conducted in particular in 
two states that are in proximity to one another on the east coast of Peninsular Malaysia—
Kelantan and Terengganu, which are particularly different from other states in Malaysia 
because their populations are predominantly of Malay ethnicity. The future population-based 
cohort study must include more stroke-specific variables and capitalise on many widely known 
stroke assessment tools. We will acquire data from all major hospitals and from the smaller—
but equally important, being the first gatekeepers to health care—district hospitals in both 
states. The population-based study will provide information on stroke incidence and outcome 
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and their relationship with environmental, social, economic and societal variables. This is 
important for the control and prevention of stroke on the ground (primary and secondary 
prevention). 
We propose a study that uses patients’ residential locations as the preferred 
coordinates. This future prospective study should be able to collect the exact locations 
(coordinates) with two attributes: a) location of the residence, and b) location where a stroke 
occurs, for better spatial analysis. The availability of such data enables the identification of the 
presence of spatial correlation between: a) residential address and risk for stroke and its 
outcome, and b) the geographical location of stroke and its relationship with the outcome and 
quality of stroke care. Information and understanding from such projects will be valuable for 
establishing intervention programmes and allocating the appropriate resources for acute 
stroke care and stroke rehabilitation in the community.  
6.4 Closing remarks 
This thesis gave me the opportunity to learn important concepts, build networks with stroke 
clinicians and acquire the necessary skills for designing an epidemiological study, collecting 
data, managing sensitive data and modelling data to address a given research question. The 
studies in this PhD project have enhanced my awareness of the difficulty in conducting 
research in the community, managing and analysing data and the limitation of generalising the 
results to the intended population. I greatly appreciate the importance and the richness that 
stems from strong professional relationships across different disciplines. The main message I 
have learnt from completing this project is that, provided there is adequate understanding of 
the natural history of a disease, all necessary variables are satisfactorily collected, all 
participants have agreed upon the direction of the undertaken research and that the results 
are clearly communicated to the appropriate audiences, epidemiological and statistical 
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methods in disease modelling continue to play an ever-increasing role in supporting and 
directing decisions in public health. Through the relationships I have forged and the skills I 
have learned, I hope to be able to continue my contributions to this field.        
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Chapter 7  Appendices  
Appendix A: Additional results for Chapter 2 
 
 
Figure A.1: The non-linear relationship between age (years) and the log odds for having stroke 
for males and females. The log odds for males increase from the age of 20 years, plateau 
between the age of 70 and 75 years, then on the decreasing trend from the age 75 years.  The 
log odds for females starts to plateau at the later age than males (between 75 to 80 years) but 





Table A.1: The classification table showing the distribution of patients with stroke (cases) and 
without stroke (controls) based on multivariable logistic model, the diagnostic accuracy and 
the predictive values of the logistic model (to predict stroke) 
 Observed data 
Classified (predicted) as stroke or no stroke 
based on model Had stroke No stroke Total 
Stroke  979 657 1636 
No stroke 390 1092 1482 
Total 1369 1749 3118 
Diagnostic accuracy and predictive values of the model to predict stroke  
Sensitivity  979/1369 Pr( + D) 71.51% 
Specificity  1092/1749 Pr( -~D) 62.44% 
Positive predictive value  979/1636 Pr( D +) 59.84% 
Negative predictive value  1092/1482 Pr(~D -) 73.68% 
False + rate for true ~D  657/1749 Pr( +~D) 37.56% 
False - rate for true D  390/1369 Pr( - D) 28.49% 
Correctly classified 2071/3118  66.42% 
Note: Classified as having stroke if predicted Pr(D=stroke) >= .5 
Table A.2: Pearson goodness-of-fit of the final multivariable logistic model for predicting 
stroke. The goodness of fit is assessed over the fitted values determined by the covariates in 
the model. For Pearson goodness-of-fit test, the difference in the observed and fitted values 
uses Pearson residuals   
number of observations = 3118 
number of covariate patterns = 2834 
Pearson chi2(2825) = 2883.99 
Prob > chi2 = 0.2153 
 
Table A.3: Hosmer-Lemeshow goodness-of-fit (HL-gof) of the multivariable logistic model for 
predicting stroke. The goodness of fit is assessed over the fitted values determined by the 
covariates in the model but for HL-gof, groupings are created based on the estimated 
probabilities. The default in Stata is 10 groups (g=10) based on the deciles of the estimated 
risk. The HL-gof statistic, C , is obtained by calculating the Pearson chi-square statistics from 
g2 table of observed and estimated expected frequencies of cases (strokes) and controls (no-
strokes)  
number of observations 3118  
number of groups 10  
Hosmer-Lemeshow chi2(8) 6.51  





Table A.4:  The deciles (the first column) of risk for having stroke based on the multivariable 
logistic model. Each row is collapsed according to the estimated probabilities for having stroke. 
The groupings were created based on the estimated probabilities. The default in Stata is to 
have 10 groups (g=10) based on the deciles of the estimated risk.    
Group (decile) Probability Obs=1 Exp=1 Obs=0 Exp=0 Total 
1 0.0733 16 13.5 296 298.5 312 
2 0.2217 37 42.2 275 269.8 312 
3 0.3625 94 92.3 218 219.7 312 
4 0.4504 134 127.8 178 184.2 312 
5 0.5132 148 150.4 163 160.6 311 
6 0.5522 160 166.7 152 145.3 312 
7 0.5809 187 176.5 125 135.5 312 
8 0.6155 177 186.8 135 125.2 312 
9 0.6565 193 197.9 119 114.1 312 
10 0.8124 223 214.9 88 96.1 311 
TOTAL    1369 1369 1749 1749 3118 





Figure A.2: The Hosmer-Lemeshow delta deviance (HL dD) against the probability of having 














Appendix B: Additional results for Chapter 3 
 
 
Figure B.1: The partial predicted values estimated from the fractional polynomial (fp) function 
during the Cox proportional hazard regression analysis in Stata are plotted against age (years) 
which is a numerical variable. Overall, the functional relationship between the variable ‘age’ 
and stroke case-fatality was linear based on the fitted straight line and the distribution of 
points in the plot. Hence, variable ‘age’ was modelled without any transformation during the 
Cox regression analysis.  

























Figure B.2: The partial predicted values from the fractional polynomial (fp) function during the 
Cox proportional hazard regression analysis in Stata are plotted against the Glasgow Coma 
Scale (GCS) which is a numerical variable. Overall, the functional relationship between the 
Glasgow Coma Scale (on-admission) and stroke case-fatality was linear and was modelled 





Table B.1: Results for the test of proportional hazard assumptions for the Cox proportional 
hazard regression model. The test is based on the Schoenfeld's residuals. It tests the overall 
model for the proportionality assumption (global test) and for each covariate in the Cox model 
(individual test). The test of non-zero slope was based on the Therneau and Grambsch idea 
with slightly different algorithm in Stata (‘estat phtest’ function).   
Time scaling   rho chi2 df                     
 Prob>chi
2
Time gcs 0.00275 0 1 0.9858 
  age2 -0.06765 0.31 1 0.5763 
  global test   0.31 2 0.8549 
log(time) gcs 0.18343 1.42 1 0.2341 
  age2 -0.06443 0.28 1 0.5945 
  globaltest   1.59 2 0.4516 
Kaplan-Meier 
estimates gcs 0.05928 0.15 1 0.7006 
  age2 -0.08352 0.48 1 0.4902 
  global test   0.58 2 0.7493 
Rank gcs 0.20012 1.69 1 0.1942 
  age2 -0.08626 0.51 1 0.4761 
  global test 2.03 2 0.3623 
Hypothesis: null hypothesis of zero slope, which is equivalent to testing that the log hazard-ratio 
function is constant over time. Thus, rejection of the null hypothesis of a zero slope indicates deviation 







Figure B.3: The lowess smooth plot of Schonfeld’s residuals from the Glasgow Coma Scale 
(GCS) estimated in the Cox hazard regression model against the follow up time (days). The 
slight rise and the straight line afterwards line indicate non-significant departure from a slope 
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Figure B.4: The lowess smooth plot of Schonfeld’s residuals for variable ‘age’ generated from 
the Cox hazard regression model against the follow up time (days). The slight rise and the 
straight line afterwards line indicate non-significant departure from a slope of zero. In Stata, 
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Appendix C: Additional results for Chapter 4 
 
Table C.1: The overall characteristics of in-hospital stroke recruited and analysed for survival 
analysis. There were 297 stroke patients (n=297) with 85 died during hospitalization (n=85) 
  Per subject 
Category total mean min median max 
no. of subjects 297     
no. of records 297 1 1 1 1 
(first) entry time  0 0 0 0 
(final) exit time  6.521886 1 4 81 
subjects with gap 0     
time on gap if gap 0     
time at risk 1937 6.521886 1 4 81 
failures 85 0.2861953 0 0 1 
 
Table C.2: The incidence for stroke fatality based on stroke subtypes. The 50% survival is also 
known as ‘the median survival time’ a    







Cerebral Infarction 719 0.025 150 12 28 41 
SAH 332 0.060 30 3 14 24 
ICB 514 0.064 84 4 14 25 
Other Hg 278 0.0468 28 1 9 . 
All 1843 0.0456 292 6 15 29 
*SAH = subarachnoid haemorrhage, ICB= intracerebral haemorrhage, Other Hg = other types of 
cerebral haemorrhage  
a ?̂?50 = min {𝑡: }?̂?(𝑡) ≤ 0.50  
 
 
Table C.3: The incidence (stroke fatality) based on stroke subtypes. The 50% survival is also 
known as ‘the median survival time’    







Cerebral infarction 719 0.0250348 150 12 28 41 
Haemorrhagic stroke 1218 0.0550082 147 4 14 29 







Figure C.1: The Kaplan-Meier survival curves for stroke patients with cerebral infarction (CI, 
n=150) and haemorrhagic stroke (HS, n=142). They show the survival probability after acute 






Figure C.2: The Kaplan-Meier survival curves for stroke patients suffering from different stroke 
subtypes: cerebral infarction (CI), subarachnoid haemorrhage (SAH), intra-cerebral 
haemorrhage (ICH) and Others (other types of haemorrhagic stroke) showing the survival 







Figure C.3: The crude survival curves for stroke patients with cerebral infarction (CI) and 
haemorrhagic stroke (HS). It shows the survival probability after acute stroke against time (in 
days). In Stata, the function ‘stcurve’ plots the survival function after running the Cox 
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Figure C.4: The crude survival curves for stroke patients with different stroke subtypes: 
cerebral infarction (CI), subarachnoid haemorrhage (SAH), intra-cerebral haemorrhage (ICH) 
and Others (other types of haemorrhagic stroke) showing the survival probability against time 
(in days). In Stata, the function ‘stcurve’ plots the survival function after running the Cox 








Figure C.5: The adjusted survival curves for stroke patients suffering from different stroke 
subtypes: cerebral infarction (CI), subarachnoid haemorrhage (SAH), intra-cerebral 
haemorrhage (ICH) and Others (other types of haemorrhagic stroke) showing the survival 
probability against time (in days) adjusting for age. In Stata, the function ‘stcurve’ plots the 
survival probability after running the Cox proportional hazard regression using ‘stcox’ function. 























Figure C.6: The estimated survival probability for male stroke patients from a model with 
covariates ‘stroke subtype’ and ‘sex’. The probability was estimated from the Cox proportional 
hazard regression using the ‘stcox’ function in Stata. In the model, there are stroke subtypes - 
cerebral infarction (CI), subarachnoid haemorrhage (SAH), intra-cerebral haemorrhage (ICH) 






















Figure C.7: The estimated survival probability for female stroke patients based on a model with 
covariates  ‘stroke subtype’ and ‘sex’. The probability was estimated from the Cox proportional 
hazard regression using the ‘stcox’ function in Stata. In the model, there are stroke subtypes - 
cerebral infarction (CI), subarachnoid haemorrhage (SAH), intra-cerebral haemorrhage (ICH) 
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Appendix D: Additional results for Chapter 5 
 
 
Figure D.1: A spaghetti plot showing the Barthel Index scores (y-axis) from baseline (zero), to 
one-month post baseline (1) and to three-month post baseline (3) (x-axis). The dark line is the 
smoothed conditional mean using the default argument in ‘ggplot2’.  No I score was taken on 
the second month. The scores were jittered to show more clearly the individual scores. There 
are two types of stokes: a) haemorrhagic stroke (bleeding inside the brain) in red lines and b) 
ischaemic stroke (inadequate blood flow to the brain) in green lines. A total of 98 (n=98) post 




Figure D.2: Spaghetti plots showing the Barthel Index (BI) scores (y-axis) from baseline (zero), 
to one-month post baseline (1) and to three-month post baseline (3) (y-axis) for post acute 
stroke patients with haemorrhagic stroke (HS) and ischaemic stroke (IS). The dark lines are 
estimated from the smoothed conditional means using the default arguments in ‘ggplot2. No 
BI score was taken on the second month. The scores were  jittered to show more clearly the 
individual scores.  
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Table D.1: The estimated regression parameters based on Generalized Estimating Equation 
(GEE) with the outcome of Barthel Index scores in post acute-stroke patients (n=98). Age was 
centred at 60.7 years. GEE using 'exchangeable' correlation structure  
 Covariates   Est naïve SE naïve Z Robust SE Robus z 
Age cons 53.65 3.52 15.23 3.53 15.22 
 c.age -0.83 0.26 -3.18 0.26 -3.25 
Age + stroke  cons 58.04 4.21 13.80 4.15 13.99 
 c.age -0.97 0.28 -3.47 0.25 -3.83 
 HS -16.00 8.43 -1.90 7.26 -2.20 
Age+stroke+sex cons 57.34 6.26 9.16 6.54 8.77 
 c.age -0.97 0.28 -3.45 0.25 -3.85 
 HS -16.24 8.61 -1.89 7.50 -2.17 
  female 1.15 7.65 0.15 7.90 0.15 
Note: Est=estimated beta, SE=standard error, cons=constant, c.age=centred age, HS=Haemorrhagic 
stroke vs ischaemic stroke, female=female vs male 
 
Table D.2: The estimated regression parameters based on random intercept linear mixed 
model (lme) with the outcome of Barthel Index scores in post acute-stroke patients (n=98). 
Age was centred at 60.7 years. The last column is the results for the log-likelihood estimates. 
 Covariates   Value SE DF t-value p-value ll 
Age Cons 53.61 3.56 168.00 15.07 0.00 -1331.347 
 c.age -0.83 0.26 96.00 -3.15 0.00  
Age + stroke  Cons 57.70 4.38 163.00 13.18 0.00 -1295.29 
 c.age -0.95 0.30 90.00 -3.20 0.00  
 HS -15.54 8.71 90.00 -1.78 0.08  
Age+stroke+sex Cons 57.34 6.26 164.00 9.16 0.00 -1295.278 
 c.age -0.97 0.28 91.00 -3.45 0.00  
 HS -16.24 8.61 91.00 -1.89 0.06  
  female 1.15 7.65 91.00 0.15 0.88   
Note: ll=log-likelihood, cons=constant, c.age=centred age, HS=Haemorrhagic stroke vs ischaemic 





The simplest model contains only measurement occasions: 
Yij = γ00 + αi + U0j + ϵij 
Where Yij is the measurement for individual j at time i 
U0j is the random effect for individual j, αi  is the fixed effect of time I and  ϵij is a random 
error component specific to individual j at time i. The assumption are that U0j  are 
independent N(0, σ2), ϵij are independent N(0, σε
2). The fixed part, αi  , does not contain a 
constant term, but is based on M dummies for the M measurement occasions. The fixed part 
is written as: 




Our model where the dependent variable is the Barthel Index score and the covariates are 
measurement occasions, age and stroke subtypes can be written as:  
scoreij = ai d1ij + ai d2ij + ai d3ij i + β1j(agej) + β1j(HSj) +  U0j + ϵij 
Which is a random intercept model.  
Model comparison 
When parameters of the statistical model are estimated by the maximum likelihood (ML) 
method, the estimation also provides the likelihood, which can be transformed into the 
deviance defined as minus twice the natural logarithm of the likelihood. The deviance can be 
regarded as a measure of lack of fit between model and data. The deviance is written as: 
D = 2[l(model2) − l(model1)] 
= 2Log − likelihood (model2) − 2Log − likelihood(model1) 
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Which under certain conditions approximately follows a chi-square distribution with t-r 
degrees of freedom.  
Residuals 
The level-2 residual can be predicted by the posterior means:  
Ŭ0j = E(U0j|Y, X, θ) 
And the level-1 residuals are: 






Figure D.1: Histogram of residuals based on the final mixed model with covariates ‘time’ 
(baseline, 1 month and 3 months post baseline), ‘age (centred)’ and ‘stroke subtypes’ (HS vs 








Figure D.2: Scatterplot of standardized residuals for the mixed model with covariates ‘time of 
follow up’, ‘age (centred)’ and ‘stroke subtypes’ (HS vs IS). The random effect was subjects 
(variable ‘id’). The Barthel Index scores range from zero (0) to 100. There were 18 out of 259 
measurements with score less than 0, and 31 out of 259 measurements above 100. The non-
linear distribution of residuals observed. The flat oblique lines reflect the nature of Barthel 
Index scores with the presence of floor and ceiling effect (above 40% with observed score of 










Data abstraction - Incidence and Outcome of Stroke and Their Related Population and Pat ient 
Factors in Kelantan, Malaysia  
Instructions: 
1. These section is to be filled by a medical doctor 
2. Fill in the blank or mark (√) where appropriate  
 
A) BIODATA Label 
Full name of patient  
(namemr) 
 












□ Missing =999       
Example: Muhd Karim 
Full number of the hospital 
registration number  
(rnmr) 
 
Example: AB1234 (without dash) 
Full number of the identification 
card (icmr) 
 
Example: 010160031234 (without dash) 
Study ID - First 6 numbers of IC 








□ Kota Bharu=1        □ Pasir Mas=2               □ Tumpat=3               
□ Bachok=4              □ Pasir Putih=5              □ Machang=6            
□ Tanah Merah=7     □ K Krai=8                     □ Jeli=9     
□ Gua Musang=10    □ Not Recorded=11       □ Missing =12 
Sex (sexmr) 
 
□ Male=1         □ Female=2       □ Not Recorded=8       □ Missing=9    
Date of birth - dd/mm/yy - 
(dobmr) 
 Age in years 
(agemr) 
 □ Not 
Recorded=99  □ 
Missing =999     
Race (racemr) 
 
□ Malay=1                      □ Chinese=2           □ Indian=3           □ Others=4  
□ Not Recorded=8          □ Missing =9 
Date of admission (doamr) 
  







=999     
dd/mm/yy dd/mm/yy 
Status at discharge (sad) 
 
□ Alive=1          □ Dead=2        □ Not Recorded=8        □ Missing =9 
 







Is this the first ever stroke? (first) 
□ Yes =1   Jump to B) if ‘Yes’ 
□ No=2                □ Not Recorded=8          □ Missing =9 
 





B) CLINICAL PROFILES Label  
Earliest Glasgow Coma Scale (gcs) 
                                              over 15 
□ Not Recorded=88                
□ Missing =99 
Earliest Systolic Blood Pressure 
in mmHg (sbp) 
 Earliest Diastolic Blood 
Pressure in mmHg (dbp) 
 
□ Not Recorded=888                
□ Missing =999 
 
C) MEDICAL AND SURGICAL HISTORY 
Diabetes (dm) □ Yes=1       □ No=2       □ Not Recorded=8        □ Missing =9 
Hypertension (hpt) □ Yes=1       □ No=2       □ Not Recorded=8        □ Missing =9 
Chronic kidney disease (ckd) □ Yes=1       □ No=2       □ Not Recorded=8        □ Missing =9 
Atrial fibrillation (af) □ Yes=1       □ No=2       □ Not Recorded=8        □ Missing =9 
Heart failure/IHD (hd) □ Yes=1       □ No=2       □ Not Recorded=8        □ Missing =9 
Dyslipidemia (dyslipid) □ Yes=1       □ No=2       □ Not Recorded=8        □ Missing =9 
Previous TIA (tia) □ Yes=1       □ No=2       □ Not Recorded=8        □ Missing =9 
Smoker (smoker) □ Yes=1       □ No=2       □ Not Recorded=8        □ Missing =9 
 
D) EARLIEST LABORATORY RESULTS Label  
Haemoglobin (hb)  Blood glucose (gluc)  
□ Not Recorded=888 
□ Missing=999   
Platelet count (plt) 
 Capillary Blood Sugar 
(cbs) 
 
White cell count (wbc)  Cholesterol (chol)  
Na (na)  Triglyceride (tg)  
Potassium (pt)  Urea (urea)  
 





□ From a tertiary hospital=1                             □ Not Recorded=8 
□ From a general practice=2                            
□ From a district hospital=3                              □ Missing=9 






□ by ambulance=1                                            □ Not Recorded=8 





F) DIAGNOSIS  
Diagnosis based on ICD-10 (icd10disc) 
□ Sub-arachnoid haemorrhage=1 
□ Intra-cerebral Haemorrhagic=2 
□ Cerebral infarction=3 
□ Stroke, not specified as haemorrhage or 
infarction=4 
□ Occlusion and stenosis of precerebral 
arteries, not resulting in cerebral 
infarction=5 
□ Occlusion and stenosis of cerebral arteries, not resulting in 
cerebral infarction=6 
□ Other cerebrovascular diseases=7 
□ Cerebrovascular disorders in diseases classified 
elsewhere=8 
□ Sequeale of cerebrovascular disease=9 
□ Not Recorded=99                 
□ Missing =999 
G) EARLIEST MRI SCAN Label  
Date of MRI (datemri)  dd/mm/yy  
 
□ Not done (jump to H) 
□ Not Recorded=99        
□ Missing =999 
Time of MRI (timemri) mm:hh  
Hyper-intense area ** not 
suppressed by FLAIR 
(hyperintmri) 
□ Yes=1   □ No=2 
□ Not Recorded=8 □ 




 □ Yes=1   □ No=2 
□ Not Recorded=8 □ 
Missing=9   
Hypo-intense area 
(hypointmri) 
□ Yes=1   □ No=2 




□ Yes=1   □ No=2 
□ Not Recorded=8 □ 
Missing=9 
H) EARLIEST CT SCAN Label  
Date of CT scan (detect) dd/mm/yy        
   
□ Not done  
□ Not Recorded=99                
□ Missing =999      Time of CT scan (timect) mm:hh  
 
Insular ribbon sign 
(insular) 
□ Yes=1   □ No=2 
□ Not Recorded=8 □ 
Missing=9  
Hypo-dense   
*lesion feature of 
ischaemic stroke 
(hypodens) 
 □ Yes=1   □ No=2 




□ Yes=1   □ No=2 
□ Not Recorded=8 □ 
Missing=9 
Effacement of basal 
cistern (efface)               
□ Yes=1   □ No=2 
□ Not Recorded=8 □ 
Missing=9 
Multiplicity (multict) □ Yes=1   □ No=2 




Name of the doctor: ………………………………………… 
 
Contact number : ………………. 










BAHAGIAN B: TEMURAMAH 
Arahan kepada penemubual:  Anda perlu memperkenalkan diri dan tujuan anda menemubual kepada 
peserta kajian iaitu pesakit atau ahli keluarga yang menjawab panggilan telefon. Contoh: 
“Selamat tengahari. Assalamualaikum, nama saya <nama anda> dan saya bekerja di Jabatan Perubatan 
Masyarakat, Hospital Universiti Sains Malaysia.. Adakah ini Encik/Puan............................?”  
 Jika jawapan [Ya]  : terus ke (PESAKIT) 
 Jika jawapan [Tidak] : tanya nama beliau ..........................dan terus ke (WARIS) 
 (PESAKIT) 
Katakan, “Encik/Puan <nama pesakit>, saya nak maklumkan tujuan saya. Untuk makluman, tuan/puan 
dijemput untuk menjawab soalan-soalan dalam projek kajian serangan strok yang tuan/puan alami pada 
<tarikh>. Sekarang saya akan terangkan beberapa perkara penting mengenai projek ini. Projek ini telah 
mendapat kelulusan Jawatankuasa Etika Kajian Manusia, Universiti Sains Malaysia. Semua maklumat 
yang diberi adalah terpelihara dan tidak akan didedah kepada orang lain. Projek ini bertujuan mengenal 
pasti faktor-faktor penting berkenaan strok di Kelantan. Temubual ini mengambil masa lebih kurang 15 
minit.  
Penyertaan dalam temubual ini sepenuhnya sukarela. Maksudnya tuan/puan tidak perlu mengambil 
bahagian jika tidak ingin berbuat demikian. Jika tuan/puan bersetuju untuk menyertai temubual ini, 
tuan/puan bebas menjawab hanya soalan-soalan yang tuan/puan sedia untuk jawab sahaja. Risiko 
dalam kajian ini adalah minimum sekali. Kerahsiaan maklumat tuan/puan dalam projek ini adalah 
keutamaan kami paling tinggi. Tuan/puan bebas menghentikan penyertaan bila-bila masa sahaja 
semasa temubual ini.  
Jika tuan/puan mempunyai soalan-soalan atau pertanyaan mengenai projek ini, tuan/puan boleh 
hubungi Ketua Penyelidik, Dr Mohd Nazri Shafei di 0199761992 atau Puan Mazlita Zainal Abidin, 
Setiausaha, Jawatankuasa Etika Kajian Manusia, Universiti Sains Malaysia (Tel: 09-7672355). 
Jawatankuasa ini menjaga kepentingan dan kebajikan peserta-peserta kajian di Universiti Sains 
Malaysia.  
Keputusan kajian mungkin diterbitkan dalam jurnal-jurnal saintifik untuk meningkatkan kefahaman 
mengenai penyakit strok dan memperbaiki pencegahan dan pengawalan penyakit ini. Kami akan 
maklumkan pautan ke bahagian keputusan kajian sebaik projek dihabiskan jika diminta.” 
 “Adakah tuan/puan mempunyai soalan?” 
"Adakah tuan/puan bersetuju untuk menyertai temubual ini dengan sukarela?" 
 [Jika persetujuan diberi, TERUSKAN, if tidak, HENTIKAN temubual]  
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Boleh kita mula sekarang? 
 Jika jawapan [Ya]   : Terus ke (B2) 
 Jika jawapan [Tidak]  : Katakan, “Malang sekali kerana kita tidak dapat 
meneruskan temuramah ini sekarang. Bila masa yang sesuai untuk saya hubungi anda 
semula? 
Tarikh (............................) Masa (..................................) 
 (WARIS) 
Katakan, “Untuk makluman, Encik/Puan <nama pesakit> dijemput untuk menjawab soalan-soalan 
dalam projek kajian serangan strok yang beliau alami. Sekarang saya akan terangkan beberapa perkara 
penting mengenai projek ini. Projek ini telah mendapat kelulusan Jawatankuasa Etika Kajian Manusia, 
Universiti Sains Malaysia.  Semua maklumat yang diberi adalah terpelihara dan tidak akan didedah 
kepada orang lain. Projek ini bertujuan mengenal pasti faktor-faktor penting berkenaan strok di 
Kelantan. Temubual ini mengambil lebih kurang 15 minit.  
Penyertaan dalam temubual ini sepenuhnya sukarela. Maksudnya tuan/puan tidak perlu mengambil 
bahagian jika tidak ingin berbuat demikian. Jika tuan/puan bersetuju untuk menyertai temubual ini, 
tuan/puan bebas menjawab hanya soalan-soalan yang tuan/puan sedia untuk jawab sahaja. Risiko 
dalam kajian ini adalah minimum sekali. Kerahsiaan maklumat tuan/puan dalam projek ini adalah 
keutamaan kami paling tinggi. Tuan/puan bebas menghentikan penyertaan bila-bila masa sahaja 
semasa temubual ini.  
Jika tuan/puan mempunyai soalan-soalan atau pertanyaan mengenai projek ini, tuan/puan boleh 
hubungi Ketua Penyelidik, Dr Mohd Nazri Shafei di 0199761992 atau Puan Mazlita Zainal Abidin, 
Setiausaha, Jawatankuasa Etika Kajian Manusia, Universiti Sains Malaysia (Tel: 09-7672355). 
Jawatankuasa ini menjaga kepentingan dan kebajikan peserta-peserta kajian di Universiti Sains 
Malaysia.  
Keputusan kajian mungkin diterbitkan dalam jurnal-jurnal saintifik untuk meningkatkan kefahaman 
mengenai penyakit strok dan memperbaiki pencegahan dan pengawalan penyakit ini. Kami akan 
maklumkan pautan ke bahagian keputusan kajian sebaik projek dihabiskan jika diminta.” 
 “Adakah tuan/puan mempunyai soalan?” 
"Adakah tuan/puan bersetuju untuk menyertai temubual ini dengan sukarela?" 
 [Jika persetujuan diberi, TERUSKAN, if tidak, HENTIKAN temuramah]  
Boleh kita mula sekarang? 
 Jika jawapan [Ya]   : Terus ke (B1) 
196 
 
 Jika jawapan [Tidak]  : Katakan, “malang sekali kerana kita tidak dapat 
meneruskan temuramah ini sekarang. Bila masa yang sesuai untuk saya hubungi anda 
semula? 
Tarikh (............................) Masa (..................................) 
 
Name of the person giving consent :…………………………………. 
Relation to patient : Patient / Next of kin (specify: ………………..) 
Contact number :…………………………………. 








         





B1) ALAMAT TEMPAT TINGGAL 
KETIKA BERLAKUNYA STROK 
Katakan: “Sekarang, saya akan tanya mengenai, 
alamat lengkap tempat tinggal tuan/puan ketika 
berlakunya strok tempoh hari.” 
 
 
1. Nama taman 
 
................................................................ 
Contoh: Taman Aman 








Contoh: Kampung Sentosa 




3. Nama jalan 
 
................................................................ 













5. Bandar  
 
................................................................. 





6. Daerah  
 
................................................................. 




B2) ALAMAT TEMPAT TINGGAL 
KINI 
Katakan: “Sekarang, saya akan tanya alamat 
penuh, tempat kediaman dalam setahun ini.” 
 
  
⃝ Alamat sama seperti di atas  
 






1 Nama taman 
 
................................................................ 
Contoh: Taman Uda 




2 Nama kampung 
 
................................................................ 
Contoh: Kampung Bahagia 




3 Nama jalan 
 
................................................................ 













5 Bandar  
 
................................................................. 





6 Daerah  
 
................................................................. 





C) DEMOGRAFI Katakan: “Sekarang, saya ingin bertanya mengenai 





berkerja sekarang?  
 
□ Ya=0             □ Sudah berhenti=1 
 



























sebulan isi rumah 

























□ Sekolah rendah=3 
 
































□ Tidak=0               □ Ya=1                      
 hstroke 
 
10. Pernah ada 





□ Tidak=0               □ Ya=1                      
hstroke2 
D) LAIN-LAIN Katakan: “Sekarang, dua soalan ini adalah sensitif 








□ Tidak pernah=0 
 
□ Ya, tetapi telah berhenti lebih 










□ Tidak pernah=0 
 
□ Ya, tetapi telah berhenti lebih 







Tarikh temuramah pertama (semasa discaj)   : ………………… dd/mm/yy 
Date of the first interview (at discharge) 
 
Tarikh temuramah kedua (30 hari selepas discaj)  : ………………… dd/mm/yy 




Tarikh temuramah ketiga (90 hari selepas discaj) : ………………… dd/mm/yy 
Date of the third interview (at day 90 post discharge) 
 
Jika temuramah tidak dapat diteruskan kerana pesakit telah meninggal, tuliskan tarikh meninggal: 




BAHAGIAN E: MODIFIED RANKIN SCALE 
Arahan: Tanyakan pesakit atau waris, carta-alir di bawah dan bulatkan SATU respon yang relevan. 
Katakan kepada pesakit atau waris “Kami akan tanyakan keadaan tuan/puan atau pesakit sekarang. 
Sebutlah pilihan yang paling hampir dengan keadaan sekarang. Ini soalannya …… ” 
 
Adakah keadaan anda 
sekarang, SAMA SEPERTI 
ANDA, SEBELUM KENA 
STROK? 
0 







Adakah anda MASIH 
BOLEH BUAT apa yang boleh 
dibuat sebelum kena strok. 
Biarpun lebih perlahan dan 












Bolehkan anda hidup TANPA SEBARANG PERTOLONGAN dari orang 
lain? Maksudnya, bolehkah anda mandi, gunakan tandas, sediakan 
makanan, dapatkan makanan, dan uruskan kewangan dengan sendiri?  
Adakah anda hanya 
TERBARING di katil dan perlu 









30 hari selepas discaj 
Day 30 post discharge 
90 hari selepas discaj 
Day 90 post discharge 
Code mrsdis mrs1 mrs3 









































BAHAGIAN F: BARTHEL INDEX 
Arahan kepada penemubual: Barthel Index hanya ditanya kepada pesakit-pesakit yang masih 
hidup. Tanyalah pesakit sendiri atau ahli keluarga terdekat. Tandakan (√) di respon yang 
paling relevan dengan pesakit dalam tempoh seminggu ini. Jawap setiap soalan:  
Katakan kepada pesakit “Tuan/Puan, soalan-soalan berikut bertanya mengenai penjagaan diri 
Tuan/Puan. Tolong maklumkan apa yang Tuan/Puan berupaya buat lebih kurang seminggu terakhir ini.” 




30 hari selepas 
discaj 
Day 30 post 
discharge 
90 hari selepas 
discaj 



















⃝ Perlu ditolong 
sepenuhnya =0 
 
⃝ Perlu ditolong sedikit =5 
 




















anda makan?  
 
⃝ Perlu banyak ditolong =0 
 






























dari katil ke 
kerusi?   
 
⃝ Tidak boleh langsung =0 
 
⃝ Perlu banyak ditolong 
dari satu atau dua orang 
=5 
 
⃝ Perlu ditolong sedikit 
dari satu orang =10 
 















































D) BARTHEL INDEX TANDAKAN (√) PADA RESPON PALING RELEVAN code 
tempat ke 
tempat lain? 
⃝ Boleh menolak sendiri 
kerusi roda tanpa di 
tolong =5 
 
⃝ Boleh berjalan, tapi ada 
seorang menolong atau 
memerhati =10 
 
⃝ Boleh berjalan sendiri 
walaupun menggunakan 



























⃝ Ya, perlu ditolong 
hampir sepenuhnya =0 
 
⃝ Ya, saya mampu pakai 
pakaian sendiri lebih 
kurang separuh =5 
 
⃝ Tidak perlu. Saya boleh 
pakai pakaian sendiri 



























anda naik atau 
turun tangga? 
 
⃝ Tidak boleh langsung =0 
 
⃝ Perlu ditolong samada 
secara lisan, fizikal =5 
 
⃝ Boleh naik turun tangga 




















7. Adakah anda 
perlu ditolong 




⃝ Ya =0 
 














8. Adakah anda 
boleh kawal 
buang air besar 
(berak)?  
 
⃝ Tidak boleh kawal buang 
air besar =0 
 
⃝ Sekali sekala (sekali 
seminggu) terbuang air 
besar dalam pakaian=5 
 
⃝ Boleh. Dapat kawal 































D) BARTHEL INDEX TANDAKAN (√) PADA RESPON PALING RELEVAN code 




⃝ Tidak boleh kawal 
kencing sendiri. Atau 
saya memakai tiub 
kencing =0 
 
⃝ Sekali sekala (paling 































Katakan “Encik/Puan <nama>, temubual kita telah berakhir. Kami akan meneliti respon temuramah ini 
dan akan menghubungi Tuan/Puan jika perlu. Jika ada persoalan, silalah hubungi kami. Kami ingin 
mengucapkan berbanyak terima kasih terhadap kerjasama Tuan/Puan. Terima kasih” 
Nama penemubual : 
 













Appendix G: Interview Form (English version) 
 
  






PART B: INTERVIEW  
Instruction to interviewer: You must introduce yourself and tell patient or relative the reasons for the 
interview. For example: 
“Good afternoon. My name is <your name> and I am working at the Department of Community 
Medicine, Hospital Universiti Sains Malaysia. Are you Mr/Mrs ……….? 
 If the answer is [Yes]  : proceed to (PATIENT) 
 If the answer is [No] : ask their name ................. and proceed to (RELATIVE) 
 (PATIENT) 
Say, “Mr/Mrs <name>, I like to inform you the reasons for this interview. For your information, you are 
invited to answer a set of questions related with stroke that you had on <date>. Now, I will tell you 
important information about this project. This project has obtained the ethical approval from the 
Human Research Ethics Committee, Universiti Sains Malaysia. All information in this study is confidential 
and will not be disclosed to others. This project aims to identify important factors related with stroke in 
Kelantan.  This interview takes about 15 minutes.  
Your participation is this interview is fully voluntary. It means that you may decide not to take part if 
you do not want to. If you agree to participate in this interview, you have the freedom to only answer 
questions that you like to. The risk in this study is minimal. The confidentiality of the information in this 
study is our utmost concern. You are free to stop anywhere and anytime during this interview.  
If you do have questions or queries with regards to this project, you may contact the Principal 
Investigator, Dr Mohd Nazri Shafei at 0199761992 or Puan Mazlita Zainal Abidin, Secretary, Human 
Research Ethics Committee, Universiti Sains Malaysia (Tel: 097672355). This committee is responsible 
for the safety and welfare of all participants in studies done by Universiti Sains Malaysia.  
The results of the study may be published in scientific journals to improve the understanding of stroke 
and to improve the control and prevention of this disease. We will inform you the link to the results 
once this project has finished, if requested.” 
 “Do you have any question?” 
"Do you agree to voluntarily participate in this interview?" 
 [If consent given, PROCEED, if not, STOP the interview]  
Can we start now? 
 If the answer is [Yes]   : Proceed to (B2) 
 If the answer is [No]  : Say, “It is unfortunate that we will not be able to 
continue with the interview now. When is the appropriate date so I can call you again?  
Date (............................) Time (..................................) 







Say, “For your information, Mr/Mrs <name> is invited to answer a set of questionnaire related with 
stroke that he/she had before. Now, I will tell you important information about this project. This project 
has obtained the ethical approval from the Human Research Ethics Committee, Universiti Sains 
Malaysia. All information in this study is confidential and will not be disclosed to others. This project 
aims to identify important factors related with stroke in Kelantan. This interview takes about 15 
minutes.  
Your participation is this interview is fully voluntary. It means that you may decide not to take part if 
you do not want to. If you agree to participate in this interview, you have the freedom to only answer 
questions that you like to. The risk in this study is minimal. The confidentiality of the information in this 
study is our utmost concern. You are free to stop anywhere and anytime during this interview.  
If you do have questions or queries with regards to this project, you may contact the Principal 
Investigator, Dr Mohd Nazri Shafei at 0199761992 or Puan Mazlita Zainal Abidin, Secretary, Human 
Research Ethics Committee, Universiti Sains Malaysia (Tel: 097672355). This committee is responsible 
for the safety and welfare of all participants in studies done by the Universiti Sains Malaysia.  
The results of the study may be published in scientific journals to improve the understanding of stroke 
and to improve the control and prevention of this disease. We will inform you the link to the results 
once this project has finished if requested.” 
 “Do you have any question?” 
"Do you agree to voluntarily participate in this interview?" 
 [If consent given, PROCEED, if not, STOP the interview]  
 If the answer is [Yes]   : Proceed to (B1) 
 If the answer is [No]  : Say, “It is unfortunate that we will not be able to continue 
with the interview now. When is the appropriate date so I can call you again?  
Date (............................) Time (..................................) 
Name of the person giving consent :…………………………………. 
Relation to patient : Patient / Next of kin (specify: ………………..) 
Contact number :…………………………………. 







         











B1) ADDRESS WHEN STROKE 
HAPPENED  
Say : “Now, I will ask the full address of your residence 
at the time you had the stroke.” 
 
 
















9. Nama of street 
 
................................................................ 





















Example: Kota Bharu 
 
district 
B2) CURRENT RESIDENTIAL 
ADDRESS  
Say : “Now, I will ask the full address of your residence 
since last year.” 
 
  
⃝ Same address as above  
 




7 Name of taman 
 
................................................................ 




8 Name of village 
 
................................................................ 




9 Name of street 
 
................................................................ 


















12 District  
 
................................................................. 













Say: “Now, I would like to ask about your 




11. Are you currently 
employed?  
 
□ Yes=0             □ Stopped working=1 
 











13. What is the estimated 








14. What is the estimated 
household income every month 




Example: RM5000 incmonth2 
 
15. What is the highest 
education attained by you? 
 




□ Secondary school=2        
 
□ Primary school=3 
 









□ No=0               □ Yes=1                      
hhpt 
 
























20. Do you have history of 
stroke among your siblings? 
 
 
□ No=0               □ Yes=1                         
hstroke2 
D) OTHERS Say : “Now, these 2 questions are sensitive 





3. Do you drink alcohol?  
 
□  Never=0   
 
□  Yes but stopped more 










□  Yes=2  
 
4. Do you smoke? 
 
□ Never=0   
 
□ Yes but stopped more 
than 6 months ago=1 
 





Tarikh temuramah pertama (semasa discaj)   : ………………… dd/mm/yy 
Date of the first interview (at discharge) 
 
Tarikh temuramah kedua (30 hari selepas discaj)  : ………………… dd/mm/yy 
Date of the second interview (at day 30 post discharge) 
 
Tarikh temuramah ketiga (90 hari selepas discaj) : ………………… dd/mm/yy 
Date of the third interview (at day 90 post discharge) 
 
Jika temuramah tidak dapat diteruskan kerana pesakit telah meninggal, tuliskan tarikh meninggal: 
Tarikh kematian : …………….. dd/mm/yy 
Date of the death 
  






SECTION E: MODIFIED RANKIN SCALE 
Instruction: Ask patient or relative using flow-chart below and circle the MOST relevant response. Say to patient or 
relative “We will ask about your current situation. Choose the one that most resemble your current situation. This 




























30 hari selepas discaj 
Day 30 post discharge 
90 hari selepas discaj 
Day 90 post discharge 
No Yes 
Are you able to do everything 
that you were doing right before 
your stroke, even if slower and 
not as much? 
Are you able to walk 













Are you completely 
back to the way you were 
right before your stroke? 
Are you bed-ridden or 
require constant supervision ? 
Could you live alone without any help from another person? This means being 
able to bathe, use the toilet, shop, prepare or get meals, and manage finances? 
 







Code Mrsdis mrs1 mrs3 






Modified Rankin Scale 
































SECTION F: BARTHEL INDEX 
Instruction to interviewer:  
This index should be asked if the patient is still ALIVE. Ask the participant or the next of kin. Tick (√) the most 
relevant option with the patient condition during this week. Answer each question.  
Say to patient “Mr/Mrs <name>, the following questions ask about how you look after yourself. Please, tell me 
which of the following, have you actually done in the last week or so.” 
D) BARTHEL INDEX TICK ONE FOR EACH QUESTION code 
 Semasa Discaj 
On discharge 
30 hari selepas 
discaj 




Day 90 post 
discharge 
 








1. Do you wash your own 
face, brush your teeth and 
hair (For men, shave)? 
 
⃝ With help?=0 
 












2. Do you use the 
toilet (or commode)? 
 
⃝ With a lot of help?=0 
 
⃝ With a little help?=5 
 















3. Do you feed 
yourself? 
 
⃝ With major help?=0 
 
⃝ With some help? E.g. 
cutting=5 
 
















4. How do you move 
from bed to the chair?   
 
⃝ Not at all =0 
 
⃝ With a lot of help from 
one or two people=5 
 
⃝ With a little help from 
one person?=10 
 


























5. How do you get 
about? 
 




⃝ Propelling yourself 




























⃝ Walking with the help or 
supervision of one 
person=10 
 
⃝ Walking with no one 
helping (even if you use a 
stick or frame=15 
 













6. Do you need any 
help with dressing? 
 
⃝ Yes, I need help for 
almost everything=0 
 
⃝ Yes, I am able to do about 
half unaided=5 
 





















7. How do you get up 
and down the stairs? 
 
⃝ No at all=0 
 






















8. Do you need help 

















9. Are you incontinent 
of bowels?  
 
⃝ Yes, incontinent=0 
 
⃝ Occasional accident (once 
per week)=5 
 





















10. Are you of 
incontinent of urine?  
 
⃝ Yes, incontinent or I have 
or the participant has a 
catheter fixed=0 
 
⃝ Occasional accident 
(maximum once per 24 
hours)=5 
 


























Say “Mr/Mrs ……………, this is the end of the interview. We will review the response and will get back to you if 
necessary. All the information given here is strictly confidential and is accessible only to the researchers in this 
project. We would like to say thank you very much for your cooperation” 






















Appendix H: Methods to deal with informative censoring  
Gamma imputation method 
The gamma imputation method quantifies the sensitivity of the conclusion from a fitted Cox 
proportional hazards model when the independent censoring is in doubt, rather than focusing 
on the reasons why the assumption of independent censoring may be false (Jackson et al., 
2014). It uses intuition that censoring associates with the severity of a person’s condition. By 
modelling the resulting association between censoring and failure, investigators gain an 
informed view of the model’s assumptions and the plausible range of sensitivity parameter or 
parameters (Burkoff et al., 2016a).  
Consider a time to event data set where subject i has time to event Ti and is censored 
at time Ci. Each subject has an observed time Yi = min(Ci; Ti) and event indicator δi  where δi = 
1 when Ti  < Ci and  δi = 0 otherwise. The multiple imputation procedure generates M imputed 
datasets where subjects who were censored now have an imputed time i
m
i YT   and a new 
event indicator  
m




iT ,  are imputed under the assumption that at the 
point of censoring the log-hazard function jumps by a constant denoted by i .  With 0i
, the independent censoring assumption has been relaxed. The user can vary the size and 
magnitude of i  to run analyses on each   i value. Based on the differences amongst 
parameter estimates from different  i  , the user can then assess the importance of these 
differences. For example, standard survival analysis can be applied to each data-set from M 
imputed data sets. Finally, the resulting parameters estimates are combined using Rubin’s 
rules.   
The approach assumes that the hazard for failure, given that censoring has not yet 




  )exp()(,,| ),0( isiii ZthSZtCth i   
where iZ are time-independent covariates for subject i,  iS is the stratum for subject 
i, )(),0( th is  is the baseline hazard function for the stratum denoted by iS  and β are the 
regression coefficients. This model can be fitted to the observed data using partial likelihood 
in the standard way. 
After censoring has occurred it is assumed that,  
  )exp()exp()(,,| ),0( iisiii ZthSZtCth i  , 
therefore if i  > 0 there is an elevated risk for failure after censoring and if i  < 0 there 
is a decreased risk after censoring (Jackson et al., 2014, Burkoff et al., 2016a). The parameter 
i represents the change in log-hazard for failure following censoring, conditional on the 
covariates in the imputation model.  
The user must specify the number of imputations to be generated. Too small a number 
will lead to non-negligible simulation variability. The user hence may use his/her personal 
judgment to determine acceptable precision. The Cox model will then be fitted to a bootstrap 
sample of the original data set.  
Given that a subject in stratum Si   and with covariates Zi, was censored at time Ci so δi 
= 0, an imputed failure time (> Ci ) is sampled from the model  
  )exp()(,,|
_




Where ),0( isjh and 
_
j are from the model fit associated with the bootstrapped sample 
j. If the imputed time is > Fi  (Fi is the maximum follow up period) then a time of Fi   and event 
indicator δi = 0 are imputed.  
Risk score multiple imputation method 
Consider a two-arm time-to-event data-set where subject i has event time Ti and potential 
censoring time Ci. For each subject we observe a time Xi = min(Ci; Ti) and event indicator Δi 
which = 1 if the subject was observed to have had an event at Xi and = 0 otherwise. The 
independent censoring assumption states that Ti and Ci are independent, and when this 
assumption is violated, standard methods for inference are in general invalidated. 
The risk score imputation approach creates multiple imputations of event times for 
those subjects whose event times were censored. The imputation procedure utilizes subject-
level covariates, including time-varying covariates, which are known or believed to be related 
to the hazard of failure and/or the hazard of censoring.   
 In risk score imputation, the method works by generating m imputed event times 
i
m
i XY   and event indicators 
m




iY , is imputed by creating a risk set of 
similar subjects to subject i and then using a procedure called Kaplan-Meier imputation (KMI). 
Once the M data sets have been imputed, standard time to event statistical analyses (for 
example the log rank test) can be applied to each data set and the results combined (as 
described below) to produce point estimates of model parameters or to perform a hypothesis 
test (e.g. of equality of survivor functions). 
 Generally, this method involves these 3 steps: a) calculation of risk set, b) Kaplan-




 When calculating the risk set, we first calculate (for each censored subject) a risk set 
),( NNiR   which contains the nearest NN subjects to subject I (in the same treatment group) 
with event/censoring time greater than Xi where NN is a user specified number. In the 
calculation of the risk sets, the separate treatment groups are considered independently.  
 Next, we use Kaplan-Meier estimates to impute  mi
m
iY , . By sampling from the 
Kaplan-Meier estimator of the survivor function for subjects in the risk set.  
 To ensure that the multiple imputations are proper, we then perform a bootstrapping 
step.  For each imputed data set, proportional hazard models are fitted to a bootstrapped data 
set and risk scores are calculated. These scores can then be used for risk set identification for 
subject i.  
Software package for multiple imputation in time-to-event data 
Standard software assumes independent censoring, conditional on the covariates in the 
analysis model. This assumption is untestable and doubtful for individuals censored before the 
scheduled end of the study. Procedures that relax this assumption will often be useful.  
In R, the ‘InformativeCensoring’ package perform methods of multiple imputation for 
time-to-event data when the non-informative censoring assumption is violated. This might be 
true if the reason for censoring is related to the failure process. The package provides two 
methods of multiple imputation: 
a) Non-parametric multiple imputation that enables nonparametric comparison of two 
survival functions with dependent censoring (Hsu and Taylor, 2009) – the risk-score 




b) Multiple imputation that allows the Cox proportional hazard method to be used with 
independent censoring assumption  (Burkoff et al., 2016a, Jackson et al., 2014) – the 
gamma-imputation method  
In both methods, the user relaxes the assumption of non-informative censoring to one of 
being non-informative conditional on the imputation model. To maintain the robustness and 
valid inferences, the Cox models should of course be correctly specified, and the conditional 
non-informative censoring assumption  satisfied (Bartlett, 2016).  
Assessing non-informative censoring in our data 
One of several possible models for informative censoring is to assume that both the 
censoring and failure times, C and F, for a patient depend on an unobserved variable U, but 
are conditionally independent given U (see Figure H-1). If we can know the value of U for each 
patient, i.e. if it becomes an observed covariate, C and F are independent and an analysis that 
includes this covariate the censoring is no longer informative. 
Next, we will show (through Cox Proportional Hazard (PH) and reversed Cox PH) how 
each of C and F depends on our observed covariate, e.g. Glasgow Coma Scale and stroke 
subtypes. We aim to estimate the relationship between the covariates with the censored 







Figure H.1. C=censoring time, F=failure time. Censoring is informative if U is unobserved, 
non-informative if U is observed covariate. 
In Table H.1, we model our data using the Cox Proportional Hazard (PH) model and in 
Table H.2, we run the reversed Cox proportional hazard model in which the roles of the 
censoring and failure times are reversed. In the Cox PH analysis, patients who died during 
admission (n= 53) were treated as the failure cases and those alive at discharge (n= 173) as 
censored cases. In the reverse Cox PH model, we run the analysis with patients who died 
during admission treated as the censored cases and patients who were discharged alive as 
failures. In both Cox PH models, The Glasgow Coma Scale (GCS) and the stroke subtype remain 
as significant and important predictors for in-hospital stroke fatality (both p-values < 0.001). 
Age however was significant at 5% level in the Cox PH model but not in the reverse Cox PH 
model. This does make sense because between the three (GCS, stroke subtype and age), GCS 
and stroke are the two most clinically plausible predictors for in-hospital stroke fatality.  It also 
underlines the importance of including both covariates to make the assumption of non-
informative censoring more plausible.  
We used a similar procedure to compare the prognostic effect between Ischaemic 
Stroke (IS) and Haemorrhagic Stroke (HS). In this analysis, we have three categories of 
outcome: 1) died during admission (n= 84), 2) discharged alive (n= 206) and 3) discharged at-




requested hospital discharge against the physicians or surgeons’ advice. But both had full 
Glasgow Coms Scale (full consciousness) based on our data.  
We ran the Cox PH model first with patients who died during admission set as failure 
cases and patients either discharged alive or aor set as censor cases. We show the results in 
Table H.3. Next, we ran the reversed Cox PH model, treating patients who were discharged 
alive and aor discharge as failure cases and patients who died during admission as censored 
cases. The results are shown in Table H.4.  
The results in Table H.4 are in reverse of that of Table H.3. In both tables, stroke 
subtype remains as an important prognostic variable for in-hospital stroke fatality and all p-
values are still less than 0.001.  
In all the four analysis that we have performed above, we found that the censored 
events (C) and failure events (F) depends on the observed covariates (U), especially the 
Glasgow Coma Scale (GCS) and stroke subtypes (see Figure H-1). In daily clinical practice, GCS 
and stroke subtypes are known as the two most important predictors in stroke fatality. 
Physicians have long used them to guide in their stroke care. We believe the shared 
dependency shown in our Cox PH and reverse Cox PH models increases the plausibility (but 






Table H.1 The regression coefficients and adjusted hazard ratios estimated from the Cox 







r 95% CIc 
Uppe
r 95% CIc 
p-
value Best model (Model 1) 
 








n=225       




0.77 0.88 <0.001 
Age (years) 0.03 1.03 0.0
1 
1.01 1.05 0.011 






n=226       
Haemorrhagic  0.88 2.40 0.7
5 
1.30 4.44 0.005 




Age (years) 0.03 1.03 0.0
1 
1.01 1.05 0.014 
a hazard ratios obtained from the multivariable Cox PH regression  b standard error for hazard 
ratio.  
c confidence interval. Alive = censor cases (coded = 0), Dead = failure cases (coded = 1)  
 
Table H.2 The regression coefficients and adjusted hazard ratios estimated from the 
reversed Cox proportional hazard model. 
 
Beta Adj HR a Lower 
95% HR CIc  
Upper 
95% HR CIc 
p-value 
Best model (Model 1) 
 








n=225      
Glasgow Coma Scale (GCS) 0.18 1.20 1.13 1.27 <0.001 
Age (years) 0.01 1.01 1.00 1.02 0.107 




n=226      
Haemorrhagic  -1.19 0.31 0.21 0.44 <0.001 
Non-haemorrhagic 0 1.00   
 
Age (years) 0.005 1.01 1.00 1.02 0.369 
a hazard ratios obtained from the inverse multivariable Cox PH regression  b standard error for 






Table H.3 The crude hazard ratios (HR) and adjusted HR (adjusted for age then sex), standard 
errors and 95% confidence intervals for HR estimated using the Cox proportional hazard 
regression model. The haemorrhagic stroke (HS) was compared against the cerebral 
infarction (CI as the baseline group). Only results for stroke subtypes are shown   












R a  
Lower 95% CI c 



















   
stroke 
















   
stroke 
















   
a HR=Hazard ratio b SE=Standard error for HR c CI=confidence interval for HR d HS=Haemorrhagic 
stroke e CI=cerebral infarction. In Cox model, the dead = failure cases (coded =1) and the alive or at-
own-risk (aor) discharge = censor cases (coded = 0) 
 
Table H.4 The crude hazard ratios (HR) and adjusted HR (adjusted for age then sex), standard 
errors and 95% confidence intervals for HR estimated using the reversed Cox proportional 
hazard regression model. The haemorrhagic stroke (HS) was compared against the cerebral 
infarction (CI as the baseline group). Only results for stroke subtypes are shown   
Covariates   n B
eta 
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R a  
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stroke 
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stroke 














0 1    
a HR=Hazard ratio b SE=Standard error for HR c CI=confidence interval for HR d HS=Haemorrhagic 
stroke e CI=cerebral infarction. In inverse Cox model, the alive or at-own-risk (aor) discharge = failure 
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